eHDSI Terminologies
0.1.0 - ci-build
eHDSI Terminologies, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/EHDSI-Terminology-package/ and changes regularly. See the Directory of published versions
| Official URL: http://terminology.ehdsi.eu/ValueSet/eHDSIActiveIngredient | Version: 0.1.0 | |||
| Draft as of 2024-11-29 | Computable Name: EHDSIActiveIngredient | |||
| Other Identifiers: OID:1.3.6.1.4.1.12559.11.10.1.3.1.42.24 | ||||
The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet eHDSIActiveIngredient
http://www.whocc.no/atc| Code | Display |
| A01AA03 | olaflur |
| A01AB12 | hexetidine |
| A01AD | Other agents for local oral treatment |
| A01AD08 | becaplermin |
| A02AA | Magnesium compounds |
| A02AB02 | algeldrate |
| A02AB10 | combinations |
| A02AG | Antacids with antispasmodics |
| A02AH | Antacids with sodium bicarbonate |
| A02BA06 | roxatidine |
| A02BB02 | enprostil |
| A02BC | Proton pump inhibitors |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BX01 | carbenoxolone |
| A02BX06 | proglumide |
| A02BX07 | gefarnate |
| A02BX09 | acetoxolone |
| A02BX11 | troxipide |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03AB13 | bevonium |
| A03AB15 | diphemanil |
| A03AB18 | prifinium bromide |
| A03AD01 | papaverine |
| A03AE03 | cilansetron |
| A03AX | Other drugs for functional gastrointestinal disorders |
| A03AX01 | fenpiprane |
| A03AX06 | idanpramine |
| A03AX10 | isometheptene |
| A03BA03 | hyoscyamine |
| A03BB02 | methylatropine |
| A03BB06 | homatropine methylbromide |
| A03CA05 | glycopyrronium bromide and psycholeptics |
| A03CB03 | atropine and psycholeptics |
| A03CB04 | homatropine methylbromide and psycholeptics |
| A03FA02 | cisapride |
| A03FA03 | domperidone |
| A03FA06 | clebopride |
| A04AA | Serotonin (5HT3) antagonists |
| A05AA03 | cholic acid |
| A05AX | Other drugs for bile therapy |
| A06AA01 | liquid paraffin |
| A06AB05 | castor oil |
| A06AB53 | dantron, combinations |
| A06AD02 | magnesium oxide |
| A06AD21 | sodium tartrate |
| A06AG01 | sodium phosphate |
| A06AG02 | bisacodyl |
| A06AG04 | glycerol |
| A06AH | Peripheral opioid receptor antagonists |
| A07A | INTESTINAL ANTIINFECTIVES |
| A07AA04 | streptomycin |
| A07AA06 | paromomycin |
| A07AA08 | kanamycin |
| A07AA09 | vancomycin |
| A07BA | Charcoal preparations |
| A07BC05 | diosmectite |
| A07DA05 | loperamide oxide |
| A07EB | Antiallergic agents, excl. corticosteroids |
| A07EC02 | mesalazine |
| A07XA01 | albumin tannate |
| A08AX01 | rimonabant |
| A09AB02 | betaine hydrochloride |
| A09AB04 | citric acid |
| A10AB04 | insulin lispro |
| A10AD02 | insulin (beef) |
| A10AE01 | insulin (human) |
| A10AE05 | insulin detemir |
| A10AE07 | insulin icodec |
| A10BB01 | glibenclamide |
| A10BB02 | chlorpropamide |
| A10BD11 | metformin and linagliptin |
| A10BF | Alpha glucosidase inhibitors |
| A10BF03 | voglibose |
| A10BX06 | benfluorex |
| A10BX15 | imeglimin |
| A11AA02 | multivitamins and calcium |
| A11AA04 | multivitamins and trace elements |
| A11CA02 | betacarotene |
| A11CC | Vitamin D and analogues |
| A11DA | Vitamin B1, plain |
| A11DA03 | benfotiamine |
| A11GA01 | ascorbic acid (vit C) |
| A11HA31 | calcium pantothenate |
| A12AA05 | calcium lactate |
| A12AA08 | calcium glycerylphosphate |
| A12AA10 | calcium glucoheptonate |
| A12AX | Calcium, combinations with vitamin D and/or other drugs |
| A12CA02 | sodium sulfate |
| A12CC02 | magnesium sulfate |
| A12CD02 | sodium monofluorophosphate |
| A12CE | Selenium |
| A14AA | Androstan derivatives |
| A16AB04 | agalsidase beta |
| A16AB20 | pegunigalsidase alfa |
| A16AB27 | pabinafusp alfa |
| A16AX | Various alimentary tract and metabolism products |
| A16AX09 | glycerol phenylbutyrate |
| A16AX15 | telotristat |
| A16AX19 | fosdenopterin |
| B01AA03 | warfarin |
| B01AB51 | heparin, combinations |
| B01AC15 | aloxiprin |
| B01AC19 | beraprost |
| B01AD01 | streptokinase |
| B01AD03 | anistreplase |
| B01AD12 | protein C |
| B01AE | Direct thrombin inhibitors |
| B01AF02 | apixaban |
| B01AX | Other antithrombotic agents |
| B02BC01 | absorbable gelatin sponge |
| B02BD07 | coagulation factor XIII |
| B02BD16 | etranacogene dezaparvovec |
| B03AC | Iron, parenteral preparations |
| B03AD04 | ferric oxide polymaltose complexes and folic acid |
| B03AE | Iron in other combinations |
| B03AE01 | iron, vitamin B12 and folic acid |
| B03AE03 | iron and multivitamins |
| B03BA | Vitamin B12 (cyanocobalamin and analogues) |
| B03BB | Folic acid and derivatives |
| B03XA07 | daprodustat |
| B05BA02 | fat emulsions |
| B05BA04 | protein hydrolysates |
| B05BA10 | combinations |
| B05CA01 | cetylpyridinium |
| B05CA10 | combinations |
| B05CB10 | combinations |
| B05CX04 | mannitol |
| B05XB01 | arginine hydrochloride |
| B05Z | HEMODIALYTICS AND HEMOFILTRATES |
| B05ZA | Hemodialytics, concentrates |
| B06AA03 | hyaluronidase |
| B06AA04 | chymotrypsin |
| B06AB | Heme products |
| B06AC | Drugs used in hereditary angioedema |
| B06AC06 | berotralstat |
| C01A | CARDIAC GLYCOSIDES |
| C01AA07 | deslanoside |
| C01AA08 | metildigoxin |
| C01AA52 | acetyldigoxin, combinations |
| C01AB51 | proscillaridin, combinations |
| C01B | ANTIARRHYTHMICS, CLASS I AND III |
| C01BA71 | quinidine, combinations with psycholeptics |
| C01CA | Adrenergic and dopaminergic agents |
| C01CA05 | norfenefrine |
| C01CA09 | metaraminol |
| C01CE | Phosphodiesterase inhibitors |
| C01CE03 | enoximone |
| C01CX | Other cardiac stimulants |
| C01DA55 | pentaerithrityl tetranitrate, combinations |
| C01DX11 | trapidil |
| C01DX15 | cloridarol |
| C01EB10 | adenosine |
| C01EB15 | trimetazidine |
| C01EX | Other cardiac combination products |
| C02AA53 | combinations of rauwolfia alkoloids, combinations |
| C02AC | Imidazoline receptor agonists |
| C02AC01 | clonidine |
| C02CC03 | guanoxan |
| C02CC06 | guanazodine |
| C02DA01 | diazoxide |
| C02KB01 | metirosine |
| C02KN01 | aprocitentan |
| C02KX | Antihypertensives for pulmonary arterial hypertension |
| C02KX03 | sitaxentan |
| C02KX04 | macitentan |
| C02LA71 | reserpine and diuretics, combinations with psycholeptics |
| C02LC | Imidazoline receptor agonists in combination with diuretics |
| C02LE01 | prazosin and diuretics |
| C02LG03 | picodralazine and diuretics |
| C02LG51 | dihydralazine and diuretics, combinations with other drugs |
| C03AB01 | bendroflumethiazide and potassium |
| C03AB05 | polythiazide and potassium |
| C03AX01 | hydrochlorothiazide, combinations |
| C03BB | Sulfonamides and potassium in combination |
| C03BB07 | clofenamide and potassium |
| C03C | HIGH-CEILING DIURETICS |
| C03CB01 | furosemide and potassium |
| C03CD | Pyrazolone derivatives |
| C03EA02 | trichlormethiazide and potassium-sparing agents |
| C03EA06 | chlortalidone and potassium-sparing agents |
| C03XA01 | tolvaptan |
| C04AA | 2-amino-1-phenylethanol derivatives |
| C04AD04 | etofylline nicotinate |
| C04AE01 | ergoloid mesylates |
| C04AE04 | dihydroergocristine |
| C04AX01 | cyclandelate |
| C04AX19 | suloctidil |
| C04AX21 | naftidrofuryl |
| C05AE03 | diltiazem |
| C05AX04 | zinc preparations |
| C05BB01 | monoethanolamine oleate |
| C05BX01 | calcium dobesilate |
| C07AA02 | oxprenolol |
| C07AA03 | pindolol |
| C07AA27 | cloranolol |
| C07AB02 | metoprolol |
| C07AB03 | atenolol |
| C07AB08 | celiprolol |
| C07BA05 | propranolol and thiazides |
| C07BG01 | labetalol and thiazides |
| C07FB07 | bisoprolol and amlodipine |
| C07FX01 | propranolol and other combinations |
| C08 | CALCIUM CHANNEL BLOCKERS |
| C08CA02 | felodipine |
| C08CA17 | levamlodipine |
| C08CA55 | nifedipine, combinations |
| C08CX | Other selective calcium channel blockers with mainly vascular effects |
| C08DA01 | verapamil |
| C08DA02 | gallopamil |
| C08EA | Phenylalkylamine derivatives |
| C08GA01 | nifedipine and diuretics |
| C09A | ACE INHIBITORS, PLAIN |
| C09AA | ACE inhibitors, plain |
| C09AA16 | imidapril |
| C09BA06 | quinapril and diuretics |
| C09BB02 | enalapril and lercanidipine |
| C09BB04 | perindopril and amlodipine |
| C09BX07 | zofenopril and nebivolol |
| C09CA08 | olmesartan medoxomil |
| C09DA04 | irbesartan and diuretics |
| C09DB07 | candesartan and amlodipine |
| C09XA52 | aliskiren and hydrochlorothiazide |
| C09XA54 | aliskiren, amlodipine and hydrochlorothiazide |
| C10AC01 | colestyramine |
| C10AD02 | nicotinic acid |
| C10AD05 | nicotinyl alcohol (pyridylcarbinol) |
| C10AX15 | bempedoic acid |
| C10BA | Combinations of various lipid modifying agents |
| C10BA02 | simvastatin and ezetimibe |
| C10BA04 | simvastatin and fenofibrate |
| C10BA06 | rosuvastatin and ezetimibe |
| C10BX05 | rosuvastatin and acetylsalicylic acid |
| D01AA03 | hachimycin |
| D01AA20 | combinations |
| D01AC04 | chlormidazole |
| D01AC15 | fluconazole |
| D01AC18 | luliconazole |
| D01AE10 | ethyl hydroxybenzoate |
| D01AE14 | ciclopirox |
| D01AE19 | tolciclate |
| D01AE22 | naftifine |
| D01AE54 | undecylenic acid, combinations |
| D01BA01 | griseofulvin |
| D02 | EMOLLIENTS AND PROTECTIVES |
| D02AF | Salicylic acid preparations |
| D02B | PROTECTIVES AGAINST UV-RADIATION |
| D02BA | Protectives against UV-radiation for topical use |
| D03AA | Cod-liver oil ointments |
| D03AX09 | crilanomer |
| D03AX14 | Centella asiatica herba, incl. combinations |
| D04AA10 | promethazine |
| D04AB06 | tetracaine |
| D04AX | Other antipruritics |
| D04AX01 | doxepin |
| D05 | ANTIPSORIATICS |
| D05AD02 | methoxsalen |
| D05AX03 | calcitriol |
| D05B | ANTIPSORIATICS FOR SYSTEMIC USE |
| D06AA | Tetracycline and derivatives |
| D06BA01 | silver sulfadiazine |
| D07A | CORTICOSTEROIDS, PLAIN |
| D07BA01 | prednisolone and antiseptics |
| D07BA04 | hydrocortisone and antiseptics |
| D07BB01 | flumetasone and antiseptics |
| D07CC01 | betamethasone and antibiotics |
| D07CD01 | clobetasol and antibiotics |
| D07XB02 | triamcinolone |
| D07XB04 | fluorometholone |
| D07XB05 | dexamethasone |
| D07XD | Corticosteroids, very potent, other combinations |
| D08AA01 | ethacridine lactate |
| D08AB | Aluminium agents |
| D08AC02 | chlorhexidine |
| D08AC05 | polihexanide |
| D08AD | Boric acid products |
| D08AG01 | iodine/octylphenoxypolyglycolether |
| D08AH03 | oxyquinoline |
| D08AJ05 | benzoxonium chloride |
| D08AK06 | thiomersal |
| D08AL01 | silver nitrate |
| D08AX | Other antiseptics and disinfectants |
| D08AX02 | eosin |
| D08AX06 | potassium permanganate |
| D08AX07 | sodium hypochlorite |
| D08AX53 | propanol, combinations |
| D09AA02 | fusidic acid |
| D09AA04 | phenylmercuric nitrate |
| D09AA11 | benzalkonium |
| D09AB | Zinc bandages |
| D10AE | Peroxides |
| D10BA01 | isotretinoin |
| D10BX | Other anti-acne preparations for systemic use |
| D11AC01 | cetrimide |
| D11AC09 | xenysalate |
| D11AH04 | alitretinoin |
| D11AX08 | tiratricol |
| D11AX16 | eflornithine |
| D11AX26 | caffeine |
| G01AA04 | candicidin |
| G01AA05 | chloramphenicol |
| G01AC | Quinoline derivatives |
| G01AD | Organic acids |
| G01AF15 | butoconazole |
| G01AG | Triazole derivatives |
| G01AX66 | octenidine, combinations |
| G01BC | Quinoline derivatives and corticosteroids |
| G02B | CONTRACEPTIVES FOR TOPICAL USE |
| G03 | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03A | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| G03BA01 | fluoxymesterone |
| G03BB02 | androstanolone |
| G03CA | Natural and semisynthetic estrogens, plain |
| G03CB03 | methallenestril |
| G03CC05 | diethylstilbestrol |
| G03CC06 | estriol |
| G03D | PROGESTOGENS |
| G03DB01 | dydrogesterone |
| G03DB03 | medrogestone |
| G03DC01 | allylestrenol |
| G03FA05 | methylnortestosterone and estrogen |
| G03FA08 | megestrol and estrogen |
| G03FA10 | norgestrel and estrogen |
| G03FA13 | norgestimate and estrogen |
| G03FA14 | dydrogesterone and estrogen |
| G03G | GONADOTROPINS AND OTHER OVULATION STIMULANTS |
| G03GA05 | follitropin alfa |
| G03GA09 | corifollitropin alfa |
| G03XA | Antigonadotropins and similar agents |
| G03XB02 | ulipristal |
| G03XB51 | mifepristone, combinations |
| G03XX | Other sex hormones and modulators of the genital system |
| G04BD06 | propiverine |
| G04BE01 | alprostadil |
| G04BE06 | moxisylyte |
| G04BE08 | tadalafil |
| G04BX03 | acetohydroxamic acid |
| G04BX11 | collagen |
| G04CA51 | alfuzosin and finasteride |
| G04CB | Testosterone-5-alpha reductase inhibitors |
| G04CX | Other drugs used in benign prostatic hypertrophy |
| H01AA01 | corticotropin |
| H01AA02 | tetracosactide |
| H01AB01 | thyrotropin alfa |
| H01AC05 | mecasermin rinfabate |
| H01AX01 | pegvisomant |
| H01BA04 | terlipressin |
| H01BB03 | carbetocin |
| H01CB03 | lanreotide |
| H02AB01 | betamethasone |
| H02AB04 | methylprednisolone |
| H02AB13 | deflazacort |
| H02BX | Corticosteroids for systemic use, combinations |
| H03AA04 | tiratricol |
| H03AA05 | thyroid gland preparations |
| H03B | ANTITHYROID PREPARATIONS |
| H03BC01 | potassium perchlorate |
| H03C | IODINE THERAPY |
| H05A | PARATHYROID HORMONES AND ANALOGUES |
| H05BX01 | cinacalcet |
| J | ANTIINFECTIVES FOR SYSTEMIC USE |
| J01AA02 | doxycycline |
| J01AA03 | chlortetracycline |
| J01AA04 | lymecycline |
| J01AA12 | tigecycline |
| J01AA13 | eravacycline |
| J01BA01 | chloramphenicol |
| J01CA07 | epicillin |
| J01CA12 | piperacillin |
| J01CA17 | temocillin |
| J01CA18 | hetacillin |
| J01CA20 | combinations |
| J01CA51 | ampicillin, combinations |
| J01CE10 | benzathine phenoxymethylpenicillin |
| J01DC05 | cefotetan |
| J01DC12 | cefminox |
| J01DC13 | cefbuperazone |
| J01DD13 | cefpodoxime |
| J01DD64 | cefpodoxime and beta-lactamase inhibitor |
| J01DH02 | meropenem |
| J01DH56 | imipenem, cilastatin and relebactam |
| J01DI02 | ceftaroline fosamil |
| J01E | SULFONAMIDES AND TRIMETHOPRIM |
| J01EC03 | sulfamoxole |
| J01ED20 | combinations |
| J01EE03 | sulfametrole and trimethoprim |
| J01EE05 | sulfadimidine and trimethoprim |
| J01FA08 | troleandomycin |
| J01GA02 | streptoduocin |
| J01GB10 | ribostamycin |
| J01M | QUINOLONE ANTIBACTERIALS |
| J01MA02 | ciprofloxacin |
| J01RA08 | tetracycline and oleandomycin |
| J01RA09 | ofloxacin and ornidazole |
| J01XA | Glycopeptide antibacterials |
| J01XA03 | telavancin |
| J01XA05 | oritavancin |
| J01XC | Steroid antibacterials |
| J01XE03 | furazidin |
| J01XX10 | bacitracin |
| J01XX12 | lefamulin |
| J02 | ANTIMYCOTICS FOR SYSTEMIC USE |
| J02AC04 | posaconazole |
| J02AX | Other antimycotics for systemic use |
| J02AX05 | micafungin |
| J02AX07 | ibrexafungerp |
| J04AA02 | sodium aminosalicylate |
| J04AB01 | cycloserine |
| J04AB03 | rifamycin |
| J04AK | Other drugs for treatment of tuberculosis |
| J04AM | Combinations of drugs for treatment of tuberculosis |
| J04AM01 | streptomycin and isoniazid |
| J04BA02 | dapsone |
| J05AB11 | valaciclovir |
| J05AD02 | fosfonet |
| J05AE01 | saquinavir |
| J05AE30 | nirmatrelvir and ritonavir |
| J05AF04 | stavudine |
| J05AF12 | clevudine |
| J05AH04 | laninamivir |
| J05AJ01 | raltegravir |
| J05AP11 | grazoprevir |
| J05AP55 | sofosbuvir and velpatasvir |
| J05AR03 | tenofovir disoproxil and emtricitabine |
| J05AR16 | lamivudine and raltegravir |
| J05AR21 | dolutegravir and rilpivirine |
| J05AX10 | maribavir |
| J05AX19 | tilorone |
| J06 | IMMUNE SERA AND IMMUNOGLOBULINS |
| J06BC01 | nebacumab |
| J06BD03 | tixagevimab and cilgavimab |
| J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell |
| J07AH01 | meningococcus A, purified polysaccharides antigen |
| J07AH06 | meningococcus B, outer membrane vesicle vaccine |
| J07BB03 | influenza, live attenuated |
| J07BC01 | hepatitis B, purified antigen |
| J07BD | Measles vaccines |
| J07BJ | Rubella vaccines |
| J07BJ01 | rubella, live attenuated |
| J07BX05 | respiratory syncytial virus vaccines |
| J07CA01 | diphtheria-poliomyelitis-tetanus |
| J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |
| J07XA01 | malaria vaccines |
| L01AA01 | cyclophosphamide |
| L01AA08 | prednimustine |
| L01AD07 | ranimustine |
| L01AD08 | uramustine |
| L01BA04 | pemetrexed |
| L01BC06 | capecitabine |
| L01CA01 | vinblastine |
| L01CA06 | vintafolide |
| L01CD01 | paclitaxel |
| L01CD04 | cabazitaxel |
| L01CE01 | topotecan |
| L01EB03 | afatinib |
| L01EB06 | olmutinib |
| L01EB08 | icotinib |
| L01ED02 | ceritinib |
| L01EE03 | binimetinib |
| L01EG02 | everolimus |
| L01EX24 | surufatinib |
| L01F | MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
| L01FD | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors |
| L01FD04 | trastuzumab deruxtecan |
| L01FE03 | necitumumab |
| L01FG02 | ramucirumab |
| L01FX04 | ipilimumab |
| L01FY | Combinations of monoclonal antibodies and antibody drug conjugates |
| L01XF02 | alitretinoin |
| L01XJ02 | sonidegib |
| L01XK01 | olaparib |
| L01XL01 | sitimagene ceradenovec |
| L01XX | Other antineoplastic agents |
| L01XX07 | lonidamine |
| L01XX27 | arsenic trioxide |
| L01XX53 | vosaroxin |
| L02AA01 | diethylstilbestrol |
| L02AB01 | megestrol |
| L02AB02 | medroxyprogesterone |
| L02AE04 | triptorelin |
| L02AE05 | histrelin |
| L02B | HORMONE ANTAGONISTS AND RELATED AGENTS |
| L02BA | Anti-estrogens |
| L02BA02 | toremifene |
| L02BB02 | nilutamide |
| L02BB06 | darolutamide |
| L02BG03 | anastrozole |
| L02BX04 | relugolix |
| L02BX53 | abiraterone and prednisolone |
| L03AA16 | empegfilgrastim |
| L03AB02 | interferon beta natural |
| L03AB15 | ropeginterferon alfa-2b |
| L03AC01 | aldesleukin |
| L03AX | Other immunostimulants |
| L03AX10 | immunocyanin |
| L04AA06 | mycophenolic acid |
| L04AB | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| L04AB02 | infliximab |
| L04AB03 | afelimomab |
| L04AB05 | certolizumab pegol |
| L04AC02 | basiliximab |
| L04AC17 | tildrakizumab |
| L04AF | Janus-associated kinase (JAK) inhibitors |
| L04AG06 | alemtuzumab |
| L04AG15 | divozilimab |
| L04AJ02 | ravulizumab |
| L04AK02 | teriflunomide |
| M01AA | Butylpyrazolidines |
| M01AB15 | ketorolac |
| M01AE08 | pirprofen |
| M01AE16 | alminoprofen |
| M01AX05 | glucosamine |
| M01AX21 | diacerein |
| M01CA | Quinolines |
| M01CB03 | auranofin |
| M01CB05 | aurotioprol |
| M02A | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA07 | piroxicam |
| M02AA12 | naproxen |
| M02AA13 | ibuprofen |
| M02AA14 | fentiazac |
| M02AA21 | tolmetin |
| M02AA23 | indometacin |
| M02AA24 | nifenazone |
| M02AC | Preparations with salicylic acid derivatives |
| M03AC01 | pancuronium |
| M03AX01 | botulinum toxin |
| M03BB53 | chlorzoxazone, combinations excl. psycholeptics |
| M03BX02 | tizanidine |
| M03BX09 | eperisone |
| M04A | ANTIGOUT PREPARATIONS |
| M04AA02 | tisopurine |
| M04AB02 | sulfinpyrazone |
| M05 | DRUGS FOR TREATMENT OF BONE DISEASES |
| M05BA06 | ibandronic acid |
| M05BB01 | etidronic acid and calcium, sequential |
| M05BB02 | risedronic acid and calcium, sequential |
| M05BB03 | alendronic acid and colecalciferol |
| M05BX02 | aluminium chlorohydrate |
| M05BX04 | denosumab |
| M05BX05 | burosumab |
| M05BX53 | strontium ranelate and colecalciferol |
| M09AB | Enzymes |
| M09AB03 | bromelains |
| M09AX05 | aceneuramic acid |
| M09AX11 | palovarotene |
| M09AX12 | viltolarsen |
| N01AB01 | halothane |
| N01AB04 | enflurane |
| N01AB06 | isoflurane |
| N01AB08 | sevoflurane |
| N01AF02 | hexobarbital |
| N01AH | Opioid anesthetics |
| N01AX07 | etomidate |
| N01AX10 | propofol |
| N01BA04 | chloroprocaine |
| N01BB04 | prilocaine |
| N01BB58 | articaine, combinations |
| N01BX04 | capsaicin |
| N02AA05 | oxycodone |
| N02AB52 | pethidine, combinations excl. psycholeptics |
| N02AC05 | bezitramide |
| N02AD01 | pentazocine |
| N02AD02 | phenazocine |
| N02AE | Oripavine derivatives |
| N02AG03 | pethidine and antispasmodics |
| N02AJ06 | codeine and paracetamol |
| N02BA16 | imidazole salicylate |
| N02BA77 | ethenzamide, combinations with psycholeptics |
| N02BB51 | phenazone, combinations excl. psycholeptics |
| N02BB71 | phenazone, combinations with psycholeptics |
| N02BE74 | bucetin, combinations with psycholeptics |
| N02BF | Gabapentinoids |
| N02BG | Other analgesics and antipyretics |
| N02BG03 | glafenine |
| N02CB01 | flumedroxone |
| N02CD04 | ubrogepant |
| N02CX | Other antimigraine preparations |
| N02CX01 | pizotifen |
| N03 | ANTIEPILEPTICS |
| N03AC02 | trimethadione |
| N03AF04 | eslicarbazepine |
| N03AX15 | zonisamide |
| N03AX17 | stiripentol |
| N03AX26 | fenfluramine |
| N04AA | Tertiary amines |
| N04AC | Ethers of tropine or tropine derivatives |
| N04BA | Dopa and dopa derivatives |
| N04BA01 | levodopa |
| N04BA02 | levodopa and decarboxylase inhibitor |
| N04BC09 | rotigotine |
| N04BX | Other dopaminergic agents |
| N05AC01 | periciazine |
| N05AD | Butyrophenone derivatives |
| N05AD06 | bromperidol |
| N05BA01 | diazepam |
| N05BA05 | potassium clorazepate |
| N05BA15 | camazepam |
| N05BA17 | fludiazepam |
| N05BA24 | bentazepam |
| N05BA25 | mexazolam |
| N05BC51 | meprobamate, combinations |
| N05C | HYPNOTICS AND SEDATIVES |
| N05CA07 | talbutal |
| N05CA16 | hexobarbital |
| N05CA20 | etallobarbital |
| N05CC01 | chloral hydrate |
| N05CC02 | chloralodol |
| N05CF04 | eszopiclone |
| N05CJ02 | lemborexant |
| N05CM05 | scopolamine |
| N05CM18 | dexmedetomidine |
| N05CX01 | meprobamate, combinations |
| N05CX03 | methylpentynol, combinations |
| N05CX04 | clomethiazole, combinations |
| N06AA02 | imipramine |
| N06AA15 | butriptyline |
| N06AB10 | escitalopram |
| N06AX10 | oxaflozane |
| N06AX15 | pivagabine |
| N06AX16 | venlafaxine |
| N06AX26 | vortioxetine |
| N06AX28 | levomilnacipran |
| N06BA06 | fencamfamin |
| N06BA07 | modafinil |
| N06BA11 | dexmethylphenidate |
| N06BX11 | aniracetam |
| N06BX16 | pramiracetam |
| N06DX03 | aducanumab |
| N07AA03 | distigmine |
| N07AX01 | pilocarpine |
| N07AX03 | cevimeline |
| N07BA01 | nicotine |
| N07BB04 | naltrexone |
| N07BC02 | methadone |
| N07BC03 | levacetylmethadol |
| N07XX04 | sodium oxybate |
| N07XX13 | valbenazine |
| N07XX18 | vutrisiran |
| P01AB07 | secnidazole |
| P01AX07 | trimetrexate |
| P01AX11 | nitazoxanide |
| P01B | ANTIMALARIALS |
| P01BE04 | artemotil |
| P01BF02 | artesunate and mefloquine |
| P01BF07 | artemisinin and piperaquine |
| P01BX01 | halofantrine |
| P01C | AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| P02C | ANTINEMATODAL AGENTS |
| P02CA | Benzimidazole derivatives |
| P02CA06 | fenbendazole |
| P03AC01 | pyrethrum |
| P03AX01 | benzyl benzoate |
| P03BX | Other insecticides and repellents |
| R | RESPIRATORY SYSTEM |
| R01AA03 | ephedrine |
| R01AA06 | tetryzoline |
| R01AA09 | tramazoline |
| R01AC08 | olopatadine |
| R01AD01 | beclometasone |
| R02AA05 | chlorhexidine |
| R02AA12 | hexylresorcinol |
| R02AA21 | octenidine |
| R02AB | Antibiotics |
| R03AC03 | terbutaline |
| R03AC05 | rimiterol |
| R03AC08 | pirbuterol |
| R03AC10 | carbuterol |
| R03AK10 | vilanterol and fluticasone furoate |
| R03CC05 | hexoprenaline |
| R03CC09 | tretoquinol |
| R03CC11 | tulobuterol |
| R03DA04 | theophylline |
| R03DA08 | bamifylline |
| R03DC02 | pranlukast |
| R03DX09 | mepolizumab |
| R03DX10 | benralizumab |
| R05CA02 | potassium iodide |
| R05CA07 | antimony pentasulfide |
| R05CA11 | levoverbenone |
| R05DA06 | normethadone |
| R05DA07 | noscapine |
| R05DA12 | acetyldihydrocodeine |
| R05DB03 | clobutinol |
| R05DB09 | oxeladin |
| R05DB16 | dibunate |
| R05DB18 | prenoxdiazine |
| R05DB29 | gefapixant |
| R05FA01 | opium derivatives and mucolytics |
| R06AA08 | carbinoxamine |
| R06AA09 | doxylamine |
| R06AA10 | trimethobenzamide |
| R06AB01 | brompheniramine |
| R06AB56 | dexbrompheniramine, combinations |
| R06AE07 | cetirizine |
| R06AX | Other antihistamines for systemic use |
| R06AX05 | antazoline |
| R06AX09 | azatadine |
| R06AX11 | astemizole |
| R06AX15 | mebhydrolin |
| R06AX19 | azelastine |
| R06AX58 | pyrrobutamine, combinations |
| R07AA02 | natural phospholipids |
| R07AB02 | nikethamide |
| R07AB07 | almitrine |
| S01AA17 | erythromycin |
| S01AA19 | ampicillin |
| S01AB03 | sulfadicramide |
| S01AB05 | sulfafenazol |
| S01AD09 | ganciclovir |
| S01AE03 | ciprofloxacin |
| S01AE06 | gatifloxacin |
| S01BA03 | cortisone |
| S01CA03 | hydrocortisone and antiinfectives |
| S01CA06 | fludrocortisone and antiinfectives |
| S01CB | Corticosteroids/antiinfectives/mydriatics in combination |
| S01EA01 | epinephrine |
| S01EA04 | clonidine |
| S01EB07 | fluostigmine |
| S01EB10 | paraoxon |
| S01ED | Beta blocking agents |
| S01ED03 | levobunolol |
| S01ED54 | metipranolol, combinations |
| S01ED55 | carteolol, combinations |
| S01EX02 | dapiprazole |
| S01EX07 | ripasudil |
| S01F | MYDRIATICS AND CYCLOPLEGICS |
| S01FB03 | ibopamine |
| S01GA04 | oxymetazoline |
| S01GA51 | naphazoline, combinations |
| S01GX01 | cromoglicic acid |
| S01GX04 | nedocromil |
| S01GX08 | ketotifen |
| S01GX11 | alcaftadine |
| S01GX12 | cetirizine |
| S01HA04 | proxymetacaine |
| S01HA08 | chloroprocaine |
| S01JA02 | rose bengal sodium |
| S01LA01 | verteporfin |
| S01LA02 | anecortave |
| S01XA09 | iodoheparinate |
| S01XA20 | artificial tears and other indifferent preparations |
| S01XA26 | riboflavin |
| S01XA31 | pegcetacoplan |
| S02 | OTOLOGICALS |
| S02AA04 | aluminium acetotartrate |
| S02AA13 | miconazole |
| S02C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S02CA05 | fluocinolone acetonide and antiinfectives |
| S02DA30 | combinations |
| S03AA | Antiinfectives |
| S03AA03 | polymyxin B |
| S03AA07 | ciprofloxacin |
| S03BA01 | dexamethasone |
| S03BA02 | prednisolone |
| V | VARIOUS |
| V01AA11 | animals |
| V03A | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB01 | ipecacuanha |
| V03AB24 | digitalis antitoxin |
| V03AC03 | deferasirox |
| V03AE07 | calcium acetate |
| V03AF | Detoxifying agents for antineoplastic treatment |
| V03AF06 | sodium folinate |
| V03AK | Tissue adhesives |
| V03AN03 | helium |
| V04B | URINE TESTS |
| V04CA | Tests for diabetes |
| V04CG02 | betazole |
| V04CX02 | folic acid |
| V04CX05 | 13C-urea |
| V04CX07 | edrophonium |
| V06A | DIET FORMULATIONS FOR TREATMENT OF OBESITY |
| V06DA | Carbohydrates/proteins/minerals/vitamins, combinations |
| V08A | X-RAY CONTRAST MEDIA, IODINATED |
| V08AA01 | diatrizoic acid |
| V08AB08 | iopentol |
| V08AC06 | iopanoic acid |
| V08BA01 | barium sulfate with suspending agents |
| V08CB01 | ferumoxsil |
| V08CB02 | ferristene |
| V08DA | Ultrasound contrast media |
| V09AB01 | iodine iofetamine (123I) |
| V09BA01 | technetium (99mTc) oxidronic acid |
| V09CA06 | technetium (99mTc) ethylenedicysteine |
| V09D | HEPATIC AND RETICULO ENDOTHELIAL SYSTEM |
| V09DA | Technetium (99mTc) compounds |
| V09EA01 | technetium (99mTc) pentetic acid |
| V09EA02 | technetium (99mTc) technegas |
| V09FX04 | sodium iodide (124I) |
| V09HA02 | technetium (99mTc) exametazime labelled cells |
| V09IA09 | technetium (99mTc) tilmanocept |
| V09IB | Indium (111In) compounds |
| V09IB04 | indium (111In) capromab pendetide |
| V09IX02 | iobenguane (131I) |
| V09IX09 | gallium (68Ga) edotreotide |
| V09IX12 | fluciclovine (18F) |
| V09X | OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| V10AA03 | yttrium (90Y) silicate colloid |
| V10AX05 | rhenium (186Re) sulfide colloid |
| V10BX01 | strontium (89Sr) chloride |
| V10BX02 | samarium (153Sm) lexidronam |
| V10XX04 | lutetium (177Lu) oxodotreotide |
| V10XX05 | lutetium (177Lu) vipivotide tetraxetan |
| A01AB14 | benzoxonium chloride |
| A02AA05 | magnesium silicate |
| A02AC10 | combinations |
| A02BA08 | lafutidine |
| A02BC02 | pantoprazole |
| A02BC05 | esomeprazole |
| A02BD02 | lansoprazole, tetracycline and metronidazole |
| A02BD13 | rabeprazole, amoxicillin and metronidazole |
| A02BX02 | sucralfate |
| A02BX04 | methiosulfonium chloride |
| A02BX16 | irsogladine |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group |
| A03AA30 | piperidolate |
| A03AB10 | hexocyclium |
| A03AB12 | mepenzolate |
| A03AX12 | phloroglucinol |
| A03BB03 | methylscopolamine |
| A03CB01 | methylscopolamine and psycholeptics |
| A03CC | Other antispasmodics in combination with psycholeptics |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA01 | tropenzilone and analgesics |
| A03DA06 | trospium and analgesics |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03FA | Propulsives |
| A03FA01 | metoclopramide |
| A03FA05 | alizapride |
| A04AD05 | metopimazine |
| A05A | BILE THERAPY |
| A05AA04 | obeticholic acid |
| A06AA02 | docusate sodium |
| A06AB06 | senna glycosides |
| A06AB52 | bisacodyl, combinations |
| A06AC01 | ispaghula (psylla seeds) |
| A06AC06 | methylcellulose |
| A06AC07 | triticum (wheat fibre) |
| A06AD | Osmotically acting laxatives |
| A06AD61 | lactulose, combinations |
| A07AC01 | miconazole |
| A07BA51 | medicinal charcoal, combinations |
| A07BC | Other intestinal adsorbents |
| A07BC01 | pectin |
| A07BC03 | crospovidone |
| A07DA06 | eluxadoline |
| A07EA01 | prednisolone |
| A08AA01 | phentermine |
| A08AA08 | clobenzorex |
| A08AA56 | ephedrine, combinations |
| A10AB01 | insulin (human) |
| A10AB03 | insulin (pork) |
| A10AC01 | insulin (human) |
| A10AE06 | insulin degludec |
| A10AE56 | insulin degludec and liraglutide |
| A10BA | Biguanides |
| A10BA02 | metformin |
| A10BB09 | gliclazide |
| A10BB31 | acetohexamide |
| A10BD03 | metformin and rosiglitazone |
| A10BD18 | metformin and gemigliptin |
| A10BD21 | saxagliptin and dapagliflozin |
| A10BD23 | metformin and ertugliflozin |
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BH01 | sitagliptin |
| A10BH03 | saxagliptin |
| A10BH05 | linagliptin |
| A10BH07 | evogliptin |
| A10BH08 | teneligliptin |
| A10BH51 | sitagliptin and simvastatin |
| A10BJ01 | exenatide |
| A10BK08 | bexagliflozin |
| A10BX16 | tirzepatide |
| A10X | OTHER DRUGS USED IN DIABETES |
| A10XA01 | tolrestat |
| A11CA01 | retinol (vit A) |
| A11CC05 | colecalciferol |
| A11ED | Vitamin B-complex with anabolic steroids |
| A11HA04 | riboflavin (vit B2) |
| A11HA06 | pyridoxal phosphate |
| A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A12AA01 | calcium phosphate |
| A12AA06 | calcium lactate gluconate |
| A12BA30 | potassium (different salts in combination) |
| A12CA | Sodium |
| A12CC07 | magnesium levulinate |
| A12CC09 | magnesium orotate |
| A12CD | Fluoride |
| A13 | TONICS |
| A13A | TONICS |
| A14AA03 | metandienone |
| A14AA04 | metenolone |
| A14AA07 | prasterone |
| A14AA08 | oxandrolone |
| A16AA01 | levocarnitine |
| A16AA03 | glutamine |
| A16AB | Enzymes |
| A16AB01 | alglucerase |
| A16AB05 | laronidase |
| A16AB13 | asfotase alfa |
| A16AB23 | cipaglucosidase alfa |
| A16AB24 | pegzilarginase |
| A16AX02 | anethole trithione |
| B | BLOOD AND BLOOD FORMING ORGANS |
| B01A | ANTITHROMBOTIC AGENTS |
| B01AA04 | phenprocoumon |
| B01AA10 | diphenadione |
| B01AC01 | ditazole |
| B01AC03 | picotamide |
| B01AC05 | ticlopidine |
| B01AC13 | abciximab |
| B01AC17 | tirofiban |
| B01AC24 | ticagrelor |
| B01AD | Enzymes |
| B01AE07 | dabigatran etexilate |
| B02AB01 | aprotinin |
| B02BA | Vitamin K |
| B02BA01 | phytomenadione |
| B02BC08 | calcium alginate |
| B02BX | Other systemic hemostatics |
| B02BX03 | batroxobin |
| B02BX05 | eltrombopag |
| B02BX06 | emicizumab |
| B03AA05 | ferrous chloride |
| B03AA11 | ferrous iodine |
| B03AB | Iron trivalent, oral preparations |
| B03AB04 | ferric hydroxide |
| B03BA53 | hydroxocobalamin, combinations |
| B03BB51 | folic acid, combinations |
| B03X | OTHER ANTIANEMIC PREPARATIONS |
| B03XA01 | erythropoietin |
| B03XA05 | roxadustat |
| B05AA01 | albumin |
| B05AA10 | hemoglobin glutamer (bovine) |
| B05AX02 | thrombocytes |
| B05AX04 | stem cells from umbilical cord blood |
| B05BB03 | trometamol |
| B05BC01 | mannitol |
| B05CA03 | nitrofural |
| B05CB | Salt solutions |
| B05CX03 | glycine |
| B05XB02 | alanyl glutamine |
| B05XX02 | trometamol |
| B06AA10 | desoxyribonuclease |
| B06AA55 | streptokinase, combinations |
| C01 | CARDIAC THERAPY |
| C01AA01 | acetyldigitoxin |
| C01AA02 | acetyldigoxin |
| C01AA06 | lanatoside C |
| C01AC03 | cymarin |
| C01BA02 | procainamide |
| C01BA03 | disopyramide |
| C01BA12 | lorajmine |
| C01BB03 | tocainide |
| C01BB04 | aprindine |
| C01BC04 | flecainide |
| C01BC09 | ethacizine |
| C01BD02 | bretylium tosilate |
| C01CA08 | oxedrine |
| C01CA13 | prenalterol |
| C01CA14 | dopexamine |
| C01CA26 | ephedrine |
| C01CA51 | etilefrine, combinations |
| C01CX07 | xamoterol |
| C01DB | Quinolone vasodilators |
| C01DB01 | flosequinan |
| C01DX04 | benziodarone |
| C01DX14 | cinepazet |
| C01DX52 | prenylamine, combinations |
| C01EA01 | alprostadil |
| C01EB04 | crataegus glycosides |
| C01EB09 | ubidecarenone |
| C02AA07 | bietaserpine |
| C02AB | Methyldopa |
| C02AC02 | guanfacine |
| C02B | ANTIADRENERGIC AGENTS, GANGLION-BLOCKING |
| C02BA01 | trimetaphan |
| C02BB01 | mecamylamine |
| C02CA | Alpha-adrenoreceptor antagonists |
| C02CC07 | guanoxabenz |
| C02DA | Thiazide derivatives |
| C02DC | Pyrimidine derivatives |
| C02DG | Guanidine derivatives |
| C02LA09 | syrosingopine and diuretics |
| C03AA | Thiazides, plain |
| C03AA06 | trichlormethiazide |
| C03AA07 | cyclopenthiazide |
| C03AB07 | cyclopenthiazide and potassium |
| C03AB09 | cyclothiazide and potassium |
| C03AH01 | chlorothiazide, combinations |
| C03AH02 | hydroflumethiazide, combinations |
| C03B | LOW-CEILING DIURETICS, EXCL. THIAZIDES |
| C03BA03 | clopamide |
| C03BA08 | metolazone |
| C03BA12 | clorexolone |
| C03BD01 | theobromine |
| C03CA | Sulfonamides, plain |
| C03CB02 | bumetanide and potassium |
| C03D | ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS |
| C03EA04 | altizide and potassium-sparing agents |
| C04AC03 | inositol nicotinate |
| C04AC07 | ciclonicate |
| C04AE | Ergot alkaloids |
| C04AX | Other peripheral vasodilators |
| C04AX17 | vinburnine |
| C04AX30 | azapetine |
| C05AA09 | dexamethasone |
| C05AA11 | fluocinonide |
| C05AD | Local anesthetics |
| C05AE01 | glyceryl trinitrate |
| C05CA05 | hidrosmin |
| C07AA | Beta blocking agents, non-selective |
| C07AB | Beta blocking agents, selective |
| C07AG01 | labetalol |
| C07B | BETA BLOCKING AGENTS AND THIAZIDES |
| C07BB12 | nebivolol and thiazides |
| C07CA02 | oxprenolol and other diuretics |
| C07DA06 | timolol, thiazides and other diuretics |
| C07FB | Beta blocking agents and calcium channel blockers |
| C08CA01 | amlodipine |
| C08CA51 | amlodipine and celecoxib |
| C08EX | Other non-selective calcium channel blockers |
| C09AA10 | trandolapril |
| C09AA12 | delapril |
| C09AA13 | moexipril |
| C09BA | ACE inhibitors and diuretics |
| C09BA01 | captopril and diuretics |
| C09BA05 | ramipril and diuretics |
| C09BA08 | cilazapril and diuretics |
| C09BA15 | zofenopril and diuretics |
| C09BX01 | perindopril, amlodipine and indapamide |
| C09BX02 | perindopril and bisoprolol |
| C09BX04 | perindopril, bisoprolol and amlodipine |
| C09C | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN |
| C09CA05 | tasosartan |
| C09CA10 | fimasartan |
| C09DA06 | candesartan and diuretics |
| C09DB04 | telmisartan and amlodipine |
| C09DX03 | olmesartan medoxomil, amlodipine and hydrochlorothiazide |
| C09XA02 | aliskiren |
| C10 | LIPID MODIFYING AGENTS |
| C10AB01 | clofibrate |
| C10AB06 | simfibrate |
| C10AD01 | niceritrol |
| C10AD03 | nicofuranose |
| C10AX | Other lipid modifying agents |
| C10AX07 | magnesium pyridoxal 5-phosphate glutamate |
| C10AX11 | mipomersen |
| C10AX17 | evinacumab |
| C10AX18 | volanesorsen |
| C10BA10 | bempedoic acid and ezetimibe |
| C10BX02 | pravastatin and acetylsalicylic acid |
| C10BX07 | rosuvastatin, amlodipine and lisinopril |
| C10BX11 | atorvastatin, amlodipine and perindopril |
| C10BX17 | rosuvastatin and ramipril |
| D01AA04 | pecilocin |
| D01AC02 | miconazole |
| D01AC06 | tiabendazole |
| D01AC13 | omoconazole |
| D01AC52 | miconazole, combinations |
| D01AE15 | terbinafine |
| D02AA | Silicone products |
| D02AC | Soft paraffin and fat products |
| D02BB | Protectives against UV-radiation for systemic use |
| D03AX12 | trolamine |
| D03AX16 | beremagene geperpavec |
| D04AB07 | pramocaine |
| D05AX | Other antipsoriatics for topical use |
| D05AX06 | roflumilast |
| D05BA02 | methoxsalen |
| D06AX01 | fusidic acid |
| D06BA05 | sulfanilamide |
| D06BB02 | tromantadine |
| D06BB03 | aciclovir |
| D06BB11 | docosanol |
| D06BX | Other chemotherapeutics |
| D07AA03 | prednisolone |
| D07AB01 | clobetasone |
| D07AB02 | hydrocortisone butyrate |
| D07AB03 | flumetasone |
| D07AB05 | fluperolone |
| D07AC21 | ulobetasol |
| D07BB03 | triamcinolone and antiseptics |
| D07CC03 | fludroxycortide and antibiotics |
| D07CC06 | fluocortolone and antibiotics |
| D08AA03 | euflavine |
| D08AE03 | phenol |
| D08AE04 | triclosan |
| D08AG03 | iodine |
| D08AJ | Quaternary ammonium compounds |
| D08AX01 | hydrogen peroxide |
| D08AX03 | propanol |
| D09A | MEDICATED DRESSINGS |
| D09AA | Medicated dressings with antiinfectives |
| D09AA01 | framycetin |
| D09AA05 | benzododecinium |
| D09AA06 | triclosan |
| D09AB02 | zinc bandage with supplements |
| D10AB05 | mesulfen |
| D10AD05 | motretinide |
| D10AF04 | meclocycline |
| D10AF52 | erythromycin, combinations |
| D11AC | Medicated shampoos |
| D11AC03 | selenium compounds |
| D11AH07 | tralokinumab |
| D11AH08 | abrocitinib |
| D11AH10 | lebrikizumab |
| D11AH12 | nemolizumab |
| D11AX03 | calcium gluconate |
| D11AX27 | oxymetazoline |
| G01AA01 | nystatin |
| G01AA02 | natamycin |
| G01AC02 | clioquinol |
| G01AF12 | fenticonazole |
| G01AF18 | flutrimazole |
| G01AF20 | combinations of imidazole derivatives |
| G01AX06 | furazolidone |
| G01AX12 | ciclopirox |
| G02AC | Ergot alkaloids and oxytocin incl. analogues, in combination |
| G02BA01 | plastic IUD |
| G02CC | Antiinflammatory products for vaginal administration |
| G02CC02 | naproxen |
| G02CC03 | benzydamine |
| G02CX05 | bremelanotide |
| G03AA | Progestogens and estrogens, fixed combinations |
| G03AA04 | megestrol and ethinylestradiol |
| G03AA05 | norethisterone and ethinylestradiol |
| G03AA12 | drospirenone and ethinylestradiol |
| G03AA17 | medroxyprogesterone and estradiol |
| G03AB | Progestogens and estrogens, sequential preparations |
| G03AB06 | gestodene and ethinylestradiol |
| G03AC05 | megestrol |
| G03AC07 | norgestrienone |
| G03AC08 | etonogestrel |
| G03BA02 | methyltestosterone |
| G03BB | 5-androstanon (3) derivatives |
| G03C | ESTROGENS |
| G03CB04 | moxestrol |
| G03CC07 | conjugated estrogens and bazedoxifene |
| G03DB06 | chlormadinone |
| G03DC | Estren derivatives |
| G03EA01 | methyltestosterone and estrogen |
| G03FA | Progestogens and estrogens, fixed combinations |
| G03FA07 | lynestrenol and estrogen |
| G03FA09 | noretynodrel and estrogen |
| G03FA11 | levonorgestrel and estrogen |
| G03FA15 | dienogest and estrogen |
| G03FA16 | trimegestone and estrogen |
| G03FA17 | drospirenone and estrogen |
| G03FB | Progestogens and estrogens, sequential preparations |
| G03FB07 | medrogestone and estrogen |
| G03GA08 | choriogonadotropin alfa |
| G03GB01 | cyclofenil |
| G03GB02 | clomifene |
| G04BA01 | ammonium chloride |
| G04BD | Drugs for urinary frequency and incontinence |
| G04BD11 | fesoterodine |
| G04BE52 | papaverine, combinations |
| G04BX13 | dimethyl sulfoxide |
| G04BX16 | tiopronin |
| G04CA02 | tamsulosin |
| G04CB01 | finasteride |
| G04CX02 | Sabalis serrulatae fructus |
| H01AA | ACTH |
| H01AC | Somatropin and somatropin agonists |
| H01AC01 | somatropin |
| H01BA01 | vasopressin (argipressin) |
| H01BA05 | ornipressin |
| H01BB01 | demoxytocin |
| H01CB02 | octreotide |
| H01CC04 | linzagolix |
| H02AB | Glucocorticoids |
| H02AB06 | prednisolone |
| H02AB09 | hydrocortisone |
| H02AB17 | cortivazol |
| H02B | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| H03AA02 | liothyronine sodium |
| H03AA03 | combinations of levothyroxine and liothyronine |
| H03BB | Sulfur-containing imidazole derivatives |
| H03BC | Perchlorates |
| H05AA01 | parathyroid gland extract |
| H05AA03 | parathyroid hormone |
| H05BA02 | calcitonin (pork natural) |
| H05BX | Other anti-parathyroid agents |
| J01AA05 | metacycline |
| J01AA07 | tetracycline |
| J01AA09 | rolitetracycline |
| J01AA14 | sarecycline |
| J01BA | Amphenicols |
| J01C | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| J01CA | Penicillins with extended spectrum |
| J01CA14 | metampicillin |
| J01CE04 | azidocillin |
| J01CE06 | penamecillin |
| J01CR05 | piperacillin and beta-lactamase inhibitor |
| J01D | OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DB02 | cefaloridine |
| J01DC02 | cefuroxime |
| J01DD03 | cefsulodin |
| J01DD06 | latamoxef |
| J01DI04 | cefiderocol |
| J01EB20 | combinations |
| J01ED02 | sulfalene |
| J01ED05 | sulfamethoxypyridazine |
| J01ED08 | sulfaphenazole |
| J01ED09 | sulfamazone |
| J01EE01 | sulfamethoxazole and trimethoprim |
| J01FA06 | roxithromycin |
| J01FA11 | miocamycin |
| J01GA | Streptomycins |
| J01GB | Other aminoglycosides |
| J01GB07 | netilmicin |
| J01GB09 | dibekacin |
| J01MA07 | lomefloxacin |
| J01MA12 | levofloxacin |
| J01MA21 | sitafloxacin |
| J01MB04 | pipemidic acid |
| J01XE51 | nitrofurantoin, combinations |
| J01XX04 | spectinomycin |
| J01XX09 | daptomycin |
| J02A | ANTIMYCOTICS FOR SYSTEMIC USE |
| J04AB06 | enviomycin |
| J04AB30 | capreomycin |
| J04AC01 | isoniazid |
| J04AK06 | delamanid |
| J04AM02 | rifampicin and isoniazid |
| J04AM06 | rifampicin, pyrazinamide, ethambutol and isoniazid |
| J05 | ANTIVIRALS FOR SYSTEMIC USE |
| J05AB03 | vidarabine |
| J05AC02 | rimantadine |
| J05AE03 | ritonavir |
| J05AE09 | tipranavir |
| J05AE10 | darunavir |
| J05AF05 | lamivudine |
| J05AF06 | abacavir |
| J05AF09 | emtricitabine |
| J05AG02 | delavirdine |
| J05AG04 | etravirine |
| J05AG06 | doravirine |
| J05AH02 | oseltamivir |
| J05AH03 | peramivir |
| J05AJ02 | elvitegravir |
| J05AP04 | faldaprevir |
| J05AP51 | sofosbuvir and ledipasvir |
| J05AR06 | emtricitabine, tenofovir disoproxil and efavirenz |
| J05AR07 | stavudine, lamivudine and nevirapine |
| J05AR10 | lopinavir and ritonavir |
| J05AR11 | lamivudine, tenofovir disoproxil and efavirenz |
| J05AR17 | emtricitabine and tenofovir alafenamide |
| J05AR24 | lamivudine, tenofovir disoproxil and doravirine |
| J05AR25 | lamivudine and dolutegravir |
| J05AX | Other antivirals |
| J05AX06 | pleconaril |
| J05AX25 | baloxavir marboxil |
| J05AX28 | bulevirtide |
| J06AA01 | diphtheria antitoxin |
| J06AA03 | snake venom antiserum |
| J06BA | Immunoglobulins, normal human |
| J06BB02 | tetanus immunoglobulin |
| J06BB11 | hepatitis A immunoglobulin |
| J06BB12 | encephalitis, tick borne immunoglobulin |
| J06BC03 | bezlotoxumab |
| J06BD04 | ansuvimab |
| J06BD06 | regdanvimab |
| J07AE02 | cholera, live attenuated |
| J07AG51 | haemophilus influenzae B, combinations with toxoids |
| J07AH07 | meningococcus C, purified polysaccharides antigen conjugated |
| J07AH09 | meningococcus B, multicomponent vaccine |
| J07AP10 | typhoid, combinations with paratyphi types |
| J07BA | Encephalitis vaccines |
| J07BA03 | encephalitis, Japanese, live attenuated |
| J07BE | Mumps vaccines |
| J07BL | Yellow fever vaccines |
| J07BM01 | papillomavirus (human types 6, 11, 16, 18) |
| J07BN05 | covid-19, virus-like particles |
| J07BX | Other viral vaccines |
| J07CA03 | diphtheria-rubella-tetanus |
| J07CA07 | diphtheria-hepatitis B-tetanus |
| J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
| L01AA07 | trofosfamide |
| L01AA09 | bendamustine |
| L01AB02 | treosulfan |
| L01AC | Ethylene imines |
| L01AD03 | semustine |
| L01AG | Epoxides |
| L01BA05 | pralatrexate |
| L01BB07 | nelarabine |
| L01BC04 | carmofur |
| L01BC08 | decitabine |
| L01BC59 | trifluridine, combinations |
| L01CA05 | vinflunine |
| L01CD | Taxanes |
| L01CE | Topoisomerase 1 (TOP1) inhibitors |
| L01CX | Other plant alkaloids and natural products |
| L01D | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| L01DB01 | doxorubicin |
| L01DB05 | zorubicin |
| L01DB09 | valrubicin |
| L01DC01 | bleomycin |
| L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
| L01EB05 | rociletinib |
| L01EC03 | encorafenib |
| L01ED | Anaplastic lymphoma kinase (ALK) inhibitors |
| L01ED03 | alectinib |
| L01EF | Cyclin-dependent kinase (CDK) inhibitors |
| L01EF02 | ribociclib |
| L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
| L01EL04 | orelabrutinib |
| L01EL05 | pirtobrutinib |
| L01EX | Other protein kinase inhibitors |
| L01EX01 | sunitinib |
| L01EX12 | larotrectinib |
| L01EX17 | capmatinib |
| L01FA02 | ofatumumab |
| L01FF02 | pembrolizumab |
| L01FF08 | prolgolimab |
| L01FF09 | tislelizumab |
| L01FG01 | bevacizumab |
| L01FX10 | olaratumab |
| L01FX14 | polatuzumab vedotin |
| L01FX15 | belantamab mafodotin |
| L01FX20 | tremelimumab |
| L01FX28 | glofitamab |
| L01XD01 | porfimer sodium |
| L01XD04 | aminolevulinic acid |
| L01XD06 | efaproxiral |
| L01XH04 | belinostat |
| L01XX23 | mitotane |
| L01XX44 | aflibercept |
| L01XX52 | venetoclax |
| L01XX77 | adagrasib |
| L01XX78 | navitoclax |
| L01XX80 | imetelstat |
| L02AE01 | buserelin |
| L02BB05 | apalutamide |
| L02BG04 | letrozole |
| L02BX03 | abiraterone |
| L03AA14 | lipegfilgrastim |
| L03AB03 | interferon gamma |
| L03AX21 | elapegademase |
| L04AB06 | golimumab |
| L04AC | Interleukin inhibitors |
| L04AC22 | spesolimab |
| L04AJ01 | eculizumab |
| L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors |
| L04AX09 | diroximel fumarate |
| M01AB08 | etodolac |
| M01AC02 | tenoxicam |
| M01AC05 | lornoxicam |
| M01AE11 | tiaprofenic acid |
| M01AE17 | dexketoprofen |
| M01AG03 | flufenamic acid |
| M01AH02 | rofecoxib |
| M01AH06 | lumiracoxib |
| M01BA02 | dipyrocetyl and corticosteroids |
| M01BA03 | acetylsalicylic acid and corticosteroids |
| M01BX | Other antiinflammatory/antirheumatic agents in combination with other drugs |
| M02AA | Antiinflammatory preparations, non-steroids for topical use |
| M02AA04 | oxyphenbutazone |
| M02AA09 | bufexamac |
| M02AA16 | feprazone |
| M02AA22 | suxibuzone |
| M02AB01 | capsaicin |
| M03AA | Curare alkaloids |
| M03AC03 | vecuronium |
| M03AC06 | pipecuronium bromide |
| M03AC10 | mivacurium chloride |
| M03AC11 | cisatracurium |
| M03BA73 | methocarbamol, combinations with psycholeptics |
| M03BC01 | orphenadrine (citrate) |
| M03BX04 | tolperisone |
| M03BX30 | fenyramidol |
| M04AA01 | allopurinol |
| M05BA04 | alendronic acid |
| M05BA05 | tiludronic acid |
| M05BX03 | strontium ranelate |
| M09AB01 | chymopapain |
| N01AA02 | vinyl ether |
| N01AB02 | chloroform |
| N01AF03 | thiopental |
| N01AG | Barbiturates in combination with other drugs |
| N01AH04 | phenoperidine |
| N01AX11 | sodium oxybate |
| N01AX13 | nitrous oxide |
| N01BA02 | procaine |
| N01BB01 | bupivacaine |
| N01BB03 | mepivacaine |
| N01BB51 | bupivacaine, combinations |
| N01BB52 | lidocaine, combinations |
| N02AA03 | hydromorphone |
| N02AA55 | oxycodone and naloxone |
| N02AA79 | codeine, combinations with psycholeptics |
| N02AC | Diphenylpropylamine derivatives |
| N02AC52 | methadone, combinations excl. psycholeptics |
| N02AJ02 | dihydrocodeine and acetylsalicylic acid |
| N02AJ08 | codeine and ibuprofen |
| N02AJ16 | tramadol and celecoxib |
| N02AJ18 | oxycodone and acetylsalicylic acid |
| N02AX | Other opioids |
| N02BA12 | potassium salicylate |
| N02BA59 | dipyrocetyl, combinations excl. psycholeptics |
| N02BB52 | metamizole sodium, combinations excl. psycholeptics |
| N02BB73 | aminophenazone, combinations with psycholeptics |
| N02BE01 | paracetamol |
| N02CA01 | dihydroergotamine |
| N02CC04 | rizatriptan |
| N02CC07 | frovatriptan |
| N02CD01 | erenumab |
| N02CD05 | eptinezumab |
| N02CX05 | dimetotiazine |
| N03AB01 | ethotoin |
| N03AB04 | mephenytoin |
| N03AD01 | ethosuximide |
| N03AF01 | carbamazepine |
| N03AG04 | vigabatrin |
| N03AX07 | phenacemide |
| N03AX09 | lamotrigine |
| N03AX14 | levetiracetam |
| N03AX22 | perampanel |
| N03AX25 | cenobamate |
| N04AA01 | trihexyphenidyl |
| N04AA02 | biperiden |
| N04AB | Ethers chemically close to antihistamines |
| N04BA06 | etilevodopa and decarboxylase inhibitor |
| N04BC02 | pergolide |
| N04BC05 | pramipexole |
| N04BX02 | entacapone |
| N04BX04 | opicapone |
| N04C | OTHER ANTIPARKINSON DRUGS |
| N05AA05 | triflupromazine |
| N05AA07 | chlorproethazine |
| N05AB01 | dixyrazine |
| N05AB02 | fluphenazine |
| N05AB06 | trifluoperazine |
| N05AF01 | flupentixol |
| N05AG03 | penfluridol |
| N05AH | Diazepines, oxazepines, thiazepines and oxepines |
| N05AH04 | quetiapine |
| N05AL02 | sultopride |
| N05AL04 | remoxipride |
| N05BA | Benzodiazepine derivatives |
| N05BA08 | bromazepam |
| N05BA11 | prazepam |
| N05BA23 | tofisopam |
| N05BX02 | gedocarnil |
| N05CA06 | secobarbital |
| N05CB | Barbiturates, combinations |
| N05CB02 | barbiturates in combination with other drugs |
| N05CD02 | nitrazepam |
| N05CD11 | loprazolam |
| N05CE | Piperidinedione derivatives |
| N05CH02 | ramelteon |
| N05CM04 | carbromal |
| N05CM16 | niaprazine |
| N06AA05 | opipramol |
| N06AA13 | iprindole |
| N06AB03 | fluoxetine |
| N06AF | Monoamine oxidase inhibitors, non-selective |
| N06AF01 | isocarboxazid |
| N06AG | Monoamine oxidase A inhibitors |
| N06AX04 | nomifensine |
| N06AX18 | reboxetine |
| N06AX19 | gepirone |
| N06AX21 | duloxetine |
| N06AX62 | bupropion and dextromethorphan |
| N06BA02 | dexamfetamine |
| N06BA03 | metamfetamine |
| N06BA10 | fenetylline |
| N06BA13 | armodafinil |
| N06BC | Xanthine derivatives |
| N06BC02 | propentofylline |
| N06BX | Other psychostimulants and nootropics |
| N06BX06 | citicoline |
| N06BX15 | pipradrol |
| N06CA01 | amitriptyline and psycholeptics |
| N06DA03 | rivastigmine |
| N06DX | Other anti-dementia drugs |
| N06DX01 | memantine |
| N06DX05 | donanemab |
| N07 | OTHER NERVOUS SYSTEM DRUGS |
| N07AA02 | pyridostigmine |
| N07AA51 | neostigmine, combinations |
| N07BC | Drugs used in opioid dependence |
| N07BC06 | diamorphine |
| N07BC51 | buprenorphine, combinations |
| N07CA01 | betahistine |
| N07XX19 | sodium phenylbutyrate and ursodoxicoltaurine |
| P01AA | Hydroxyquinoline derivatives |
| P01AB01 | metronidazole |
| P01AB02 | tinidazole |
| P01BB | Biguanides |
| P01BD | Diaminopyrimidines |
| P01BE | Artemisinin and derivatives, plain |
| P01BF01 | artemether and lumefantrine |
| P01BX02 | arterolane and piperaquine |
| P02BA02 | oxamniquine |
| P02BX | Other antitrematodal agents |
| P02CA05 | flubendazole |
| P02CC | Tetrahydropyrimidine derivatives |
| P02CX01 | pyrvinium |
| P02DX02 | dichlorophen |
| P03AB02 | lindane |
| P03AC53 | phenothrin, combinations |
| P03B | INSECTICIDES AND REPELLENTS |
| P03BX05 | dimethylcarbate |
| P03BX06 | etohexadiol |
| R01 | NASAL PREPARATIONS |
| R01AA12 | fenoxazoline |
| R01AC05 | spaglumic acid |
| R01AC07 | nedocromil |
| R01AC51 | cromoglicic acid, combinations |
| R01AD | Corticosteroids |
| R01AD60 | hydrocortisone, combinations |
| R01AX10 | various |
| R02AB04 | bacitracin |
| R02AB30 | gramicidin |
| R02AD01 | benzocaine |
| R02AD04 | dyclonine |
| R02AX02 | ibuprofen |
| R03AB | Non-selective beta-adrenoreceptor agonists |
| R03AC06 | hexoprenaline |
| R03AC11 | tulobuterol |
| R03AK09 | formoterol and mometasone |
| R03AL03 | vilanterol and umeclidinium bromide |
| R03AL12 | indacaterol, glycopyrronium bromide and mometasone |
| R03B | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| R03BB04 | tiotropium bromide |
| R03BB05 | aclidinium bromide |
| R03BB08 | revefenacin |
| R03BX | Other drugs for obstructive airway diseases, inhalants |
| R03CA | Alpha- and beta-adrenoreceptor agonists |
| R03CB | Non-selective beta-adrenoreceptor agonists |
| R03CB03 | orciprenaline |
| R03CC | Selective beta-2-adrenoreceptor agonists |
| R03CC08 | procaterol |
| R03DA09 | acefylline piperazine |
| R03DA12 | mepyramine theophyllinacetate |
| R03DA20 | combinations of xanthines |
| R05CB | Mucolytics |
| R05CB13 | dornase alfa (desoxyribonuclease) |
| R05DA09 | dextromethorphan |
| R05DB11 | pipazetate |
| R05DB22 | meprotixol |
| R05DB23 | piperidione |
| R05DB27 | levodropropizine |
| R05DB28 | dimethoxanate |
| R06AA11 | dimenhydrinate |
| R06AA59 | doxylamine, combinations |
| R06AB04 | chlorphenamine |
| R06AB51 | brompheniramine, combinations |
| R06AC02 | histapyrrodine |
| R06AC03 | chloropyramine |
| R06AD01 | alimemazine |
| R06AD02 | promethazine |
| R06AD52 | promethazine, combinations |
| R06AD55 | hydroxyethylpromethazine, combinations |
| R06AE | Piperazine derivatives |
| R06AE53 | cyclizine, combinations |
| R06AX01 | bamipine |
| R06AX02 | cyproheptadine |
| R06AX12 | terfenadine |
| R06AX18 | acrivastine |
| R07AA30 | combinations |
| R07AB | Respiratory stimulants |
| R07AX30 | ivacaftor and lumacaftor |
| S01A | ANTIINFECTIVES |
| S01AA | Antibiotics |
| S01AA10 | natamycin |
| S01AA15 | dihydrostreptomycin |
| S01AA24 | kanamycin |
| S01AA25 | azidamfenicol |
| S01AA31 | cefmenoxime |
| S01AA32 | bacitracin |
| S01AD08 | fomivirsen |
| S01AE01 | ofloxacin |
| S01AE05 | levofloxacin |
| S01AX06 | resorcinol |
| S01AX09 | chlorhexidine |
| S01BA10 | alclometasone |
| S01BB01 | hydrocortisone and mydriatics |
| S01BC03 | diclofenac |
| S01BC11 | bromfenac |
| S01CB04 | betamethasone |
| S01CC01 | diclofenac and antiinfectives |
| S01EB02 | carbachol |
| S01EB06 | neostigmine |
| S01EB51 | pilocarpine, combinations |
| S01ED02 | betaxolol |
| S01FA05 | homatropine |
| S01GA05 | phenylephrine |
| S01GA07 | brimonidine |
| S01GX02 | levocabastine |
| S01GX06 | emedastine |
| S01GX09 | olopatadine |
| S01L | OCULAR VASCULAR DISORDER AGENTS |
| S01XA08 | acetylcysteine |
| S01XA19 | limbal stem cells, autologous |
| S02AA10 | acetic acid |
| S02AA12 | rifamycin |
| S02BA | Corticosteroids |
| S02DA04 | cinchocaine |
| S03AA05 | hexamidine |
| S03AA08 | chloramphenicol |
| V01AA04 | mould fungus and yeast fungus |
| V01AA09 | textiles |
| V01AA10 | flowers |
| V03AB02 | nalorphine |
| V03AB13 | obidoxime |
| V03AB36 | phentolamine |
| V03AB37 | idarucizumab |
| V03AC01 | deferoxamine |
| V03AF02 | dexrazoxane |
| V03AN05 | medical air |
| V03AX03 | cobicistat |
| V04CD04 | corticorelin |
| V04CE | Tests for liver functional capacity |
| V04CE01 | galactose |
| V04CH03 | phenolsulfonphthalein |
| V04CH30 | aminohippuric acid |
| V04CJ02 | protirelin |
| V04CK01 | secretin |
| V04CX08 | carbon monoxide |
| V06DC | Carbohydrates |
| V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations |
| V06DX | Other combinations of nutrients |
| V07A | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07AN | Incontinence equipment |
| V08AA04 | iotalamic acid |
| V08AA06 | ioglicic acid |
| V08AC04 | adipiodone |
| V08BA02 | barium sulfate without suspending agents |
| V08CA07 | ferric ammonium citrate |
| V08CB03 | iron oxide, nanoparticles |
| V08DA01 | perflutren, human albumin microspheres |
| V08DA02 | microparticles of galactose |
| V09AX03 | iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane |
| V09C | RENAL SYSTEM |
| V09CA | Technetium (99mTc) compounds |
| V09CX | Other renal system diagnostic radiopharmaceuticals |
| V09DX01 | selenium (75Se) tauroselcholic acid |
| V09FX | Various thyroid diagnostic radiopharmaceuticals |
| V09G | CARDIOVASCULAR SYSTEM |
| V09H | INFLAMMATION AND INFECTION DETECTION |
| V09HA03 | technetium (99mTc) antigranulocyte antibody |
| V09HB | Indium (111In) compounds |
| V09IA07 | technetium (99mTc) hynic-octreotide |
| V09IA08 | technetium (99mTc) etarfolatide |
| V09IB02 | indium (111In) satumomab pendetide |
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection |
| V09IX06 | sodium fluoride (18F) |
| V09IX08 | fluoroethylcholine (18F) |
| V10A | ANTIINFLAMMATORY AGENTS |
| V10B | PAIN PALLIATION (BONE SEEKING AGENTS) |
| V10XX01 | sodium phosphate (32P) |
| A01AA04 | stannous fluoride |
| A01AB | Antiinfectives and antiseptics for local oral treatment |
| A01AB03 | chlorhexidine |
| A01AB21 | chlortetracycline |
| A01AB23 | minocycline |
| A01AC | Corticosteroids for local oral treatment |
| A01AC01 | triamcinolone |
| A01AD11 | various |
| A02A | ANTACIDS |
| A02AC | Calcium compounds |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AF02 | ordinary salt combinations and antiflatulents |
| A02BA03 | famotidine |
| A02BC04 | rabeprazole |
| A02BC07 | dexrabeprazole |
| A02BC54 | rabeprazole, combinations |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin |
| A02BD15 | vonoprazan, amoxicillin and metronidazole |
| A03AB02 | glycopyrronium bromide |
| A03AB21 | fenpiverinium |
| A03AC | Synthetic antispasmodics, amides with tertiary amines |
| A03AD30 | moxaverine |
| A03AE | Serotonin receptor antagonists |
| A03AX02 | diisopromine |
| A03AX11 | caroverine |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics |
| A03CA07 | ambutonium and psycholeptics |
| A04AA05 | palonosetron |
| A04AD04 | chlorobutanol |
| A04AD11 | nabilone |
| A04AD14 | rolapitant |
| A05AA01 | chenodeoxycholic acid |
| A05AA02 | ursodeoxycholic acid |
| A05AX03 | cyclobutyrol |
| A05BA06 | ornithine oxoglurate |
| A05BA07 | tidiacic arginine |
| A06AA51 | liquid paraffin, combinations |
| A06AB | Contact laxatives |
| A06AB20 | contact laxatives in combination |
| A06AC | Bulk-forming laxatives |
| A06AD04 | magnesium sulfate |
| A06AD14 | pentaerithrityl |
| A06AX03 | lubiprostone |
| A06AX07 | plecanatide |
| A06AX08 | tenapanor |
| A07AA | Antibiotics |
| A07AA10 | colistin |
| A07AA11 | rifaximin |
| A07AA54 | streptomycin, combinations |
| A07AX01 | broxyquinoline |
| A07DA01 | diphenoxylate |
| A07DA03 | loperamide |
| A07FA | Antidiarrheal microorganisms |
| A07FA02 | saccharomyces boulardii |
| A09AB01 | glutamic acid hydrochloride |
| A10AC03 | insulin (pork) |
| A10AC30 | combinations |
| A10AE03 | insulin (pork) |
| A10AE30 | combinations |
| A10AE54 | insulin glargine and lixisenatide |
| A10BA03 | buformin |
| A10BB | Sulfonylureas |
| A10BB05 | tolazamide |
| A10BB06 | carbutamide |
| A10BC | Sulfonamides (heterocyclic) |
| A10BD | Combinations of oral blood glucose lowering drugs |
| A10BD09 | pioglitazone and alogliptin |
| A10BD10 | metformin and saxagliptin |
| A10BD27 | metformin, linagliptin and empagliflozin |
| A10BD29 | sitagliptin and dapagliflozin |
| A10BJ06 | semaglutide |
| A10BK02 | canagliflozin |
| A10BX17 | carfloglitazar |
| A10XA | Aldose reductase inhibitors |
| A11AA03 | multivitamins and other minerals, incl. combinations |
| A11AB | Multivitamins, other combinations |
| A11CA | Vitamin A, plain |
| A11CC01 | ergocalciferol |
| A11CC02 | dihydrotachysterol |
| A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11HA07 | inositol |
| A12AA13 | calcium citrate |
| A12AA30 | calcium laevulate |
| A12BA02 | potassium citrate |
| A12BA51 | potassium chloride, combinations |
| A12CC06 | magnesium lactate |
| A12CC10 | magnesium oxide |
| A12CD01 | sodium fluoride |
| A12CE01 | sodium selenate |
| A14AA05 | oxymetholone |
| A14AB | Estren derivatives |
| A16AA02 | ademetionine |
| A16AA04 | mercaptamine |
| A16AB02 | imiglucerase |
| A16AB09 | idursulfase |
| A16AB11 | taliglucerase alfa |
| A16AB26 | eladocagene exuparvovec |
| A16AX05 | zinc acetate |
| A16AX07 | sapropterin |
| A16AX11 | sodium benzoate |
| A16AX16 | givosiran |
| B01AA02 | phenindione |
| B01AB02 | antithrombin III |
| B01AB05 | enoxaparin |
| B01AB12 | bemiparin |
| B01AC04 | clopidogrel |
| B01AD02 | alteplase |
| B01AD09 | ancrod |
| B01AF03 | edoxaban |
| B02AA | Amino acids |
| B02BC30 | combinations |
| B02BD | Blood coagulation factors |
| B02BD05 | coagulation factor VII |
| B02BD13 | coagulation factor X |
| B03AD05 | ferrous gluconate and folic acid |
| B03AE04 | iron, multivitamins and minerals |
| B03BA02 | cyanocobalamin tannin complex |
| B03BA03 | hydroxocobalamin |
| B03BB01 | folic acid |
| B03XA06 | luspatercept |
| B03XA08 | vadadustat |
| B05A | BLOOD AND RELATED PRODUCTS |
| B05AA | Blood substitutes and plasma protein fractions |
| B05AA07 | hydroxyethylstarch |
| B05BA03 | carbohydrates |
| B05BB04 | electrolytes in combination with other drugs |
| B05C | IRRIGATING SOLUTIONS |
| B05CA02 | chlorhexidine |
| B05D | PERITONEAL DIALYTICS |
| B05XA05 | magnesium sulfate |
| B05XA07 | calcium chloride |
| B05XA08 | sodium acetate |
| B05XA11 | magnesium chloride |
| B05XA17 | potassium acetate |
| B05XB03 | lysine |
| B06AA07 | trypsin |
| B06AC02 | icatibant |
| B06AC03 | ecallantide |
| B06AX | Other hematological agents |
| B06AX02 | betibeglogene autotemcel |
| C01AA04 | digitoxin |
| C01AA05 | digoxin |
| C01AA09 | gitoformate |
| C01AB01 | proscillaridin |
| C01BB | Antiarrhythmics, class Ib |
| C01BB01 | lidocaine |
| C01BD07 | dronedarone |
| C01BG | Other antiarrhythmics, class I and III |
| C01CA10 | methoxamine |
| C01CA19 | fenoldopam |
| C01CA21 | cafedrine |
| C01CE04 | bucladesine |
| C01CX08 | levosimendan |
| C01DA08 | isosorbide dinitrate |
| C01DA09 | trolnitrate |
| C01DA13 | eritrityl tetranitrate |
| C01DA38 | tenitramine |
| C01DA63 | eritrityl tetranitrate, combinations |
| C01DX01 | itramin tosilate |
| C01DX02 | prenylamine |
| C01DX05 | carbocromen |
| C01DX08 | heptaminol |
| C01DX18 | linsidomine |
| C01EB07 | fructose 1,6-diphosphate |
| C01EB17 | ivabradine |
| C01EB23 | tiazotic acid |
| C02AB02 | methyldopa (racemic) |
| C02AC04 | tolonidine |
| C02CC | Guanidine derivatives |
| C02CC01 | betanidine |
| C02DB03 | endralazine |
| C02KX02 | ambrisentan |
| C02KX05 | riociguat |
| C02LA03 | deserpidine and diuretics |
| C02LB | Methyldopa and diuretics in combination |
| C02LC01 | clonidine and diuretics |
| C03AA13 | mebutizide |
| C03BA05 | mefruside |
| C03BA13 | fenquizone |
| C03CC | Aryloxyacetic acid derivatives |
| C03CC02 | tienilic acid |
| C03DA | Aldosterone antagonists |
| C03DA05 | finerenone |
| C03EA05 | mebutizide and potassium-sparing agents |
| C03EB | High-ceiling diuretics and potassium-sparing agents |
| C04AC01 | nicotinic acid |
| C04AX20 | buflomedil |
| C04AX26 | cetiedil |
| C05AA01 | hydrocortisone |
| C05AA08 | fluocortolone |
| C05AD02 | tetracaine |
| C05AD04 | cinchocaine |
| C05AD06 | oxetacaine |
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use |
| C05AX02 | bismuth preparations, combinations |
| C05BA | Heparins or heparinoids for topical use |
| C05BA02 | sodium apolate |
| C05CA01 | rutoside |
| C05CA02 | monoxerutin |
| C05CA53 | diosmin, combinations |
| C07AA14 | mepindolol |
| C07AA15 | carteolol |
| C07AB06 | bevantolol |
| C07AB07 | bisoprolol |
| C07BB04 | acebutolol and thiazides |
| C07CA23 | penbutolol and other diuretics |
| C07CB | Beta blocking agents, selective, and other diuretics |
| C07CB53 | atenolol and other diuretics, combinations |
| C07CG | Alpha and beta blocking agents and other diuretics |
| C07FX | Beta blocking agents, other combinations |
| C07FX05 | metoprolol and ivabradine |
| C07FX06 | carvedilol and ivabradine |
| C08C | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS |
| C08CA08 | nitrendipine |
| C08DB | Benzothiazepine derivatives |
| C08G | CALCIUM CHANNEL BLOCKERS AND DIURETICS |
| C09AA01 | captopril |
| C09AA05 | ramipril |
| C09AA14 | temocapril |
| C09BB | ACE inhibitors and calcium channel blockers |
| C09BB05 | ramipril and felodipine |
| C09BB07 | ramipril and amlodipine |
| C09BX | ACE inhibitors, other combinations |
| C09BX06 | perindopril, bisoprolol, amlodipine and indapamide |
| C09CA | Angiotensin II receptor blockers (ARBs), plain |
| C09DA02 | eprosartan and diuretics |
| C09DA07 | telmisartan and diuretics |
| C09DB08 | valsartan and lercanidipine |
| C09DX01 | valsartan, amlodipine and hydrochlorothiazide |
| C10AA06 | cerivastatin |
| C10AB04 | gemfibrozil |
| C10AC | Bile acid sequestrants |
| C10AD52 | nicotinic acid, combinations |
| C10AX08 | policosanol |
| C10BA09 | rosuvastatin and fenofibrate |
| C10BX03 | atorvastatin and amlodipine |
| C10BX10 | rosuvastatin and valsartan |
| D01AA01 | nystatin |
| D01AC05 | isoconazole |
| D01AC07 | tioconazole |
| D01AC08 | ketoconazole |
| D01AC09 | sulconazole |
| D01AC17 | eberconazole |
| D01AC19 | efinaconazole |
| D01BA03 | fosravuconazole |
| D03A | CICATRIZANTS |
| D03AX02 | dextranomer |
| D03AX13 | Betulae cortex |
| D03BA02 | collagenase |
| D05A | ANTIPSORIATICS FOR TOPICAL USE |
| D05AC01 | dithranol |
| D05AX52 | calcipotriol, combinations |
| D05BA01 | trioxysalen |
| D05BB01 | etretinate |
| D05BX51 | fumaric acid derivatives, combinations |
| D06AA04 | tetracycline |
| D06AX04 | neomycin |
| D06AX10 | virginiamycin |
| D06AX15 | rifamycin |
| D07AC03 | desoximetasone |
| D07AC08 | fluocinonide |
| D07AC18 | prednicarbate |
| D07AD02 | halcinonide |
| D07BA | Corticosteroids, weak, combinations with antiseptics |
| D07BC03 | fluocortolone and antiseptics |
| D07C | CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS |
| D07CC | Corticosteroids, potent, combinations with antibiotics |
| D07CC02 | fluocinolone acetonide and antibiotics |
| D07XA | Corticosteroids, weak, other combinations |
| D07XC02 | desoximetasone |
| D08AE02 | policresulen |
| D08AG | Iodine products |
| D08AH30 | clioquinol |
| D08AK30 | mercuric iodide |
| D09AA07 | cetylpyridinium |
| D09AA10 | clioquinol |
| D10AF02 | erythromycin |
| D10AF03 | chloramphenicol |
| D10AX | Other anti-acne preparations for topical use |
| D10AX01 | aluminium chloride |
| D10AX02 | resorcinol |
| D10AX04 | aluminium oxide |
| D10AX06 | clascoterone |
| D10B | ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| D11AA01 | glycopyrronium |
| D11AC08 | sulfur compounds |
| D11AF | Wart and anti-corn preparations |
| D11AH05 | dupilumab |
| D11AX06 | mequinol |
| D11AX09 | oxaceprol |
| D11AX11 | hydroquinone |
| G01AA | Antibiotics |
| G01AC06 | broxyquinoline |
| G01AX11 | povidone-iodine |
| G02AB01 | methylergometrine |
| G02AB02 | ergot alkaloids |
| G02BB | Intravaginal contraceptives |
| G02CX | Other gynecologicals |
| G03AA08 | medroxyprogesterone and ethinylestradiol |
| G03AA18 | drospirenone and estetrol |
| G03AB01 | megestrol and ethinylestradiol |
| G03AC09 | desogestrel |
| G03AD02 | ulipristal |
| G03CA06 | chlorotrianisene |
| G03CA07 | estrone |
| G03CB01 | dienestrol |
| G03CC03 | methallenestril |
| G03DA03 | hydroxyprogesterone |
| G03DA04 | progesterone |
| G03E | ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION |
| G03FA04 | progesterone and estrogen |
| G03FB03 | chlormadinone and estrogen |
| G03FB12 | nomegestrol and estrogen |
| G04BA03 | calcium chloride |
| G04BC | Urinary concrement solvents |
| G04BD01 | emepronium |
| G04BD07 | tolterodine |
| G04BD12 | mirabegron |
| G04BD15 | vibegron |
| G04BE02 | papaverine |
| G04BE07 | apomorphine |
| G04BE09 | vardenafil |
| G04BX01 | magnesium hydroxide |
| G04CA03 | terazosin |
| G04CB51 | finasteride and tadalafil |
| G04CX03 | mepartricin |
| H01AC03 | mecasermin |
| H01CC53 | elagolix, estradiol and norethisterone |
| H02 | CORTICOSTEROIDS FOR SYSTEMIC USE |
| H02AB15 | meprednisone |
| H02AB18 | vamorolone |
| H03BB02 | thiamazole |
| H03BX | Other antithyroid preparations |
| H04AA02 | dasiglucagon |
| H05 | CALCIUM HOMEOSTASIS |
| H05AA04 | abaloparatide |
| H05BA | Calcitonin preparations |
| H05BX05 | calcifediol |
| J01A | TETRACYCLINES |
| J01AA01 | demeclocycline |
| J01AA06 | oxytetracycline |
| J01AA15 | omadacycline |
| J01AA56 | oxytetracycline, combinations |
| J01CA03 | carbenicillin |
| J01CA15 | talampicillin |
| J01CE01 | benzylpenicillin |
| J01CE05 | pheneticillin |
| J01CE30 | combinations |
| J01DB04 | cefazolin |
| J01DB05 | cefadroxil |
| J01DB06 | cefazedone |
| J01DB07 | cefatrizine |
| J01DB08 | cefapirin |
| J01DB12 | ceftezole |
| J01DD01 | cefotaxime |
| J01DD54 | ceftriaxone, combinations |
| J01DH51 | imipenem and cilastatin |
| J01DI54 | ceftolozane and beta-lactamase inhibitor |
| J01EA01 | trimethoprim |
| J01EA02 | brodimoprim |
| J01EA03 | iclaprim |
| J01EC20 | combinations |
| J01ED04 | sulfametoxydiazine |
| J01FA01 | erythromycin |
| J01FA07 | josamycin |
| J01FA12 | rokitamycin |
| J01FG01 | pristinamycin |
| J01GB05 | neomycin |
| J01GB06 | amikacin |
| J01GB13 | bekanamycin |
| J01MA04 | enoxacin |
| J01MA10 | rufloxacin |
| J01MA16 | gatifloxacin |
| J01MA22 | tosufloxacin |
| J01MB02 | nalidixic acid |
| J01RA05 | levofloxacin and ornidazole |
| J01RA06 | cefepime and amikacin |
| J01RA14 | norfloxacin and metronidazole |
| J01XA04 | dalbavancin |
| J01XD03 | ornidazole |
| J01XX01 | fosfomycin |
| J01XX03 | clofoctol |
| J01XX05 | methenamine |
| J01XX08 | linezolid |
| J01XX11 | tedizolid |
| J02AB | Imidazole derivatives |
| J02AB02 | ketoconazole |
| J04AC51 | isoniazid, combinations |
| J04AD02 | tiocarlide |
| J04AK08 | pretomanid |
| J04AM04 | thioacetazone and isoniazid |
| J04AM07 | rifampicin, ethambutol and isoniazid |
| J05AC03 | tromantadine |
| J05AF11 | telbivudine |
| J05AG | Non-nucleoside reverse transcriptase inhibitors |
| J05AG03 | efavirenz |
| J05AJ | Integrase inhibitors |
| J05AP09 | dasabuvir |
| J05AP10 | elbasvir |
| J05AR13 | lamivudine, abacavir and dolutegravir |
| J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir |
| J05AR28 | stavudine and lamivudine |
| J05AX02 | lysozyme |
| J05AX17 | enisamium iodide |
| J05AX27 | favipiravir |
| J06AA02 | tetanus antitoxin |
| J06AA06 | rabies serum |
| J06BB08 | staphylococcus immunoglobulin |
| J06BB09 | cytomegalovirus immunoglobulin |
| J06BB30 | combinations |
| J06BD | Antiviral monoclonal antibodies |
| J07A | BACTERIAL VACCINES |
| J07AH05 | other meningococcal polyvalent purified polysaccharides antigen |
| J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |
| J07AH10 | meningococcus A, purified polysaccharides antigen conjugated |
| J07AP02 | typhoid, inactivated, whole cell |
| J07AX | Other bacterial vaccines |
| J07BD53 | measles, combinations with rubella, live attenuated |
| J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated |
| J07BF | Poliomyelitis vaccines |
| J07BF01 | poliomyelitis oral, monovalent, live attenuated |
| J07BF04 | poliomyelitis oral, bivalent, live attenuated |
| J07BG | Rabies vaccines |
| J07BH | Rota virus diarrhea vaccines |
| J07BH01 | rota virus, live attenuated |
| J07BM | Papillomavirus vaccines |
| J07BN | Covid-19 vaccines |
| J07BN03 | covid-19, inactivated virus |
| J07CA05 | diphtheria-hepatitis B-pertussis-tetanus |
| J07XA | Parasitic vaccines |
| L01AA | Nitrogen mustard analogues |
| L01AD06 | nimustine |
| L01BA | Folic acid analogues |
| L01BB04 | cladribine |
| L01BC | Pyrimidine analogues |
| L01C | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| L01CA04 | vinorelbine |
| L01CC01 | demecolcine |
| L01CD02 | docetaxel |
| L01CD51 | paclitaxel and encequidar |
| L01DB07 | mitoxantrone |
| L01DC03 | mitomycin |
| L01EA02 | dasatinib |
| L01EA04 | bosutinib |
| L01ED05 | lorlatinib |
| L01EF03 | abemaciclib |
| L01EG04 | sirolimus |
| L01EJ04 | momelotinib |
| L01EK01 | axitinib |
| L01EM02 | copanlisib |
| L01EM03 | alpelisib |
| L01EN03 | infigratinib |
| L01EX11 | quizartinib |
| L01EX26 | sitravatinib |
| L01FB01 | inotuzumab ozogamicin |
| L01FC01 | daratumumab |
| L01FD01 | trastuzumab |
| L01FF04 | avelumab |
| L01FX03 | catumaxomab |
| L01FX05 | brentuximab vedotin |
| L01FX06 | dinutuximab beta |
| L01FX07 | blinatumomab |
| L01FX13 | enfortumab vedotin |
| L01FX27 | epcoritamab |
| L01FY01 | pertuzumab and trastuzumab |
| L01XA03 | oxaliplatin |
| L01XA05 | polyplatillen |
| L01XJ01 | vismodegib |
| L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| L01XK03 | rucaparib |
| L01XK52 | niraparib and abiraterone |
| L01XL06 | brexucabtagene autoleucel |
| L01XX02 | asparaginase |
| L01XX03 | altretamine |
| L01XX74 | belzutifan |
| L02AA | Estrogens |
| L02AA04 | fosfestrol |
| L02AE03 | goserelin |
| L02BA03 | fulvestrant |
| L02BG | Aromatase inhibitors |
| L02BG05 | vorozole |
| L03AA02 | filgrastim |
| L03AA15 | balugrastim |
| L03AA19 | eflapegrastim |
| L03AB07 | interferon beta-1a |
| L03AX02 | roquinimex |
| L03AX04 | pegademase |
| L03AX07 | poly I:C |
| L04 | IMMUNOSUPPRESSANTS |
| L04AA28 | belatacept |
| L04AB01 | etanercept |
| L04AC05 | ustekinumab |
| L04AC08 | canakinumab |
| L04AD01 | ciclosporin |
| L04AH01 | sirolimus |
| L04AJ07 | crovalimab |
| L04AJ08 | iptacopan |
| L04AK01 | leflunomide |
| L04AX | Other immunosuppressants |
| L04AX02 | thalidomide |
| L04AX03 | methotrexate |
| L04AX06 | pomalidomide |
| L04AX07 | dimethyl fumarate |
| M | MUSCULO-SKELETAL SYSTEM |
| M01AA06 | kebuzone |
| M01AB11 | acemetacin |
| M01AB12 | difenpiramide |
| M01AC04 | droxicam |
| M01AC06 | meloxicam |
| M01AE | Propionic acid derivatives |
| M01AE06 | benoxaprofen |
| M01AE53 | ketoprofen, combinations |
| M01AE57 | naproxen and diphenhydramine |
| M01AG01 | mefenamic acid |
| M01AG02 | tolfenamic acid |
| M01AH | Coxibs |
| M01AX07 | benzydamine |
| M01AX13 | proquazone |
| M01AX18 | feprazone |
| M01AX68 | feprazone, combinations |
| M01CA03 | oxycinchophen |
| M01CB | Gold preparations |
| M01CX | Other specific antirheumatic agents |
| M02AA03 | clofezone |
| M02AA05 | benzydamine |
| M02AA17 | niflumic acid |
| M03 | MUSCLE RELAXANTS |
| M03A | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| M03AC02 | gallamine |
| M03AC05 | hexafluronium |
| M03BA02 | carisoprodol |
| M03BA04 | styramate |
| M03BA72 | carisoprodol, combinations with psycholeptics |
| M03BB | Oxazol, thiazine, and triazine derivatives |
| M03BB72 | chlormezanone, combinations with psycholeptics |
| M03BC | Ethers, chemically close to antihistamines |
| M03C | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| M04 | ANTIGOUT PREPARATIONS |
| M05B | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| M05BA02 | clodronic acid |
| M05BB09 | ibandronic acid and colecalciferol |
| M05BX01 | ipriflavone |
| M09AX07 | nusinersen |
| N01AH02 | alfentanil |
| N01AX | Other general anesthetics |
| N01BB02 | lidocaine |
| N01BB05 | butanilicaine |
| N01BB20 | combinations |
| N01BX | Other local anesthetics |
| N01BX03 | phenol |
| N02 | ANALGESICS |
| N02AA11 | oxymorphone |
| N02AA53 | hydromorphone and naloxone |
| N02AA56 | oxycodone and naltrexone |
| N02AB02 | pethidine |
| N02AD | Benzomorphan derivatives |
| N02AD51 | pentazocine and naloxone |
| N02AE01 | buprenorphine |
| N02AG02 | ketobemidone and antispasmodics |
| N02AJ | Opioids in combination with non-opioid analgesics |
| N02AJ01 | dihydrocodeine and paracetamol |
| N02AJ07 | codeine and acetylsalicylic acid |
| N02AJ15 | tramadol and other non-opioid analgesics |
| N02AJ22 | hydrocodone and paracetamol |
| N02AJ23 | hydrocodone and ibuprofen |
| N02AX02 | tramadol |
| N02AX05 | meptazinol |
| N02BA06 | salsalate |
| N02BA51 | acetylsalicylic acid, combinations excl. psycholeptics |
| N02BA65 | carbasalate calcium combinations excl. psycholeptics |
| N02BB03 | aminophenazone |
| N02BE04 | bucetin |
| N02BE71 | paracetamol, combinations with psycholeptics |
| N02BF02 | pregabalin |
| N02BG05 | viminol |
| N02CA02 | ergotamine |
| N02CA52 | ergotamine, combinations excl. psycholeptics |
| N02CD06 | rimegepant |
| N03AA03 | primidone |
| N03AA04 | barbexaclone |
| N03AC | Oxazolidine derivatives |
| N03AG06 | tiagabine |
| N03AX10 | felbamate |
| N03AX11 | topiramate |
| N04A | ANTICHOLINERGIC AGENTS |
| N04BA03 | levodopa, decarboxylase inhibitor and COMT inhibitor |
| N04BA05 | melevodopa and decarboxylase inhibitor |
| N04BC03 | dihydroergocryptine mesylate |
| N04BC04 | ropinirole |
| N04BC07 | apomorphine |
| N04BD03 | safinamide |
| N05 | PSYCHOLEPTICS |
| N05AE02 | molindone |
| N05AH01 | loxapine |
| N05AL06 | veralipride |
| N05AX08 | risperidone |
| N05AX11 | zotepine |
| N05AX12 | aripiprazole |
| N05AX15 | cariprazine |
| N05AX16 | brexpiprazole |
| N05AX17 | pimavanserin |
| N05BA10 | ketazolam |
| N05BA16 | nordazepam |
| N05BA22 | cloxazolam |
| N05BA56 | lorazepam, combinations |
| N05BD01 | benzoctamine |
| N05BX05 | Lavandulae aetheroleum |
| N05CA02 | amobarbital |
| N05CA10 | cyclobarbital |
| N05CA11 | heptabarbital |
| N05CC03 | acetylglycinamide chloral hydrate |
| N05CD04 | estazolam |
| N05CD10 | quazepam |
| N05CD12 | doxefazepam |
| N05CE01 | glutethimide |
| N05CH | Melatonin receptor agonists |
| N05CH01 | melatonin |
| N05CM07 | triclofos |
| N05CM13 | valnoctamide |
| N05CX02 | methaqualone, combinations |
| N06A | ANTIDEPRESSANTS |
| N06AA08 | dibenzepin |
| N06AA11 | protriptyline |
| N06AA18 | dimetacrine |
| N06AB09 | etoperidone |
| N06AF02 | nialamide |
| N06AF04 | tranylcypromine |
| N06AX09 | viloxazine |
| N06AX14 | tianeptine |
| N06AX27 | esketamine |
| N06BA | Centrally acting sympathomimetics |
| N06BA14 | solriamfetol |
| N06BX04 | deanol |
| N06BX08 | pirisudanol |
| N06CA03 | fluoxetine and psycholeptics |
| N06D | ANTI-DEMENTIA DRUGS |
| N06DA01 | tacrine |
| N06DA04 | galantamine |
| N06DX04 | lecanemab |
| N07AA | Anticholinesterases |
| N07AB01 | carbachol |
| N07AB02 | bethanechol |
| N07AX | Other parasympathomimetics |
| N07BB03 | acamprosate |
| N07BC01 | buprenorphine |
| N07CA03 | flunarizine |
| N07CA52 | cinnarizine, combinations |
| N07XX10 | laquinimod |
| N07XX17 | arimoclomol |
| N07XX22 | tofersen |
| N07XX59 | dextromethorphan, combinations |
| P01AB06 | nimorazole |
| P01AR01 | arsthinol |
| P01AX01 | chiniofon |
| P01AX04 | phanquinone |
| P01AX05 | mepacrine |
| P01AX10 | fumagillin |
| P01BA06 | amodiaquine |
| P01BB01 | proguanil |
| P01BF | Artemisinin and derivatives, combinations |
| P01BF08 | artemisinin and naphthoquine |
| P01CA | Nitroimidazole derivatives |
| P01CA02 | benznidazole |
| P01CD01 | melarsoprol |
| P01CD02 | acetarsol |
| P02BB | Organophosphorous compounds |
| P03AA54 | disulfiram, combinations |
| P03AB01 | clofenotane |
| P03AB51 | clofenotane, combinations |
| P03AC52 | bioallethrin, combinations |
| P03AX06 | benzyl alcohol |
| P03BX01 | diethyltoluamide |
| R01AA10 | metizoline |
| R01AA14 | epinephrine |
| R01AB07 | oxymetazoline |
| R01AC01 | cromoglicic acid |
| R01AC04 | antazoline |
| R01AD03 | dexamethasone |
| R01AD07 | tixocortol |
| R01AD09 | mometasone |
| R01AD12 | fluticasone furoate |
| R01AD52 | prednisolone, combinations |
| R01AD57 | tixocortol, combinations |
| R01AX02 | retinol |
| R01AX05 | ritiometan |
| R01AX06 | mupirocin |
| R01BA | Sympathomimetics |
| R01BA53 | phenylephrine, combinations |
| R02AA01 | ambazone |
| R02AA03 | dichlorobenzyl alcohol |
| R02AA18 | hexamidine |
| R02AB01 | neomycin |
| R02AX | Other throat preparations |
| R03AA01 | epinephrine |
| R03AC12 | salmeterol |
| R03AC13 | formoterol |
| R03AC18 | indacaterol |
| R03AC19 | olodaterol |
| R03AK01 | epinephrine and other drugs for obstructive airway diseases |
| R03AK06 | salmeterol and fluticasone |
| R03AK12 | salmeterol and budesonide |
| R03AL02 | salbutamol and ipratropium bromide |
| R03BA04 | betamethasone |
| R03BA05 | fluticasone |
| R03BA07 | mometasone |
| R03BB01 | ipratropium bromide |
| R03BC01 | cromoglicic acid |
| R03BC03 | nedocromil |
| R03CA02 | ephedrine |
| R03CB01 | isoprenaline |
| R03CC07 | pirbuterol |
| R03CC12 | bambuterol |
| R03CC14 | reproterol |
| R03CK | Adrenergics and other drugs for obstructive airway diseases |
| R03D | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03DA01 | diprophylline |
| R03DA05 | aminophylline |
| R03DA07 | theobromine |
| R03DA54 | theophylline, combinations excl. psycholeptics |
| R03DX | Other systemic drugs for obstructive airway diseases |
| R03DX06 | seratrodast |
| R05CA04 | ipecacuanha |
| R05CA13 | cineole |
| R05CB02 | bromhexine |
| R05DA11 | dimemorfan |
| R05DA20 | combinations |
| R05DB05 | pentoxyverine |
| R05DB10 | clofedanol |
| R05DB17 | droxypropine |
| R05DB21 | cloperastine |
| R06AA | Aminoalkyl ethers |
| R06AA56 | chlorphenoxamine, combinations |
| R06AA57 | diphenylpyraline, combinations |
| R06AB05 | pheniramine |
| R06AC | Substituted ethylene diamines |
| R06AC01 | mepyramine |
| R06AC05 | methapyrilene |
| R06AC06 | thonzylamine |
| R06AD09 | isothipendyl |
| R06AX26 | fexofenadine |
| R07AB04 | etamivan |
| R07AB06 | prethcamide |
| S | SENSORY ORGANS |
| S01 | OPHTHALMOLOGICALS |
| S01AA13 | fusidic acid |
| S01AA26 | azithromycin |
| S01AB01 | sulfamethizole |
| S01AD03 | aciclovir |
| S01AE | Fluoroquinolones |
| S01BA08 | medrysone |
| S01CA12 | loteprednol and antiinfectives |
| S01CB02 | prednisolone |
| S01EA51 | epinephrine, combinations |
| S01EB58 | aceclidine, combinations |
| S01EC | Carbonic anhydrase inhibitors |
| S01ED51 | timolol, combinations |
| S01EE02 | unoprostone |
| S01FA06 | tropicamide |
| S01GA53 | xylometazoline, combinations |
| S01GA55 | phenylephrine, combinations |
| S01GX03 | spaglumic acid |
| S01GX10 | epinastine |
| S01HA06 | cinchocaine |
| S01JA01 | fluorescein |
| S01JA51 | fluorescein, combinations |
| S01LA | Antineovascularisation agents |
| S01LA04 | ranibizumab |
| S01LA09 | faricimab |
| S01X | OTHER OPHTHALMOLOGICALS |
| S01XA12 | dexpanthenol |
| S01XA28 | varenicline |
| S02AA08 | tetracycline |
| S02AA16 | ofloxacin |
| S02AA30 | antiinfectives, combinations |
| S02BA06 | dexamethasone |
| S02CA | Corticosteroids and antiinfectives in combination |
| S02D | OTHER OTOLOGICALS |
| S03BA03 | betamethasone |
| S03C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| S03CA05 | fludrocortisone and antiinfectives |
| V01 | ALLERGENS |
| V01AA07 | insects |
| V03AB03 | edetates |
| V03AB05 | prednisolone and promethazine |
| V03AB15 | naloxone |
| V03AB21 | potassium iodide |
| V03AB23 | acetylcysteine |
| V03AB25 | flumazenil |
| V03AC02 | deferiprone |
| V03AF09 | glucarpidase |
| V03AN01 | oxygen |
| V04CB | Tests for fat absorption |
| V04CB01 | vitamin A concentrates |
| V04CC | Tests for bile duct patency |
| V04CD03 | sermorelin |
| V04CG | Tests for gastric secretion |
| V04CG04 | pentagastrin |
| V04CG05 | methylthioninium chloride |
| V04CG30 | caffeine and sodium benzoate |
| V04CX01 | indocyanine green |
| V04CX09 | patent blue |
| V06DD | Amino acids, incl. combinations with polypeptides |
| V07AR | Sensitivity tests, discs and tablets |
| V08AA03 | iodamide |
| V08AA09 | methiodal |
| V08AB04 | iopamidol |
| V08AB06 | iotrolan |
| V08AC01 | iodoxamic acid |
| V08AC02 | iotroxic acid |
| V08AC03 | ioglycamic acid |
| V08AD | Non-watersoluble X-ray contrast media |
| V08AD02 | iopydol |
| V08AD03 | propyliodone |
| V08C | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| V08CA02 | gadoteric acid |
| V08CA12 | gadopiclenol |
| V08CB | Superparamagnetic contrast media |
| V09AB02 | iodine iolopride (123I) |
| V09CX04 | chromium (51Cr) edetate |
| V09DA03 | technetium (99mTc) lidofenin |
| V09DB04 | technetium (99mTc) tin colloid |
| V09DB05 | technetium (99mTc) sulfur colloid |
| V09EA03 | technetium (99mTc) nanocolloid |
| V09F | THYROID |
| V09FX01 | technetium (99mTc) pertechnetate |
| V09FX03 | sodium iodide (131I) |
| V09GA | Technetium (99mTc) compounds |
| V09GA05 | technetium (99mTc) furifosmin |
| V09GA07 | technetium (99mTc) apcitide |
| V09HA01 | technetium (99mTc) human immunoglobulin |
| V09I | TUMOUR DETECTION |
| V09IA10 | technetium (99mTc)trofolastat chloride |
| V09XX01 | cobalt (57Co) cyanocobalamine |
| V09XX03 | selenium (75Se) norcholesterol |
| V10XA | Iodine (131I) compounds |
| A01AA | Caries prophylactic agents |
| A01AA01 | sodium fluoride |
| A01AB08 | neomycin |
| A01AB09 | miconazole |
| A01AD02 | benzydamine |
| A02AA01 | magnesium carbonate |
| A02AA02 | magnesium oxide |
| A02AA10 | combinations |
| A02AB05 | aluminium acetoacetate |
| A02AB07 | aluminium glycinate |
| A02AD02 | magaldrate |
| A02AD03 | almagate |
| A02AD04 | hydrotalcite |
| A02AF01 | magaldrate and antiflatulents |
| A02BA02 | ranitidine |
| A02BA07 | ranitidine bismuth citrate |
| A02BB | Prostaglandins |
| A02BC01 | omeprazole |
| A02BC09 | tegoprazan |
| A02BC51 | omeprazole, combinations |
| A02BC53 | lansoprazole, combinations |
| A02BD03 | lansoprazole, amoxicillin and metronidazole |
| A02BD05 | omeprazole, amoxicillin and clarithromycin |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole |
| A02BD16 | omeprazole, amoxicillin and rifabutin |
| A02BX03 | pirenzepine |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics |
| A03AA03 | camylofin |
| A03AA05 | trimebutine |
| A03AA06 | rociverine |
| A03AB09 | isopropamide |
| A03AB53 | oxyphenonium, combinations |
| A03AC04 | nicofetamide |
| A03AE01 | alosetron |
| A03BA | Belladonna alkaloids, tertiary amines |
| A03CA02 | clidinium and psycholeptics |
| A03CA06 | bevonium and psycholeptics |
| A03CA09 | pipenzolate and psycholeptics |
| A03DA04 | ciclonium and analgesics |
| A03FA07 | itopride |
| A04AA02 | granisetron |
| A04AA03 | tropisetron |
| A04AD10 | dronabinol |
| A05AX05 | odevixibat |
| A05BA04 | citiolone |
| A06 | DRUGS FOR CONSTIPATION |
| A06A | DRUGS FOR CONSTIPATION |
| A06AB08 | sodium picosulfate |
| A06AB58 | sodium picosulfate, combinations |
| A06AC51 | ispaghula, combinations |
| A06AC55 | linseed, combinations |
| A06AD03 | magnesium peroxide |
| A06AD11 | lactulose |
| A06AD12 | lactitol |
| A06AG07 | sorbitol |
| A06AG20 | combinations |
| A06AH04 | naloxone |
| A06AX01 | glycerol |
| A07AA01 | neomycin |
| A07AA05 | polymyxin B |
| A07AB03 | sulfaguanidine |
| A07AX | Other intestinal antiinfectives |
| A07BB | Bismuth preparations |
| A07BC30 | combinations |
| A07C | ELECTROLYTES WITH CARBOHYDRATES |
| A07EA02 | hydrocortisone |
| A07FA01 | lactic acid producing organisms |
| A07FA51 | lactic acid producing organisms, combinations |
| A08AA04 | dexfenfluramine |
| A08AA07 | cathine |
| A08AA12 | setmelanotide |
| A08AB | Peripherally acting antiobesity products |
| A09 | DIGESTIVES, INCL. ENZYMES |
| A09AA | Enzyme preparations |
| A09AB | Acid preparations |
| A10AB05 | insulin aspart |
| A10AD01 | insulin (human) |
| A10AD04 | insulin lispro |
| A10AD06 | insulin degludec and insulin aspart |
| A10AD30 | combinations |
| A10BB03 | tolbutamide |
| A10BB04 | glibornuride |
| A10BB08 | gliquidone |
| A10BC01 | glymidine |
| A10BD12 | pioglitazone and sitagliptin |
| A10BD24 | sitagliptin and ertugliflozin |
| A10BF01 | acarbose |
| A10BG04 | lobeglitazone |
| A10BH04 | alogliptin |
| A10BH06 | gemigliptin |
| A10BJ07 | beinaglutide |
| A10BK01 | dapagliflozin |
| A11B | MULTIVITAMINS, PLAIN |
| A11DA02 | sulbutiamine |
| A11EA | Vitamin B-complex, plain |
| A11EC | Vitamin B-complex with minerals |
| A11HA32 | pantethine |
| A12AA | Calcium |
| A12BA04 | potassium hydrogencarbonate |
| A12BA05 | potassium gluconate |
| A12CC03 | magnesium gluconate |
| A12CC08 | magnesium pidolate |
| A12CC30 | magnesium (different salts in combination) |
| A12CD51 | fluoride, combinations |
| A12CX | Other mineral products |
| A14AB01 | nandrolone |
| A16AA06 | betaine |
| A16AB14 | sebelipase alfa |
| A16AB17 | cerliponase alfa |
| A16AB18 | vestronidase alfa |
| A16AX03 | sodium phenylbutyrate |
| A16AX04 | nitisinone |
| B01AB | Heparin group |
| B01AC02 | cloricromen |
| B01AC06 | acetylsalicylic acid |
| B01AC10 | indobufen |
| B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors |
| B01AD04 | urokinase |
| B01AD05 | fibrinolysin |
| B01AD06 | brinase |
| B01AE05 | ximelagatran |
| B02A | ANTIFIBRINOLYTICS |
| B02AA01 | aminocaproic acid |
| B02AB | Proteinase inhibitors |
| B02AB04 | camostat |
| B02BA02 | menadione |
| B02BB | Fibrinogen |
| B02BC | Local hemostatics |
| B02BC05 | adrenalone |
| B02BD04 | coagulation factor IX |
| B02BX01 | etamsylate |
| B02BX02 | carbazochrome |
| B02BX04 | romiplostim |
| B03AA04 | ferrous carbonate |
| B03AA09 | ferrous aspartate |
| B03AA12 | ferrous sodium citrate |
| B03AB07 | chondroitin sulfate-iron complex |
| B03AD | Iron in combination with folic acid |
| B03AD03 | ferrous sulfate and folic acid |
| B03AE10 | various combinations |
| B05AA05 | dextran |
| B05AX01 | erythrocytes |
| B05CA09 | neomycin |
| B05CB01 | sodium chloride |
| B05X | I.V. SOLUTION ADDITIVES |
| B05XA | Electrolyte solutions |
| B05XA13 | hydrochloric acid |
| B05XA14 | sodium glycerophosphate |
| B05XA16 | cardioplegia solutions |
| B06AA | Enzymes |
| B06AC01 | c1-inhibitor, plasma derived |
| C01BA01 | quinidine |
| C01BA08 | prajmaline |
| C01BC03 | propafenone |
| C01BG07 | cibenzoline |
| C01C | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| C01CA11 | mephentermine |
| C01CA17 | midodrine |
| C01CA22 | arbutamine |
| C01CA23 | theodrenaline |
| C01CA27 | droxidopa |
| C01CE02 | milrinone |
| C01CX10 | omecamtiv mecarbil |
| C01DA | Organic nitrates |
| C01DA05 | pentaerithrityl tetranitrate |
| C01DA07 | propatylnitrate |
| C01DA14 | isosorbide mononitrate |
| C01DA20 | organic nitrates in combination |
| C01DX09 | imolamine |
| C01DX10 | dilazep |
| C01DX13 | efloxate |
| C01DX53 | oxyfedrine, combinations |
| C01EB02 | camphora |
| C01EB16 | ibuprofen |
| C01EB18 | ranolazine |
| C01EB21 | regadenoson |
| C02AA | Rauwolfia alkaloids |
| C02AA57 | bietaserpine, combinations |
| C02C | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
| C02CC02 | guanethidine |
| C02DB | Hydrazinophthalazine derivatives |
| C02DB04 | cadralazine |
| C02KN | Other antihypertensives |
| C02KX52 | ambrisentan and tadalafil |
| C02KX54 | macitentan and tadalafil |
| C02LK01 | veratrum and diuretics |
| C02LL01 | pargyline and diuretics |
| C02LN | Serotonin antagonists and diuretics |
| C02LX | Other antihypertensives and diuretics |
| C03A | LOW-CEILING DIURETICS, THIAZIDES |
| C03BA82 | clorexolone, combinations with psycholeptics |
| C03BB05 | mefruside and potassium |
| C03BC01 | mersalyl |
| C03BX03 | cicletanine |
| C03CA02 | bumetanide |
| C03DB02 | triamterene |
| C03E | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION |
| C03EA03 | epitizide and potassium-sparing agents |
| C04 | PERIPHERAL VASODILATORS |
| C04AB01 | phentolamine |
| C04AD01 | pentifylline |
| C04AD03 | pentoxifylline |
| C04AF01 | kallidinogenase |
| C04AX07 | vincamine |
| C04AX11 | bencyclane |
| C04AX24 | visnadine |
| C05 | VASOPROTECTIVES |
| C05AA06 | fluorometholone |
| C05AE02 | isosorbide dinitrate |
| C05BA01 | organo-heparinoid |
| C05BA53 | heparin, combinations |
| C05CX | Other capillary stabilizing agents |
| C05X | OTHER VASOPROTECTIVES |
| C05XX | Other vasoprotectives |
| C07AA07 | sotalol |
| C07AA12 | nadolol |
| C07AB04 | acebutolol |
| C07AB05 | betaxolol |
| C07AB09 | esmolol |
| C07AB12 | nebivolol |
| C07BB02 | metoprolol and thiazides |
| C07BB06 | bevantolol and thiazides |
| C07CG01 | labetalol and other diuretics |
| C07F | BETA BLOCKING AGENTS, OTHER COMBINATIONS |
| C07FB12 | nebivolol and amlodipine |
| C08CA | Dihydropyridine derivatives |
| C08CA03 | isradipine |
| C08CA14 | cilnidipine |
| C08CX01 | mibefradil |
| C08DA | Phenylalkylamine derivatives |
| C08DA51 | verapamil, combinations |
| C08EX01 | lidoflazine |
| C09AA03 | lisinopril |
| C09AA06 | quinapril |
| C09AA11 | spirapril |
| C09BB13 | benazepril and amlodipine |
| C09DA | Angiotensin II receptor blockers (ARBs) and diuretics |
| C09DA08 | olmesartan medoxomil and diuretics |
| C09DB02 | olmesartan medoxomil and amlodipine |
| C09DX | Angiotensin II receptor blockers (ARBs), other combinations |
| C09DX02 | valsartan and aliskiren |
| C09DX08 | telmisartan, amlodipine and hydrochlorothiazide |
| C09XA | Renin-inhibitors |
| C10AA | HMG CoA reductase inhibitors |
| C10AA03 | pravastatin |
| C10AA04 | fluvastatin |
| C10AX10 | alipogene tiparvovec |
| C10AX13 | evolocumab |
| C10BA08 | atorvastatin and omega-3 fatty acids |
| C10BX01 | simvastatin and acetylsalicylic acid |
| C10BX08 | atorvastatin and acetylsalicylic acid |
| C10BX18 | atorvastatin, amlodipine and ramipril |
| D01 | ANTIFUNGALS FOR DERMATOLOGICAL USE |
| D01AC | Imidazole and triazole derivatives |
| D01AC03 | econazole |
| D01AC10 | bifonazole |
| D01AE05 | polynoxylin |
| D01AE08 | ticlatone |
| D02AD | Liquid plasters |
| D02AE | Carbamide products |
| D02AE01 | carbamide |
| D02BA02 | octinoxate |
| D03B | ENZYMES |
| D04 | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA | Antihistamines for topical use |
| D04AB01 | lidocaine |
| D05AC | Antracen derivatives |
| D05AC51 | dithranol, combinations |
| D05AX01 | fumaric acid |
| D05AX07 | tapinarof |
| D05BX | Other antipsoriatics for systemic use |
| D06 | ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE |
| D06AA01 | demeclocycline |
| D06AX05 | bacitracin |
| D06AX08 | tyrothricin |
| D06AX12 | amikacin |
| D06BA03 | mafenide |
| D06BB05 | inosine |
| D07AB04 | fluocortin |
| D07AB06 | fluorometholone |
| D07AB21 | clocortolone |
| D07AC | Corticosteroids, potent (group III) |
| D07AC04 | fluocinolone acetonide |
| D07AD | Corticosteroids, very potent (group IV) |
| D07BC04 | diflucortolone and antiseptics |
| D08 | ANTISEPTICS AND DISINFECTANTS |
| D08AC03 | propamidine |
| D08AE | Phenol and derivatives |
| D08AE05 | chloroxylenol |
| D08AG02 | povidone-iodine |
| D08AH | Quinoline derivatives |
| D08AJ02 | cetrimonium |
| D08AJ08 | benzethonium chloride |
| D08AJ58 | benzethonium chloride, combinations |
| D08AJ59 | dodeclonium bromide, combinations |
| D08AK01 | mercuric amidochloride |
| D08AK03 | mercuric chloride |
| D08AX04 | tosylchloramide sodium |
| D09AA08 | aluminium chlorohydrate |
| D09AA09 | povidone-iodine |
| D09AA13 | iodoform |
| D10AA01 | fluorometholone |
| D10AD01 | tretinoin |
| D10AF01 | clindamycin |
| D10AF06 | sulfacetamide |
| D11A | OTHER DERMATOLOGICAL PREPARATIONS |
| D11AA | Antihidrotics |
| D11AC06 | povidone-iodine |
| D11AH03 | cromoglicic acid |
| D11AH06 | crisaborole |
| D11AX10 | finasteride |
| D11AX13 | monobenzone |
| G01AA03 | amphotericin B |
| G01AA07 | oxytetracycline |
| G01AC03 | chlorquinaldol |
| G01AC30 | oxyquinoline |
| G01AE10 | combinations of sulfonamides |
| G01AF13 | azanidazole |
| G01AF16 | omoconazole |
| G01AG02 | terconazole |
| G01AX03 | policresulen |
| G02AB | Ergot alkaloids |
| G02AD | Prostaglandins |
| G02BB02 | vaginal ring with progestogen |
| G02CA01 | ritodrine |
| G02CX03 | Agni casti fructus |
| G03AA01 | etynodiol and ethinylestradiol |
| G03AA03 | lynestrenol and ethinylestradiol |
| G03AA06 | norgestrel and ethinylestradiol |
| G03AA09 | desogestrel and ethinylestradiol |
| G03AA14 | nomegestrol and estradiol |
| G03AB04 | norethisterone and ethinylestradiol |
| G03AC01 | norethisterone |
| G03AD | Emergency contraceptives |
| G03CA03 | estradiol |
| G03CA04 | estriol |
| G03CB | Synthetic estrogens, plain |
| G03DA02 | medroxyprogesterone |
| G03DB04 | nomegestrol |
| G03DB08 | dienogest |
| G03DC03 | lynestrenol |
| G03EA | Androgens and estrogens |
| G03EA02 | testosterone and estrogen |
| G03EB | Androgen, progestogen and estrogen in combination |
| G03FA12 | medroxyprogesterone and estrogen |
| G03FB01 | norgestrel and estrogen |
| G03FB02 | lynestrenol and estrogen |
| G03FB06 | medroxyprogesterone and estrogen |
| G03FB10 | desogestrel and estrogen |
| G03GA | Gonadotropins |
| G03GA30 | combinations |
| G03GB03 | epimestrol |
| G03H | ANTIANDROGENS |
| G03HB01 | cyproterone and estrogen |
| G03XB | Progesterone receptor modulators |
| G03XC01 | raloxifene |
| G03XC02 | bazedoxifene |
| G03XX01 | prasterone |
| G04BD14 | imidafenacin |
| G04BE03 | sildenafil |
| G04BE30 | combinations |
| G04CA53 | tamsulosin and solifenacin |
| H01A | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| H01AB | Thyrotropin |
| H01AC08 | somatrogon |
| H01CB01 | somatostatin |
| H02AA02 | fludrocortisone |
| H02AB07 | prednisone |
| H02AB12 | rimexolone |
| H02C | ANTIADRENAL PREPARATIONS |
| H02CA | Anticorticosteroids |
| H03AA51 | levothyroxine sodium and iodine compounds |
| H03BA02 | propylthiouracil |
| H03BX02 | dibromotyrosine |
| H03CA | Iodine therapy |
| J01AA08 | minocycline |
| J01AA11 | clomocycline |
| J01BA02 | thiamphenicol |
| J01CA09 | azlocillin |
| J01CA11 | mecillinam |
| J01CA13 | ticarcillin |
| J01CA16 | sulbenicillin |
| J01CA19 | aspoxicillin |
| J01CG02 | tazobactam |
| J01DB09 | cefradine |
| J01DC01 | cefoxitin |
| J01DC04 | cefaclor |
| J01DC52 | cefuroxime and beta-lactamase inhibitor |
| J01DD12 | cefoperazone |
| J01DD17 | cefcapene |
| J01DD18 | cefteram |
| J01DD51 | cefotaxime and beta-lactamase inhibitor |
| J01DD58 | cefixime and beta-lactamase inhibitor |
| J01DH05 | biapenem |
| J01DI03 | faropenem |
| J01EB02 | sulfamethizole |
| J01EB06 | sulfanilamide |
| J01EB08 | sulfathiourea |
| J01ED03 | sulfametomidine |
| J01ED06 | sulfaperin |
| J01ED07 | sulfamerazine |
| J01FA15 | telithromycin |
| J01FA16 | solithromycin |
| J01FG02 | quinupristin/dalfopristin |
| J01GB11 | isepamicin |
| J01MA18 | pazufloxacin |
| J01MB | Other quinolones |
| J01MB05 | oxolinic acid |
| J01MB06 | cinoxacin |
| J01R | COMBINATIONS OF ANTIBACTERIALS |
| J01RA15 | cefixime and ornidazole |
| J01XC01 | fusidic acid |
| J01XE02 | nifurtoinol |
| J01XX06 | mandelic acid |
| J02AC | Triazole and tetrazole derivatives |
| J02AC01 | fluconazole |
| J02AC02 | itraconazole |
| J04A | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| J04AA01 | 4-aminosalicylic acid |
| J04AK02 | ethambutol |
| J04BA01 | clofazimine |
| J05AB17 | brincidofovir |
| J05AF07 | tenofovir disoproxil |
| J05AP01 | ribavirin |
| J05AP05 | simeprevir |
| J05AP53 | ombitasvir, paritaprevir and ritonavir |
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir |
| J05AR01 | zidovudine and lamivudine |
| J05AR05 | zidovudine, lamivudine and nevirapine |
| J05AR09 | emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |
| J05AX21 | pentanedioic acid imidazolyl ethanamide |
| J06A | IMMUNE SERA |
| J06AA04 | botulinum antitoxin |
| J06BB03 | varicella/zoster immunoglobulin |
| J06BB19 | anthrax immunoglobulin |
| J06BD01 | palivizumab |
| J07AC01 | anthrax antigen |
| J07AE01 | cholera, inactivated, whole cell |
| J07AF | Diphtheria vaccines |
| J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated |
| J07AH | Meningococcal vaccines |
| J07AJ01 | pertussis, inactivated, whole cell |
| J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
| J07AM51 | tetanus toxoid, combinations with diphtheria toxoid |
| J07AP01 | typhoid, oral, live attenuated |
| J07AP03 | typhoid, purified polysaccharide antigen |
| J07BA01 | encephalitis, tick borne, inactivated, whole virus |
| J07BA02 | encephalitis, Japanese, inactivated, whole virus |
| J07BD51 | measles, combinations with mumps, live attenuated |
| J07BK03 | zoster, purified antigen |
| J07BN02 | covid-19, viral vector, non-replicating |
| J07BN04 | covid-19, protein subunit |
| J07CA | Bacterial and viral vaccines, combined |
| J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus |
| J07CA10 | typhoid-hepatitis A |
| J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B |
| J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B |
| L01 | ANTINEOPLASTIC AGENTS |
| L01AA10 | melphalan flufenamide |
| L01AB | Alkyl sulfonates |
| L01AD05 | fotemustine |
| L01AX03 | temozolomide |
| L01BB03 | tioguanine |
| L01BC02 | fluorouracil |
| L01CA | Vinca alkaloids and analogues |
| L01CC | Colchicine derivatives |
| L01CE02 | irinotecan |
| L01DB04 | aclarubicin |
| L01E | PROTEIN KINASE INHIBITORS |
| L01EA03 | nilotinib |
| L01EB07 | dacomitinib |
| L01EB10 | mobocertinib |
| L01EB11 | aumolertinib |
| L01EE02 | cobimetinib |
| L01EG03 | ridaforolimus |
| L01EH01 | lapatinib |
| L01EH02 | neratinib |
| L01EJ01 | ruxolitinib |
| L01EK02 | cediranib |
| L01EL02 | acalabrutinib |
| L01EM01 | idelalisib |
| L01EM05 | parsaclisib |
| L01EX03 | pazopanib |
| L01EX05 | regorafenib |
| L01EX06 | masitinib |
| L01EX14 | entrectinib |
| L01EX18 | avapritinib |
| L01EX23 | pralsetinib |
| L01FE01 | cetuximab |
| L01FF13 | toripalimab |
| L01FX08 | elotuzumab |
| L01FX12 | tafasitamab |
| L01FX21 | naxitamab |
| L01FX24 | teclistamab |
| L01FY03 | prolgolimab and nurulimab |
| L01X | OTHER ANTINEOPLASTIC AGENTS |
| L01XF01 | tretinoin |
| L01XJ | Hedgehog pathway inhibitors |
| L01XJ03 | glasdegib |
| L01XL05 | ciltacabtagene autoleucel |
| L01XX01 | amsacrine |
| L01XX05 | hydroxycarbamide |
| L01XX11 | estramustine |
| L01XX18 | tiazofurine |
| L01XX41 | eribulin |
| L01XX67 | tagraxofusp |
| L01XY01 | cytarabine and daunorubicin |
| L02AE | Gonadotropin releasing hormone analogues |
| L02BB | Anti-androgens |
| L02BG06 | exemestane |
| L02BX | Other hormone antagonists and related agents |
| L02BX02 | degarelix |
| L03 | IMMUNOSTIMULANTS |
| L03AA | Colony stimulating factors |
| L03AA03 | molgramostim |
| L03AB09 | interferon alfacon-1 |
| L03AB13 | peginterferon beta-1a |
| L03AB16 | peginterferon alfacon-2 |
| L03AB17 | sampeginterferon beta-1a |
| L03AB60 | peginterferon alfa-2b, combinations |
| L03AX05 | pidotimod |
| L03AX14 | histamine dihydrochloride |
| L03AX17 | sipuleucel-T |
| L03AX18 | cridanimod |
| L04A | IMMUNOSUPPRESSANTS |
| L04AA40 | cladribine |
| L04AC09 | briakinumab |
| L04AC10 | secukinumab |
| L04AC14 | sarilumab |
| L04AC18 | risankizumab |
| L04AC19 | satralizumab |
| L04AC24 | mirikizumab |
| L04AD | Calcineurin inhibitors |
| L04AE | Sphingosine-1-phosphate (S1P) receptor modulators |
| L04AE02 | ozanimod |
| L04AE05 | etrasimod |
| L04AF01 | tofacitinib |
| L04AF04 | filgotinib |
| L04AF06 | peficitinib |
| L04AF08 | ritlecitinib |
| L04AG02 | efalizumab |
| L04AG08 | ocrelizumab |
| L04AG12 | ofatumumab |
| M01AB06 | alclofenac |
| M01AB10 | fentiazac |
| M01AB13 | oxametacin |
| M01AB16 | aceclofenac |
| M01AB51 | indometacin, combinations |
| M01AC01 | piroxicam |
| M01AE13 | ibuproxam |
| M01AG04 | meclofenamic acid |
| M01AH03 | valdecoxib |
| M01AH07 | polmacoxib |
| M01C | SPECIFIC ANTIRHEUMATIC AGENTS |
| M02AA29 | esflurbiprofen |
| M02AA31 | loxoprofen |
| M02AB | Capsaicin and similar agents |
| M02AX05 | idrocilamide |
| M03BX03 | pridinol |
| M03BX06 | mephenesin |
| M03BX07 | tetrazepam |
| M03CA | Dantrolene and derivatives |
| M04AA03 | febuxostat |
| M04AA51 | allopurinol, combinations |
| M04AC51 | colchicine and probenecid |
| M04AX01 | urate oxidase |
| M05BA08 | zoledronic acid |
| M05BB06 | alendronic acid and alfacalcidol, sequential |
| M09AA | Quinine and derivatives |
| M09AA72 | quinine, combinations with psycholeptics |
| M09AX14 | givinostat |
| N01AA01 | diethyl ether |
| N01AB05 | trichloroethylene |
| N01AF01 | methohexital |
| N01BA | Esters of aminobenzoic acid |
| N01BA03 | tetracaine |
| N01BB | Amides |
| N01BB08 | articaine |
| N01BB09 | ropivacaine |
| N01BB54 | prilocaine, combinations |
| N01BB59 | bupivacaine and meloxicam |
| N02AA04 | nicomorphine |
| N02AA10 | papaveretum |
| N02AA51 | morphine, combinations |
| N02AB01 | ketobemidone |
| N02AB03 | fentanyl |
| N02AB72 | pethidine, combinations with psycholeptics |
| N02AC03 | piritramide |
| N02AC54 | dextropropoxyphene, combinations excl. psycholeptics |
| N02AF | Morphinan derivatives |
| N02AF01 | butorphanol |
| N02AG | Opioids in combination with antispasmodics |
| N02AG01 | morphine and antispasmodics |
| N02AJ03 | dihydrocodeine and other non-opioid analgesics |
| N02AX06 | tapentadol |
| N02AX07 | oliceridine |
| N02BA02 | aloxiprin |
| N02BA03 | choline salicylate |
| N02BA07 | ethenzamide |
| N02BA08 | morpholine salicylate |
| N02BA11 | diflunisal |
| N02BA14 | guacetisal |
| N02BA71 | acetylsalicylic acid, combinations with psycholeptics |
| N02BB01 | phenazone |
| N02BB54 | propyphenazone, combinations excl. psycholeptics |
| N02BG06 | nefopam |
| N02BG09 | methoxyflurane |
| N02CA | Ergot alkaloids |
| N02CA07 | lisuride |
| N02CC05 | almotriptan |
| N02CC08 | lasmiditan |
| N02CD | Calcitonin gene-related peptide (CGRP) antagonists |
| N02CX02 | clonidine |
| N03AA01 | methylphenobarbital |
| N03AF | Carboxamide derivatives |
| N03AX24 | cannabidiol |
| N04AA04 | procyclidine |
| N04AA08 | dexetimide |
| N04AA10 | mazaticol |
| N04AC01 | benzatropine |
| N04BB01 | amantadine |
| N04BC08 | piribedil |
| N04BD01 | selegiline |
| N04CX | Other antiparkinson drugs |
| N05AA03 | promazine |
| N05AC | Phenothiazines with piperidine structure |
| N05AC03 | mesoridazine |
| N05AD01 | haloperidol |
| N05AD04 | moperone |
| N05AD08 | droperidol |
| N05AD09 | fluanisone |
| N05AE01 | oxypertine |
| N05AE03 | sertindole |
| N05AH02 | clozapine |
| N05AH53 | olanzapine and samidorphan |
| N05AX14 | iloperidone |
| N05BA18 | ethyl loflazepate |
| N05BA19 | etizolam |
| N05BB02 | captodiame |
| N05BC03 | emylcamate |
| N05CA01 | pentobarbital |
| N05CC05 | paraldehyde |
| N05CM09 | Valerianae radix |
| N05CX05 | emepronium, combinations |
| N06AA12 | doxepin |
| N06AA19 | amineptine |
| N06AB | Selective serotonin reuptake inhibitors |
| N06AB06 | sertraline |
| N06AB07 | alaproclate |
| N06AF03 | phenelzine |
| N06AX13 | medifoxamine |
| N06AX17 | milnacipran |
| N06AX24 | vilazodone |
| N06AX29 | brexanolone |
| N06B | PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS |
| N06BX01 | meclofenoxate |
| N06BX02 | pyritinol |
| N06BX07 | oxiracetam |
| N06BX12 | acetylcarnitine |
| N06BX14 | prolintane |
| N06CA | Antidepressants in combination with psycholeptics |
| N06CA02 | melitracen and psycholeptics |
| N06DA53 | donepezil, memantine and Ginkgo folium |
| N07AA30 | ambenonium |
| N07BB | Drugs used in alcohol dependence |
| N07CA02 | cinnarizine |
| N07XX05 | amifampridine |
| N07XX06 | tetrabenazine |
| N07XX14 | edaravone |
| N07XX16 | deutetrabenazine |
| N07XX23 | troriluzole |
| P01AB05 | propenidazole |
| P01AB52 | metronidazole and diloxanide |
| P01AC04 | teclozan |
| P01AR | Arsenic compounds |
| P01AR02 | difetarsone |
| P01AR03 | glycobiarsol |
| P01AR53 | glycobiarsol, combinations |
| P01AX06 | atovaquone |
| P01AX09 | dehydroemetine |
| P01BA | Aminoquinolines |
| P01BF04 | artesunate, sulfalene and pyrimethamine |
| P01BF09 | artesunate, sulfadoxine and pyrimethamine |
| P01CC01 | nifurtimox |
| P01CD | Arsenic compounds |
| P01CX | Other agents against leishmaniasis and trypanosomiasis |
| P01CX01 | pentamidine isethionate |
| P01CX03 | eflornithine |
| P01CX04 | miltefosine |
| P02BA01 | praziquantel |
| P02BX03 | stibophen |
| P02CA03 | albendazole |
| P02CA51 | mebendazole, combinations |
| P02DX | Other anticestodals |
| P03AA03 | mesulfen |
| P03AB | Chlorine containing products |
| P03AC04 | permethrin |
| P03AX03 | malathion |
| P03AX04 | quassia |
| P03AX05 | dimeticone |
| P03BA03 | decamethrin |
| R01AA02 | cyclopentamine |
| R01AA04 | phenylephrine |
| R01AA05 | oxymetazoline |
| R01AB02 | naphazoline |
| R01AB06 | xylometazoline |
| R01AB08 | tuaminoheptane |
| R01BA01 | phenylpropanolamine |
| R01BA03 | phenylephrine |
| R02AA11 | chlorquinaldol |
| R02AA15 | povidone-iodine |
| R03A | ADRENERGICS, INHALANTS |
| R03AA | Alpha- and beta-adrenoreceptor agonists |
| R03AC14 | clenbuterol |
| R03AH | Combinations of adrenergics |
| R03AK15 | salbutamol and budesonide |
| R03AL | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids |
| R03BB03 | stramoni preparations |
| R03CC04 | fenoterol |
| R03CC06 | isoetarine |
| R03DB05 | aminophylline and adrenergics |
| R03DC04 | ibudilast |
| R03DC53 | montelukast, combinations |
| R03DX08 | reslizumab |
| R03DX11 | tezepelumab |
| R05 | COUGH AND COLD PREPARATIONS |
| R05CA01 | tyloxapol |
| R05CB04 | eprazinone |
| R05CB07 | sobrerol |
| R05CB09 | letosteine |
| R05DA05 | opium alkaloids with morphine |
| R05DB14 | fedrilate |
| R05FB01 | cough suppressants and mucolytics |
| R05FB02 | cough suppressants and expectorants |
| R06AA01 | bromazine |
| R06AA02 | diphenhydramine |
| R06AA61 | dimenhydrinate, combinations |
| R06AB03 | dimetindene |
| R06AC53 | chloropyramine, combinations |
| R06AD | Phenothiazine derivatives |
| R06AD06 | thiazinam |
| R06AE03 | cyclizine |
| R06AK | Combinations of antihistamines |
| R06AX03 | thenalidine |
| R07AA | Lung surfactants |
| R07AB52 | nikethamide, combinations |
| R07AX01 | nitric oxide |
| S01AA16 | rifamycin |
| S01AD | Antivirals |
| S01AD01 | idoxuridine |
| S01AE02 | norfloxacin |
| S01AX02 | silver compounds |
| S01AX03 | zinc compounds |
| S01AX05 | bibrocathol |
| S01AX18 | povidone-iodine |
| S01BA | Corticosteroids, plain |
| S01BA02 | hydrocortisone |
| S01BA06 | betamethasone |
| S01BA15 | fluocinolone acetonide |
| S01BB03 | fluorometholone and mydriatics |
| S01BC | Antiinflammatory agents, non-steroids |
| S01BC05 | ketorolac |
| S01BC09 | pranoprofen |
| S01C | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| S01CA02 | prednisolone and antiinfectives |
| S01CA04 | fluocortolone and antiinfectives |
| S01CA10 | fluocinolone acetonide and antiinfectives |
| S01EA | Sympathomimetics in glaucoma therapy |
| S01EB | Parasympathomimetics |
| S01EB04 | demecarium |
| S01EB05 | physostigmine |
| S01EC54 | brinzolamide, combinations |
| S01EE05 | tafluprost |
| S01FA56 | tropicamide, combinations |
| S01GA | Sympathomimetics used as decongestants |
| S01GA02 | tetryzoline |
| S01GA56 | oxedrine, combinations |
| S01GX51 | cromoglicic acid, combinations |
| S01KA01 | hyaluronic acid |
| S01KX02 | trypan blue |
| S01LA05 | aflibercept |
| S01XA | Other ophthalmologicals |
| S01XA07 | alum |
| S01XA13 | alteplase |
| S01XA21 | mercaptamine |
| S01XA25 | lifitegrast |
| S01XA27 | voretigene neparvovec |
| S01XA29 | sepofarsen |
| S02AA01 | chloramphenicol |
| S02AA02 | nitrofural |
| S02AA03 | boric acid |
| S02CA02 | flumetasone and antiinfectives |
| S02CA04 | triamcinolone and antiinfectives |
| S02DA | Analgesics and anesthetics |
| S02DA01 | lidocaine |
| S02DA03 | phenazone |
| S03A | ANTIINFECTIVES |
| S03AA02 | tetracycline |
| S03AA06 | gentamicin |
| S03BA | Corticosteroids |
| V01A | ALLERGENS |
| V03AB04 | pralidoxime |
| V03AB08 | sodium nitrite |
| V03AB32 | glutathione |
| V03AB38 | andexanet alfa |
| V03AE03 | lanthanum carbonate |
| V03AE05 | sucroferric oxyhydroxide |
| V03AE06 | colestilan |
| V03AE09 | patiromer calcium |
| V03AF05 | amifostine |
| V03AF12 | trilaciclib |
| V03AG | Drugs for treatment of hypercalcemia |
| V03AH01 | diazoxide |
| V03AN02 | carbon dioxide |
| V04C | OTHER DIAGNOSTIC AGENTS |
| V04CC03 | sincalide |
| V04CD05 | somatorelin |
| V04CF01 | tuberculin |
| V04CG01 | cation exchange resins |
| V04CH01 | inulin and other polyfructosans |
| V04CH02 | indigo carmine |
| V04CH04 | alsactide |
| V04CJ | Tests for thyreoidea function |
| V04CK02 | pancreozymin (cholecystokinin) |
| V06DC01 | glucose |
| V07 | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V07AD | Blood tests, auxiliary products |
| V07AX | Washing agents etc. |
| V07AY | Other non-therapeutic auxiliary products |
| V08AA05 | ioxitalamic acid |
| V08AA10 | diodone |
| V08AB09 | iodixanol |
| V08AB12 | ioxilan |
| V08CA04 | gadoteridol |
| V08CA06 | gadoversetamide |
| V08CA10 | gadoxetic acid |
| V08CX01 | perflubron |
| V08DA03 | perflenapent |
| V09 | DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09B | SKELETON |
| V09CA03 | technetium (99mTc) mertiatide |
| V09DA04 | technetium (99mTc) mebrofenin |
| V09DB02 | technetium (99mTc) microcolloid |
| V09DB06 | technetium (99mTc) rheniumsulfide colloid |
| V09EA | Technetium (99mTc), inhalants |
| V09EB | Technetium (99mTc), particles for injection |
| V09GB01 | fibrinogen (125I) |
| V09GB02 | iodine (125I) human albumin |
| V09GX05 | ammonia (13N) |
| V09HA | Technetium (99mTc) compounds |
| V09IA03 | technetium (99mTc) pentavalent succimer |
| V09IB03 | indium (111In) antiovariumcarcinoma antibody |
| V09IX07 | fluorocholine (18F) |
| V09IX14 | gallium (68Ga) gozetotide |
| V09IX16 | piflufolastat (18F) |
| V09XX02 | cobalt (58Co) cyanocobalamine |
| V10AX | Other antiinflammatory therapeutic radiopharmaceuticals |
| V10AX01 | phosphorous (32P) chromicphosphate colloid |
| V10XA01 | sodium iodide (131I) |
| V10XA02 | iobenguane (131I) |
| A01AA02 | sodium monofluorophosphate |
| A01AB17 | metronidazole |
| A01AB22 | doxycycline |
| A02AB03 | aluminium phosphate |
| A02AB04 | dihydroxialumini sodium carbonate |
| A02AD01 | ordinary salt combinations |
| A02BA01 | cimetidine |
| A02BC03 | lansoprazole |
| A02BC08 | vonoprazan |
| A02BD09 | lansoprazole, clarithromycin and tinidazole |
| A02BX15 | teprenone |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AB01 | benzilone |
| A03AB04 | penthienate |
| A03AB05 | propantheline |
| A03AB07 | methantheline |
| A03AB11 | poldine |
| A03AX03 | chlorbenzoxamine |
| A03AX07 | proxazole |
| A03AX08 | alverine |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA04 | belladonna total alkaloids |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA04 | otilonium bromide and psycholeptics |
| A03CA08 | diphemanil and psycholeptics |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination |
| A03F | PROPULSIVES |
| A04AA04 | dolasetron |
| A05B | LIVER THERAPY, LIPOTROPICS |
| A05BA10 | phospholipids |
| A06AB01 | oxyphenisatine |
| A06AB02 | bisacodyl |
| A06AB07 | cascara |
| A06AB30 | contact laxatives in combination with belladonna alkaloids |
| A06AC02 | ethulose |
| A06AC03 | sterculia |
| A06AC05 | linseed |
| A06AC53 | sterculia, combinations |
| A06AD16 | mannitol |
| A06AG06 | oil |
| A06AX | Other drugs for constipation |
| A06AX02 | carbon dioxide producing drugs |
| A06AX05 | prucalopride |
| A06AX06 | tegaserod |
| A07AB | Sulfonamides |
| A07AC | Imidazole derivatives |
| A07AX04 | nifurzide |
| A07BC54 | attapulgite, combinations |
| A07DA52 | morphine, combinations |
| A07E | INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA | Corticosteroids acting locally |
| A07EA03 | prednisone |
| A08AA02 | fenfluramine |
| A08AA03 | amfepramone |
| A08AA05 | mazindol |
| A08AA09 | mefenorex |
| A08AA11 | lorcaserin |
| A08AA62 | bupropion and naltrexone |
| A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10AD03 | insulin (pork) |
| A10AF01 | insulin (human) |
| A10BB11 | glisoxepide |
| A10BD05 | metformin and pioglitazone |
| A10BD15 | metformin and dapagliflozin |
| A10BD19 | linagliptin and empagliflozin |
| A10BD20 | metformin and empagliflozin |
| A10BH52 | gemigliptin and rosuvastatin |
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues |
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| A10BK05 | ipragliflozin |
| A10BK06 | sotagliflozin |
| A10BK07 | luseogliflozin |
| A10BX | Other blood glucose lowering drugs, excl. insulins |
| A10BX02 | repaglinide |
| A10BX08 | mitiglinide |
| A11A | MULTIVITAMINS, COMBINATIONS |
| A11BA | Multivitamins, plain |
| A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CC20 | combinations |
| A11CC55 | colecalciferol, combinations |
| A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| A11GA | Ascorbic acid (vitamin C), plain |
| A11GB | Ascorbic acid (vitamin C), combinations |
| A11HA | Other plain vitamin preparations |
| A11JB | Vitamins with minerals |
| A12 | MINERAL SUPPLEMENTS |
| A12AA03 | calcium gluconate |
| A12AA04 | calcium carbonate |
| A12CC01 | magnesium chloride |
| A12CE02 | sodium selenite |
| A14AA06 | quinbolone |
| A14AB02 | ethylestrenol |
| A14AB03 | oxabolone cipionate |
| A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AB03 | agalsidase alfa |
| A16AB07 | alglucosidase alfa |
| A16AB10 | velaglucerase alfa |
| A16AB12 | elosulfase alfa |
| A16AB22 | avalglucosidase alfa |
| A16AX12 | trientine |
| A16AX18 | lumasiran |
| B01AA | Vitamin K antagonists |
| B01AA11 | tioclomarol |
| B01AB01 | heparin |
| B01AB04 | dalteparin |
| B01AB11 | sulodexide |
| B01AC08 | carbasalate calcium |
| B01AC21 | treprostinil |
| B01AC22 | prasugrel |
| B01AC26 | vorapaxar |
| B01AD07 | reteplase |
| B01AE01 | desirudin |
| B01AF | Direct factor Xa inhibitors |
| B01AX01 | defibrotide |
| B01AX05 | fondaparinux |
| B02 | ANTIHEMORRHAGICS |
| B02AA02 | tranexamic acid |
| B02BC03 | tetragalacturonic acid hydroxymethylester |
| B02BD14 | susoctocog alfa |
| B02BD15 | valoctocogene roxaparvovec |
| B02BD30 | thrombin |
| B02BX07 | lusutrombopag |
| B03AA06 | ferrous succinate |
| B03AB03 | sodium feredetate |
| B03AB05 | ferric oxide polymaltose complexes |
| B03B | VITAMIN B12 AND FOLIC ACID |
| B03XA03 | methoxy polyethylene glycol-epoetin beta |
| B03XA04 | peginesatide |
| B05AA03 | fluorocarbon blood substitutes |
| B05AA09 | hemoglobin raffimer |
| B05BB01 | electrolytes |
| B05BB02 | electrolytes with carbohydrates |
| B05BC | Solutions producing osmotic diuresis |
| B05CA07 | noxytiolin |
| B05CA08 | ethacridine lactate |
| B05CB04 | sodium bicarbonate |
| B05CX | Other irrigating solutions |
| B05XA01 | potassium chloride |
| B05XA04 | ammonium chloride |
| B05XA10 | magnesium phosphate |
| B05XA19 | calcium gluconate |
| B05XX | Other i.v. solution additives |
| B06AB01 | hemin |
| B06AC04 | conestat alfa |
| B06AC05 | lanadelumab |
| B06AX01 | crizanlizumab |
| B06AX04 | mitapivat |
| C | CARDIOVASCULAR SYSTEM |
| C01AA | Digitalis glycosides |
| C01AC | Strophanthus glycosides |
| C01BA13 | hydroquinidine |
| C01BC07 | lorcainide |
| C01BC08 | encainide |
| C01BD01 | amiodarone |
| C01BD03 | bunaftine |
| C01BD06 | tedisamil |
| C01CA02 | isoprenaline |
| C01CA07 | dobutamine |
| C01CA18 | octopamine |
| C01CA25 | amezinium metilsulfate |
| C01DA57 | propatylnitrate, combinations |
| C01DX06 | hexobendine |
| C01DX16 | nicorandil |
| C01DX19 | nesiritide |
| C01E | OTHER CARDIAC PREPARATIONS |
| C01EB06 | fosfocreatine |
| C01EB11 | tiracizine |
| C01EB13 | acadesine |
| C01EB24 | mavacamten |
| C02 | ANTIHYPERTENSIVES |
| C02A | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| C02AA02 | reserpine |
| C02AA05 | deserpidine |
| C02AA52 | reserpine, combinations |
| C02AB01 | methyldopa (levorotatory) |
| C02CA01 | prazosin |
| C02CA02 | indoramin |
| C02DC01 | minoxidil |
| C02DG01 | pinacidil |
| C02KA01 | veratrum |
| C02KC01 | pargyline |
| C02KD01 | ketanserin |
| C02LA08 | rauwolfia alkaloids, whole root and diuretics |
| C02LC51 | clonidine and diuretics, combinations with other drugs |
| C02LE | Alpha-adrenoreceptor antagonists and diuretics |
| C02LG | Hydrazinophthalazine derivatives and diuretics |
| C02LX01 | pinacidil and diuretics |
| C03AX | Thiazides, combinations with other drugs |
| C03BA02 | quinethazone |
| C03BA10 | xipamide |
| C03CA03 | piretanide |
| C03CA04 | torasemide |
| C03CB | Sulfonamides and potassium in combination |
| C03CX01 | etozolin |
| C03DA01 | spironolactone |
| C03DA02 | potassium canrenoate |
| C03DB | Other potassium-sparing agents |
| C03EB01 | furosemide and potassium-sparing agents |
| C03XA | Vasopressin antagonists |
| C04AA01 | isoxsuprine |
| C04AB | Imidazoline derivatives |
| C04AB02 | tolazoline |
| C04AE51 | ergoloid mesylates, combinations |
| C04AX02 | phenoxybenzamine |
| C04AX28 | ifenprodil |
| C04AX32 | fasudil |
| C05AA04 | prednisolone |
| C05AA12 | triamcinolone |
| C05AD05 | procaine |
| C05AD07 | pramocaine |
| C05AX05 | tribenoside |
| C05BB | Sclerosing agents for local injection |
| C05BB02 | polidocanol |
| C05BB56 | glucose, combinations |
| C05BX | Other sclerosing agents |
| C05CA | Bioflavonoids |
| C05CA03 | diosmin |
| C05CA04 | troxerutin |
| C05CA51 | rutoside, combinations |
| C07 | BETA BLOCKING AGENTS |
| C07AA16 | tertatolol |
| C07AA23 | penbutolol |
| C07AB13 | talinolol |
| C07AG02 | carvedilol |
| C07BA07 | sotalol and thiazides |
| C07BB | Beta blocking agents, selective, and thiazides |
| C07BB07 | bisoprolol and thiazides |
| C07CA17 | bopindolol and other diuretics |
| C07CB02 | metoprolol and other diuretics |
| C07D | BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS |
| C07E | BETA BLOCKING AGENTS AND VASODILATORS |
| C07FB02 | metoprolol and felodipine |
| C07FB03 | atenolol and nifedipine |
| C07FX02 | sotalol and acetylsalicylic acid |
| C08CA06 | nimodipine |
| C08CA12 | barnidipine |
| C08CA13 | lercanidipine |
| C08CA16 | clevidipine |
| C08D | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
| C08GA | Calcium channel blockers and diuretics |
| C09AA08 | cilazapril |
| C09AA15 | zofenopril |
| C09BA02 | enalapril and diuretics |
| C09BA07 | benazepril and diuretics |
| C09BA09 | fosinopril and diuretics |
| C09BB03 | lisinopril and amlodipine |
| C09BB06 | enalapril and nitrendipine |
| C09CA06 | candesartan |
| C09CA09 | azilsartan medoxomil |
| C09DA01 | losartan and diuretics |
| C09DB | Angiotensin II receptor blockers (ARBs) and calcium channel blockers |
| C09DX05 | valsartan and nebivolol |
| C09XA01 | remikiren |
| C10A | LIPID MODIFYING AGENTS, PLAIN |
| C10AB | Fibrates |
| C10AB11 | choline fenofibrate |
| C10AC02 | colestipol |
| C10AC03 | colextran |
| C10AC04 | colesevelam |
| C10AX09 | ezetimibe |
| C10AX14 | alirocumab |
| C10B | LIPID MODIFYING AGENTS, COMBINATIONS |
| C10BA12 | pravastatin, ezetimibe and fenofibrate |
| C10BX06 | atorvastatin, acetylsalicylic acid and ramipril |
| C10BX12 | atorvastatin, acetylsalicylic acid and perindopril |
| C10BX15 | atorvastatin and perindopril |
| C10BX21 | rosuvastatin and perindopril |
| D01AA02 | natamycin |
| D01AA06 | mepartricin |
| D01AC20 | imidazoles/triazoles in combination with corticosteroids |
| D01AE02 | methylrosaniline |
| D01AE11 | haloprogin |
| D01AE13 | selenium sulfide |
| D01AE16 | amorolfine |
| D01AE20 | combinations |
| D02BB01 | betacarotene |
| D03AX | Other cicatrizants |
| D03AX03 | dexpanthenol |
| D03AX04 | calcium pantothenate |
| D03AX11 | sodium chlorite |
| D03BA52 | collagenase, combinations |
| D04AA13 | dimetindene |
| D04AA32 | diphenhydramine |
| D04AA34 | chlorphenoxamine |
| D04AB | Anesthetics for topical use |
| D04AB03 | oxybuprocaine |
| D05AX55 | tazarotene and ulobetasol |
| D05BB | Retinoids for treatment of psoriasis |
| D05BB02 | acitretin |
| D06A | ANTIBIOTICS FOR TOPICAL USE |
| D06BA | Sulfonamides |
| D06BA04 | sulfamethizole |
| D06BA06 | sulfamerazine |
| D06BB04 | podophyllotoxin |
| D06BB07 | lysozyme |
| D07 | CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS |
| D07AA01 | methylprednisolone |
| D07AB09 | triamcinolone |
| D07AC01 | betamethasone |
| D07AC13 | mometasone |
| D07B | CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS |
| D07BB | Corticosteroids, moderately potent, combinations with antiseptics |
| D07BC02 | fluocinolone acetonide and antiseptics |
| D07CA03 | prednisolone and antibiotics |
| D07CB02 | fluprednidene and antibiotics |
| D07CC05 | fluocinonide and antibiotics |
| D07XB03 | fluprednidene |
| D07XB30 | combinations of corticosteroids |
| D07XC | Corticosteroids, potent, other combinations |
| D08AA | Acridine derivatives |
| D08AA02 | aminoacridine |
| D08AE06 | biphenylol |
| D08AG04 | diiodohydroxypropane |
| D08AJ10 | decamethoxine |
| D08AL30 | silver |
| D09AA03 | nitrofural |
| D10 | ANTI-ACNE PREPARATIONS |
| D10AB01 | bithionol |
| D10AB02 | sulfur |
| D10AD03 | adapalene |
| D10AD53 | adapalene, combinations |
| D10AF | Antiinfectives for treatment of acne |
| D10AF07 | minocycline |
| D10AX30 | various combinations |
| D11AC02 | cadmium compounds |
| D11AC30 | others |
| D11AE | Androgens for topical use |
| D11AH01 | tacrolimus |
| D11AH02 | pimecrolimus |
| D11AX | Other dermatologicals |
| D11AX02 | gamolenic acid |
| G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS |
| G01AA08 | carfecillin |
| G01AF08 | tioconazole |
| G01AF14 | propenidazole |
| G01AF19 | sertaconazole |
| G01AF55 | econazole, combinations |
| G01AX05 | nifuratel |
| G01AX14 | lactobacillus |
| G01AX17 | dapivirine |
| G01B | ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS |
| G01BD | Antiseptics and corticosteroids |
| G01BF | Imidazole derivatives and corticosteroids |
| G02AC01 | methylergometrine and oxytocin |
| G02AD02 | dinoprostone |
| G02AD05 | sulprostone |
| G02AD06 | misoprostol |
| G02BA02 | plastic IUD with copper |
| G02BA03 | plastic IUD with progestogen |
| G02BB01 | vaginal ring with progestogen and estrogen |
| G02CA02 | buphenine |
| G02CB01 | bromocriptine |
| G02CX02 | flibanserin |
| G03AA07 | levonorgestrel and ethinylestradiol |
| G03AA10 | gestodene and ethinylestradiol |
| G03AA13 | norelgestromin and ethinylestradiol |
| G03AB08 | dienogest and estradiol |
| G03AC03 | levonorgestrel |
| G03BA | 3-oxoandrosten (4) derivatives |
| G03BB01 | mesterolone |
| G03CA01 | ethinylestradiol |
| G03CB02 | diethylstilbestrol |
| G03CC02 | dienestrol |
| G03CX | Other estrogens |
| G03CX01 | tibolone |
| G03DB05 | demegestone |
| G03DC06 | etynodiol |
| G03EK01 | methyltestosterone |
| G03FA03 | ethisterone and estrogen |
| G03FB04 | megestrol and estrogen |
| G03FB05 | norethisterone and estrogen |
| G03FB09 | levonorgestrel and estrogen |
| G03GA02 | human menopausal gonadotrophin |
| G03GA07 | lutropin alfa |
| G03GA10 | follitropin delta |
| G03GB | Ovulation stimulants, synthetic |
| G03HB | Antiandrogens and estrogens |
| G03XA02 | gestrinone |
| G03XC03 | lasofoxifene |
| G04B | UROLOGICALS |
| G04BD02 | flavoxate |
| G04BD08 | solifenacin |
| G04BD13 | desfesoterodine |
| G04BE10 | avanafil |
| G04BX | Other urologicals |
| H01BA02 | desmopressin |
| H01C | HYPOTHALAMIC HORMONES |
| H01CA | Gonadotropin-releasing hormones |
| H01CA02 | nafarelin |
| H01CC03 | elagolix |
| H02A | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| H02AB03 | fluocortolone |
| H02BX01 | methylprednisolone, combinations |
| H02CA01 | trilostane |
| H03AA | Thyroid hormones |
| H03BA03 | benzylthiouracil |
| H05AA05 | palopegteriparatide |
| H05B | ANTI-PARATHYROID AGENTS |
| H05BX02 | paricalcitol |
| J01AA | Tetracyclines |
| J01CA05 | carindacillin |
| J01CA10 | mezlocillin |
| J01CE | Beta-lactamase sensitive penicillins |
| J01CE07 | clometocillin |
| J01CE09 | procaine benzylpenicillin |
| J01CF02 | cloxacillin |
| J01CF06 | nafcillin |
| J01CR03 | ticarcillin and beta-lactamase inhibitor |
| J01DB01 | cefalexin |
| J01DB10 | cefacetrile |
| J01DC07 | cefotiam |
| J01DC14 | flomoxef |
| J01DD09 | cefodizime |
| J01DE02 | cefpirome |
| J01DE03 | cefozopran |
| J01DH03 | ertapenem |
| J01DH52 | meropenem and vaborbactam |
| J01EA | Trimethoprim and derivatives |
| J01EB07 | sulfathiazole |
| J01EC01 | sulfamethoxazole |
| J01EE04 | sulfamoxole and trimethoprim |
| J01FA02 | spiramycin |
| J01FA03 | midecamycin |
| J01FA05 | oleandomycin |
| J01FA10 | azithromycin |
| J01FF01 | clindamycin |
| J01FF02 | lincomycin |
| J01G | AMINOGLYCOSIDE ANTIBACTERIALS |
| J01GA01 | streptomycin |
| J01GB01 | tobramycin |
| J01GB08 | sisomicin |
| J01GB14 | plazomicin |
| J01MA | Fluoroquinolones |
| J01MA13 | trovafloxacin |
| J01MA24 | levonadifloxacin |
| J01MB03 | piromidic acid |
| J01RA | Combinations of antibacterials |
| J01RA02 | sulfonamides, combinations with other antibacterials (excl. trimethoprim) |
| J01RA03 | cefuroxime and metronidazole |
| J01RA10 | ciprofloxacin and metronidazole |
| J01XD | Imidazole derivatives |
| J02AC03 | voriconazole |
| J02AX06 | anidulafungin |
| J02AX08 | rezafungin acetate |
| J04 | ANTIMYCOBACTERIALS |
| J04AB04 | rifabutin |
| J04AK03 | terizidone |
| J04AK07 | thioacetazone |
| J04B | DRUGS FOR TREATMENT OF LEPRA |
| J04BA | Drugs for treatment of lepra |
| J04BA51 | dapsone, rifampicin and clofazimine |
| J05AB06 | ganciclovir |
| J05AB09 | famciclovir |
| J05AE08 | atazanavir |
| J05AF03 | zalcitabine |
| J05AF10 | entecavir |
| J05AJ04 | cabotegravir |
| J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir |
| J05AP57 | glecaprevir and pibrentasvir |
| J05AR12 | lamivudine and tenofovir disoproxil |
| J05AR14 | darunavir and cobicistat |
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat |
| J05AX05 | inosine pranobex |
| J05AX07 | enfuvirtide |
| J05AX26 | amenamevir |
| J05AX29 | fostemsavir |
| J06B | IMMUNOGLOBULINS |
| J06BB | Specific immunoglobulins |
| J06BB13 | pertussis immunoglobulin |
| J06BD08 | nirsevimab |
| J07AE | Cholera vaccines |
| J07AG01 | haemophilus influenzae B, purified antigen conjugated |
| J07AH02 | other meningococcal monovalent purified polysaccharides antigen |
| J07AL | Pneumococcal vaccines |
| J07AL01 | pneumococcus, purified polysaccharides antigen |
| J07AM01 | tetanus toxoid |
| J07AN | Tuberculosis vaccines |
| J07AP | Typhoid vaccines |
| J07AR01 | typhus exanthematicus, inactivated, whole cell |
| J07AX01 | leptospira vaccines |
| J07BC20 | combinations |
| J07BD52 | measles, combinations with mumps and rubella, live attenuated |
| J07BE01 | mumps, live attenuated |
| J07BK02 | zoster, live attenuated |
| J07BM02 | papillomavirus (human types 16, 18) |
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |
| J07BX04 | dengue virus vaccines |
| J07CA04 | haemophilus influenzae B and poliomyelitis |
| L01AA03 | melphalan |
| L01AA06 | ifosfamide |
| L01AD02 | lomustine |
| L01BB06 | clofarabine |
| L01BC05 | gemcitabine |
| L01BC07 | azacitidine |
| L01BC53 | tegafur, combinations |
| L01CD03 | paclitaxel poliglumex |
| L01CX01 | trabectedin |
| L01DA | Actinomycines |
| L01DB02 | daunorubicin |
| L01DB03 | epirubicin |
| L01DB10 | amrubicin |
| L01DB11 | pixantrone |
| L01DC04 | ixabepilone |
| L01EA05 | ponatinib |
| L01EB01 | gefitinib |
| L01EB02 | erlotinib |
| L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors |
| L01EC01 | vemurafenib |
| L01EH03 | tucatinib |
| L01EJ02 | fedratinib |
| L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| L01EL | Bruton's tyrosine kinase (BTK) inhibitors |
| L01EN02 | pemigatinib |
| L01EX13 | gilteritinib |
| L01EX22 | selpercatinib |
| L01EX27 | capivasertib |
| L01FA03 | obinutuzumab |
| L01FD03 | trastuzumab emtansine |
| L01FE02 | panitumumab |
| L01FF01 | nivolumab |
| L01FG | VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors |
| L01FX | Other monoclonal antibodies and antibody drug conjugates |
| L01FX18 | amivantamab |
| L01FX19 | sabatolimab |
| L01FX26 | mirvetuximab soravtansine |
| L01FY02 | nivolumab and relatlimab |
| L01XA | Platinum compounds |
| L01XA01 | cisplatin |
| L01XA04 | satraplatin |
| L01XD03 | methyl aminolevulinate |
| L01XD05 | temoporfin |
| L01XH03 | panobinostat |
| L01XK04 | talazoparib |
| L01XL02 | talimogene laherparepvec |
| L01XL03 | axicabtagene ciloleucel |
| L01XL07 | idecabtagene vicleucel |
| L01XX62 | ivosidenib |
| L01XX79 | eflornithine |
| L02 | ENDOCRINE THERAPY |
| L02AX | Other hormones |
| L02BB01 | flutamide |
| L03AA13 | pegfilgrastim |
| L03AA17 | pegteograstim |
| L03AA18 | efbemalenograstim alfa |
| L03AB01 | interferon alfa natural |
| L03AB11 | peginterferon alfa-2a |
| L03AB61 | peginterferon alfa-2a, combinations |
| L03AC02 | oprelvekin |
| L03AX12 | melanoma vaccine |
| L03AX13 | glatiramer acetate |
| L03AX15 | mifamurtide |
| L04AA03 | antilymphocyte immunoglobulin (horse) |
| L04AA04 | antithymocyte immunoglobulin (rabbit) |
| L04AA22 | abetimus |
| L04AA32 | apremilast |
| L04AA48 | belumosudil |
| L04AB04 | adalimumab |
| L04AC03 | anakinra |
| L04AC04 | rilonacept |
| L04AC21 | bimekizumab |
| L04AE04 | ponesimod |
| L04AF03 | upadacitinib |
| L04AG01 | muromonab-CD3 |
| L04AG03 | natalizumab |
| L04AG04 | belimumab |
| L04AJ06 | zilucoplan |
| L04AJ09 | danicopan |
| L04AX01 | azathioprine |
| L04AX04 | lenalidomide |
| L04AX08 | darvadstrocel |
| M01A | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS |
| M01AA05 | clofezone |
| M01AB04 | zomepirac |
| M01AB09 | lonazolac |
| M01AB55 | diclofenac, combinations |
| M01AE02 | naproxen |
| M01AE07 | suprofen |
| M01AE09 | flurbiprofen |
| M01AE15 | flunoxaprofen |
| M01AE52 | naproxen and esomeprazole |
| M01AH01 | celecoxib |
| M01AH04 | parecoxib |
| M01AX02 | niflumic acid |
| M01AX04 | azapropazone |
| M01AX24 | oxaceprol |
| M01BA | Antiinflammatory/antirheumatic agents in combination with corticosteroids |
| M01CB04 | aurothioglucose |
| M01CC01 | penicillamine |
| M02AA01 | phenylbutazone |
| M02AA08 | felbinac |
| M02AA18 | meclofenamic acid |
| M02AX02 | tolazoline |
| M02AX03 | dimethyl sulfoxide |
| M03AC09 | rocuronium bromide |
| M03B | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| M03BA | Carbamic acid esters |
| M03BC51 | orphenadrine, combinations |
| M03BX | Other centrally acting agents |
| M03BX05 | thiocolchicoside |
| M03CA01 | dantrolene |
| M04AC | Preparations with no effect on uric acid metabolism |
| M05BB | Bisphosphonates, combinations |
| M05BB04 | risedronic acid, calcium and colecalciferol, sequential |
| M05BB05 | alendronic acid, calcium and colecalciferol, sequential |
| M05BC02 | eptotermin alfa |
| M05BX07 | vosoritide |
| M09 | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09AX02 | chondrocytes, autologous |
| M09AX04 | drisapersen |
| M09AX13 | casimersen |
| N01AB07 | desflurane |
| N01AX14 | esketamine |
| N01B | ANESTHETICS, LOCAL |
| N01BB53 | mepivacaine, combinations |
| N01BC | Esters of benzoic acid |
| N02AA01 | morphine |
| N02AA08 | dihydrocodeine |
| N02AB | Phenylpiperidine derivatives |
| N02AC04 | dextropropoxyphene |
| N02AX01 | tilidine |
| N02AX51 | tilidine and naloxone |
| N02BA55 | salicylamide, combinations excl. psycholeptics |
| N02BA75 | salicylamide, combinations with psycholeptics |
| N02BB53 | aminophenazone, combinations excl. psycholeptics |
| N02BE | Anilides |
| N02BE03 | phenacetin |
| N02BE05 | propacetamol |
| N02BE53 | phenacetin, combinations excl. psycholeptics |
| N02BE54 | bucetin, combinations excl. psycholeptics |
| N02BE73 | phenacetin, combinations with psycholeptics |
| N02BG04 | floctafenine |
| N02BG12 | tanezumab |
| N02C | ANTIMIGRAINE PREPARATIONS |
| N02CA72 | ergotamine, combinations with psycholeptics |
| N02CC | Selective serotonin (5HT1) agonists |
| N02CC51 | sumatriptan and naproxen |
| N02CX03 | iprazochrome |
| N03AA30 | metharbital |
| N03AB54 | mephenytoin, combinations |
| N03AE | Benzodiazepine derivatives |
| N03AF03 | rufinamide |
| N03AG01 | valproic acid |
| N03AG03 | aminobutyric acid |
| N03AX | Other antiepileptics |
| N03AX13 | pheneturide |
| N03AX18 | lacosamide |
| N03AX27 | ganaxolone |
| N03AX30 | beclamide |
| N04AB01 | etanautine |
| N04BC | Dopamine agonists |
| N05AA01 | chlorpromazine |
| N05AA02 | levomepromazine |
| N05AA06 | cyamemazine |
| N05AB | Phenothiazines with piperazine structure |
| N05AB03 | perphenazine |
| N05AB07 | acetophenazine |
| N05AB09 | butaperazine |
| N05AB10 | perazine |
| N05AC04 | pipotiazine |
| N05AF | Thioxanthene derivatives |
| N05AG | Diphenylbutylpiperidine derivatives |
| N05AL01 | sulpiride |
| N05AL05 | amisulpride |
| N05B | ANXIOLYTICS |
| N05BA09 | clobazam |
| N05BA21 | clotiazepam |
| N05BB51 | hydroxyzine, combinations |
| N05BE01 | buspirone |
| N05CA05 | aprobarbital |
| N05CA08 | vinylbital |
| N05CA22 | proxibarbal |
| N05CD09 | brotizolam |
| N05CF02 | zolpidem |
| N05CJ | Orexin receptor antagonists |
| N05CM01 | methaqualone |
| N05CM02 | clomethiazole |
| N05CM08 | ethchlorvynol |
| N05CM11 | bromides |
| N06 | PSYCHOANALEPTICS |
| N06AA01 | desipramine |
| N06AA14 | melitracen |
| N06AF05 | iproniazide |
| N06AX07 | minaprine |
| N06BA09 | atomoxetine |
| N06BX05 | fipexide |
| N06BX13 | idebenone |
| N06BX17 | adrafinil |
| N06DA02 | donepezil |
| N07BC04 | lofexidine |
| N07XA | Gangliosides and ganglioside derivatives |
| P | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| P01AB | Nitroimidazole derivatives |
| P01AX | Other agents against amoebiasis and other protozoal diseases |
| P01AX08 | tenonitrozole |
| P01BA02 | hydroxychloroquine |
| P01BA07 | tafenoquine |
| P01BD01 | pyrimethamine |
| P01BD51 | pyrimethamine, combinations |
| P01BE05 | artenimol |
| P01BF06 | artesunate and pyronaridine |
| P01CC | Nitrofuran derivatives |
| P02 | ANTHELMINTICS |
| P02B | ANTITREMATODALS |
| P02BA | Quinoline derivatives and related substances |
| P02CA01 | mebendazole |
| P02CA04 | ciclobendazole |
| P02CB | Piperazine and derivatives |
| P02CC02 | oxantel |
| P02CF | Avermectines |
| P02CF01 | ivermectin |
| P03AA01 | dixanthogen |
| P03AC02 | bioallethrin |
| P03BX03 | dibutylphthalate |
| R01AA15 | indanazoline |
| R01AB | Sympathomimetics, combinations excl. corticosteroids |
| R01AB01 | phenylephrine |
| R01AC03 | azelastine |
| R01AD53 | dexamethasone, combinations |
| R01AD59 | mometasone, combinations |
| R01AX | Other nasal preparations |
| R01AX09 | hyaluronic acid |
| R01BA02 | pseudoephedrine |
| R01BA52 | pseudoephedrine, combinations |
| R02AA10 | myristyl-benzalkonium |
| R02AD02 | lidocaine |
| R02AD05 | ambroxol |
| R02AX01 | flurbiprofen |
| R03AB02 | isoprenaline |
| R03AB03 | orciprenaline |
| R03AC | Selective beta-2-adrenoreceptor agonists |
| R03AC04 | fenoterol |
| R03AC16 | procaterol |
| R03AK | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics |
| R03AK05 | reproterol and sodium cromoglicate |
| R03AK07 | formoterol and budesonide |
| R03AL09 | formoterol, glycopyrronium bromide and beclometasone |
| R03AL10 | formoterol and tiotropium bromide |
| R03BA01 | beclometasone |
| R03BA08 | ciclesonide |
| R03BX01 | fenspiride |
| R03CB51 | isoprenaline, combinations |
| R03CB53 | orciprenaline, combinations |
| R03CC53 | terbutaline, combinations |
| R03CC63 | clenbuterol and ambroxol |
| R03DA74 | theophylline, combinations with psycholeptics |
| R03DB02 | choline theophyllinate and adrenergics |
| R03DB06 | etamiphylline and adrenergics |
| R03DC | Leukotriene receptor antagonists |
| R03DC01 | zafirlukast |
| R03DX02 | eprozinol |
| R03DX07 | roflumilast |
| R05CA05 | altheae radix |
| R05CA10 | combinations |
| R05CB01 | acetylcysteine |
| R05CB08 | domiodol |
| R05CB14 | neltenexine |
| R05CB16 | mannitol |
| R05DA | Opium alkaloids and derivatives |
| R05DA04 | codeine |
| R05DA10 | thebacon |
| R05DB | Other cough suppressants |
| R05DB02 | benproperine |
| R05DB25 | morclofone |
| R06AB02 | dexchlorpheniramine |
| R06AB06 | dexbrompheniramine |
| R06AB54 | chlorphenamine, combinations |
| R06AD03 | thiethylperazine |
| R06AD08 | oxomemazine |
| R06AE01 | buclizine |
| R06AE51 | buclizine, combinations |
| R06AE55 | meclozine, combinations |
| R06AX04 | phenindamine |
| R06AX16 | deptropine |
| R06AX21 | tritoqualine |
| R06AX22 | ebastine |
| R06AX23 | pimethixene |
| R07AA01 | colfosceril palmitate |
| S01AA01 | chloramphenicol |
| S01AA04 | oxytetracycline |
| S01AA09 | tetracycline |
| S01AA23 | netilmicin |
| S01AA28 | vancomycin |
| S01AB04 | sulfacetamide |
| S01AD05 | interferon |
| S01AE09 | tosufloxacin |
| S01AX10 | sodium propionate |
| S01B | ANTIINFLAMMATORY AGENTS |
| S01BA05 | triamcinolone |
| S01BA09 | clobetasone |
| S01BA13 | rimexolone |
| S01BA14 | loteprednol |
| S01BB04 | betamethasone and mydriatics |
| S01CA01 | dexamethasone and antiinfectives |
| S01CA05 | betamethasone and antiinfectives |
| S01CA07 | fluorometholone and antiinfectives |
| S01CC02 | indometacin and antiinfectives |
| S01EB03 | ecothiopate |
| S01EB09 | acetylcholine |
| S01EC01 | acetazolamide |
| S01ED52 | betaxolol, combinations |
| S01EE03 | bimatoprost |
| S01EE06 | latanoprostene bunod |
| S01FA02 | scopolamine |
| S01FA03 | methylscopolamine |
| S01FA04 | cyclopentolate |
| S01GA06 | oxedrine |
| S01GX | Other antiallergics |
| S01GX05 | lodoxamide |
| S01GX07 | azelastine |
| S01HA | Local anesthetics |
| S01HA02 | oxybuprocaine |
| S01HA03 | tetracaine |
| S01JX | Other ophthalmological diagnostic agents |
| S01KA | Viscoelastic substances |
| S01LA06 | brolucizumab |
| S01LA08 | bevacizumab |
| S01XA03 | sodium chloride, hypertonic |
| S01XA04 | potassium iodide |
| S01XA05 | sodium edetate |
| S01XA10 | inosine |
| S01XA15 | ascorbic acid |
| S01XA18 | ciclosporin |
| S01XA23 | sirolimus |
| S02AA | Antiinfectives |
| S02AA09 | chlorhexidine |
| S02B | CORTICOSTEROIDS |
| S02BA01 | hydrocortisone |
| S02BA03 | prednisolone |
| S02CA01 | prednisolone and antiinfectives |
| S02CA07 | fludrocortisone and antiinfectives |
| S02DA02 | cocaine |
| S03CA01 | dexamethasone and antiinfectives |
| S03CA04 | hydrocortisone and antiinfectives |
| V01AA02 | grass pollen |
| V03AB14 | protamine |
| V03AB16 | ethanol |
| V03AB18 | potassium permanganate |
| V03AB19 | physostigmine |
| V03AB33 | hydroxocobalamin |
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AF01 | mesna |
| V03AG01 | sodium cellulose phosphate |
| V03AN | Medical gases |
| V03AN04 | nitrogen |
| V04CD | Tests for pituitary function |
| V04CD06 | macimorelin |
| V04CK03 | bentiromide |
| V06 | GENERAL NUTRIENTS |
| V06CA | Nutrients without phenylalanine |
| V06D | OTHER NUTRIENTS |
| V08AA | Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| V08AB07 | ioversol |
| V08AC05 | iobenzamic acid |
| V08AC07 | iocetamic acid |
| V08AC10 | calcium iopodate |
| V08AD01 | ethyl esters of iodised fatty acids |
| V08AD04 | iofendylate |
| V08BA | Barium sulfate containing X-ray contrast media |
| V08CA01 | gadopentetic acid |
| V08D | ULTRASOUND CONTRAST MEDIA |
| V08DA04 | perflutren, phospholipid microspheres |
| V09AX04 | flutemetamol (18F) |
| V09AX05 | florbetapir (18F) |
| V09AX07 | flortaucipir (18F) |
| V09BA03 | technetium (99mTc) pyrophosphate |
| V09BA04 | technetium (99mTc) butedronic acid |
| V09CA02 | technetium (99mTc) succimer |
| V09CA04 | technetium (99mTc) gluceptate |
| V09CA05 | technetium (99mTc) gluconate |
| V09CX02 | sodium iodohippurate (131I) |
| V09DA01 | technetium (99mTc) disofenin |
| V09EB02 | technetium (99mTc) microspheres |
| V09EX02 | xenon (127Xe) gas |
| V09GA04 | technetium (99mTc) human albumin |
| V09GX02 | indium (111In) imciromab |
| V09GX03 | chromium (51Cr) chromate labelled cells |
| V09GX04 | rubidium (82Rb) chloride |
| V09IX05 | fluorodopa (18F) |
| V09XA01 | iodine (131I) norcholesterol |
| V10AA | Yttrium (90Y) compounds |
| V10AA01 | yttrium (90Y) citrate colloid |
| V10AX02 | samarium (153Sm) hydroxyapatite colloid |
| V10AX06 | gold (198Au) colloidal |
| A | ALIMENTARY TRACT AND METABOLISM |
| A01AA30 | combinations |
| A01AB02 | hydrogen peroxide |
| A01AB04 | amphotericin B |
| A01AB11 | various |
| A01AB13 | tetracycline |
| A01AB53 | chlorhexidine and cetylpyridinium |
| A01AC02 | dexamethasone |
| A01AC03 | hydrocortisone |
| A02AB | Aluminium compounds |
| A02AF | Antacids with antiflatulents |
| A02BA05 | niperotidine |
| A02BA53 | famotidine, combinations |
| A02BD | Combinations for eradication of Helicobacter pylori |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin |
| A02BX10 | zolimidine |
| A02BX14 | rebamipide |
| A02BX71 | carbenoxolone, combinations with psycholeptics |
| A03AA01 | oxyphencyclimine |
| A03AA04 | mebeverine |
| A03AA08 | dihexyverine |
| A03AB06 | otilonium bromide |
| A03AB08 | tridihexethyl |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| A03AC02 | dimethylaminopropionylphenothiazine |
| A03AC05 | tiropramide |
| A03AX05 | fenoverine |
| A03AX09 | trepibutone |
| A03AX30 | trimethyldiphenylpropylamine |
| A03CA01 | isopropamide and psycholeptics |
| A03CA30 | emepronium and psycholeptics |
| A03DA03 | bevonium and analgesics |
| A03DA05 | camylofin and analgesics |
| A03DA07 | tiemonium iodide and analgesics |
| A03ED | Antispasmodics in combination with other drugs |
| A04A | ANTIEMETICS AND ANTINAUSEANTS |
| A04AA55 | palonosetron, combinations |
| A04AD01 | scopolamine |
| A04AD51 | scopolamine, combinations |
| A04AD54 | chlorobutanol, combinations |
| A05AB | Preparations for biliary tract therapy |
| A05AB01 | nicotinyl methylamide |
| A05AX01 | piprozolin |
| A05AX04 | maralixibat chloride |
| A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06AB03 | dantron |
| A06AB04 | phenolphthalein |
| A06AD19 | magnesium citrate |
| A06AD65 | macrogol, combinations |
| A06AG11 | sodium lauryl sulfoacetate, incl. combinations |
| A06AH03 | naloxegol |
| A06AH05 | naldemedine |
| A06AX04 | linaclotide |
| A06AX09 | elobixibat |
| A07AA02 | nystatin |
| A07AB04 | succinylsulfathiazole |
| A07AX02 | acetarsol |
| A07DA53 | loperamide, combinations |
| A07EA04 | betamethasone |
| A07EC | Aminosalicylic acid and similar agents |
| A07XA03 | calcium compounds |
| A07XA06 | crofelemer |
| A08AA51 | phentermine and topiramate |
| A09A | DIGESTIVES, INCL. ENZYMES |
| A09AA02 | multienzymes (lipase, protease etc.) |
| A09AB03 | hydrochloric acid |
| A09AC | Enzyme and acid preparations, combinations |
| A09AC02 | multienzymes and acid preparations |
| A10AB | Insulins and analogues for injection, fast-acting |
| A10AB30 | combinations |
| A10AC | Insulins and analogues for injection, intermediate-acting |
| A10AC02 | insulin (beef) |
| A10AD05 | insulin aspart |
| A10BD01 | phenformin and sulfonylureas |
| A10BD02 | metformin and sulfonylureas |
| A10BD07 | metformin and sitagliptin |
| A10BD08 | metformin and vildagliptin |
| A10BD17 | metformin and acarbose |
| A10BG02 | rosiglitazone |
| A10BG03 | pioglitazone |
| A10BJ03 | lixisenatide |
| A10BK04 | ertugliflozin |
| A10BX03 | nateglinide |
| A11AA01 | multivitamins and iron |
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11HA01 | nicotinamide |
| A11HA03 | tocopherol (vit E) |
| A12AA02 | calcium glubionate |
| A12BA01 | potassium chloride |
| A12BA03 | potassium hydrogentartrate |
| A12C | OTHER MINERAL SUPPLEMENTS |
| A12CC | Magnesium |
| A12CC05 | magnesium aspartate |
| A14 | ANABOLIC AGENTS FOR SYSTEMIC USE |
| A14AA02 | stanozolol |
| A14B | OTHER ANABOLIC AGENTS |
| A15 | APPETITE STIMULANTS |
| A16AA07 | metreleptin |
| A16AB06 | sacrosidase |
| A16AX01 | thioctic acid |
| A16AX08 | teduglutide |
| A16AX13 | uridine triacetate |
| A16AX17 | triheptanoin |
| A16AX21 | elivaldogene autotemcel |
| A16AX30 | sodium benzoate and sodium phenylacetate |
| B01AA12 | fluindione |
| B01AB09 | danaparoid |
| B01AC16 | eptifibatide |
| B01AC25 | cangrelor |
| B01AC27 | selexipag |
| B01AC30 | combinations |
| B01AE06 | bivalirudin |
| B01AX07 | caplacizumab |
| B02AA03 | aminomethylbenzoic acid |
| B02AB02 | alfa1 antitrypsin |
| B02AB05 | ulinastatin |
| B02BC06 | thrombin |
| B02BD01 | coagulation factor IX, II, VII and X in combination |
| B02BD02 | coagulation factor VIII |
| B02BD06 | von Willebrand factor and coagulation factor VIII in combination |
| B02BD08 | coagulation factor VIIa |
| B02BD10 | von Willebrand factor |
| B02BX08 | avatrombopag |
| B02BX10 | concizumab |
| B03A | IRON PREPARATIONS |
| B03AA07 | ferrous sulfate |
| B03AA08 | ferrous tartrate |
| B03AB01 | ferric sodium citrate |
| B03AB09 | ferric proteinsuccinylate |
| B03AB10 | ferric maltol |
| B03BA04 | cobamamide |
| B03BA05 | mecobalamin |
| B03XA | Other antianemic preparations |
| B05AX03 | blood plasma |
| B05BA | Solutions for parenteral nutrition |
| B05CB02 | sodium citrate |
| B05XA12 | zinc chloride |
| B05XA30 | combinations of electrolytes |
| B06A | OTHER HEMATOLOGICAL AGENTS |
| C01AX | Other cardiac glycosides |
| C01BA | Antiarrhythmics, class Ia |
| C01BD | Antiarrhythmics, class III |
| C01BD04 | dofetilide |
| C01CA01 | etilefrine |
| C01CA15 | gepefrine |
| C01CA16 | ibopamine |
| C01CX06 | angiotensinamide |
| C01D | VASODILATORS USED IN CARDIAC DISEASES |
| C01DA54 | methylpropylpropanediol dinitrate, combinations |
| C01DA58 | isosorbide dinitrate, combinations |
| C01DA59 | trolnitrate, combinations |
| C01DA70 | organic nitrates in combination with psycholeptics |
| C02AA04 | rauwolfia alkaloids, whole root |
| C02CA04 | doxazosin |
| C02CC04 | debrisoquine |
| C02CC05 | guanoclor |
| C02DB02 | hydralazine |
| C02K | OTHER ANTIHYPERTENSIVES |
| C02KA | Alkaloids, excl. rauwolfia |
| C02KC | MAO inhibitors |
| C02L | ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION |
| C02LA01 | reserpine and diuretics |
| C02LA02 | rescinnamine and diuretics |
| C02LA51 | reserpine and diuretics, combinations with other drugs |
| C02LF | Guanidine derivatives and diuretics |
| C02LG01 | dihydralazine and diuretics |
| C02LL | MAO inhibitors and diuretics |
| C03 | DIURETICS |
| C03AA02 | hydroflumethiazide |
| C03AA05 | polythiazide |
| C03AA08 | methyclothiazide |
| C03AB | Thiazides and potassium in combination |
| C03AB04 | chlorothiazide and potassium |
| C03AB08 | methyclothiazide and potassium |
| C03BK | Sulfonamides, combinations with other drugs |
| C03BX | Other low-ceiling diuretics |
| C03DA04 | eplerenone |
| C03DB01 | amiloride |
| C03EA14 | butizide and potassium-sparing agents |
| C03EB02 | bumetanide and potassium-sparing agents |
| C03X | OTHER DIURETICS |
| C03XA02 | conivaptan |
| C04AA02 | buphenine |
| C04AC | Nicotinic acid and derivatives |
| C04AD | Purine derivatives |
| C04AX33 | clazosentan |
| C05A | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| C05AA05 | betamethasone |
| C05AX01 | aluminium preparations |
| C05BA51 | heparinoid, combinations |
| C05BB03 | invert sugar |
| C05C | CAPILLARY STABILIZING AGENTS |
| C07A | BETA BLOCKING AGENTS |
| C07AA05 | propranolol |
| C07BA | Beta blocking agents, non-selective, and thiazides |
| C07BA02 | oxprenolol and thiazides |
| C07BA06 | timolol and thiazides |
| C07BA12 | nadolol and thiazides |
| C07BA68 | metipranolol and thiazides, combinations |
| C07C | BETA BLOCKING AGENTS AND OTHER DIURETICS |
| C07FB13 | metoprolol and amlodipine |
| C08CA10 | nilvadipine |
| C08E | NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
| C08EA02 | bepridil |
| C09AA07 | benazepril |
| C09BA04 | perindopril and diuretics |
| C09BB12 | delapril and manidipine |
| C09BX03 | ramipril, amlodipine and hydrochlorothiazide |
| C09CA01 | losartan |
| C09CA07 | telmisartan |
| C09DB06 | losartan and amlodipine |
| C09DB09 | fimasartan and amlodipine |
| C10AA02 | lovastatin |
| C10AA07 | rosuvastatin |
| C10AB02 | bezafibrate |
| C10AB03 | aluminium clofibrate |
| C10AB05 | fenofibrate |
| C10AX01 | dextrothyroxine |
| C10AX03 | tiadenol |
| C10AX12 | lomitapide |
| C10BA01 | lovastatin and nicotinic acid |
| C10BA03 | pravastatin and fenofibrate |
| C10BX04 | simvastatin, acetylsalicylic acid and ramipril |
| C10BX13 | rosuvastatin, perindopril and indapamide |
| C10BX16 | rosuvastatin and fimasartan |
| D01A | ANTIFUNGALS FOR TOPICAL USE |
| D01AC14 | sertaconazole |
| D01AE | Other antifungals for topical use |
| D01AE04 | undecylenic acid |
| D01AE06 | 2-(4-chlorphenoxy)-ethanol |
| D01AE12 | salicylic acid |
| D01AE21 | flucytosine |
| D01B | ANTIFUNGALS FOR SYSTEMIC USE |
| D02A | EMOLLIENTS AND PROTECTIVES |
| D02AX | Other emollients and protectives |
| D02BB02 | afamelanotide |
| D03AX01 | cadexomer iodine |
| D03AX06 | becaplermin |
| D03AX15 | trafermin |
| D03BA | Proteolytic enzymes |
| D03BA03 | bromelains |
| D04AA03 | thenalidine |
| D04AA14 | clemastine |
| D05AD | Psoralens for topical use |
| D05AD01 | trioxysalen |
| D05BA03 | bergapten |
| D06AX02 | chloramphenicol |
| D06AX11 | rifaximin |
| D06AX14 | ozenoxacin |
| D06B | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| D06BB06 | penciclovir |
| D06BB08 | ibacitabine |
| D06BB12 | sinecatechins |
| D06C | ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| D07AB | Corticosteroids, moderately potent (group II) |
| D07AB07 | fluprednidene |
| D07AB08 | desonide |
| D07AB10 | alclometasone |
| D07AB30 | combinations of corticosteroids |
| D07AC06 | diflucortolone |
| D07AC10 | diflorasone |
| D07AC11 | amcinonide |
| D07AC15 | beclometasone |
| D07AC19 | difluprednate |
| D07AD01 | clobetasol |
| D07BB04 | hydrocortisone butyrate and antiseptics |
| D07BD | Corticosteroids, very potent, combinations with antiseptics |
| D07CA01 | hydrocortisone and antibiotics |
| D07CB04 | dexamethasone and antibiotics |
| D07CB05 | flumetasone and antibiotics |
| D07XA01 | hydrocortisone |
| D07XB01 | flumetasone |
| D07XC01 | betamethasone |
| D07XC05 | fluocortolone |
| D08A | ANTISEPTICS AND DISINFECTANTS |
| D08AC04 | hexamidine |
| D08AH02 | chlorquinaldol |
| D08AJ01 | benzalkonium |
| D08AJ57 | octenidine, combinations |
| D08AK02 | phenylmercuric borate |
| D08AK04 | merbromin |
| D08AL | Silver compounds |
| D08AX05 | isopropanol |
| D09 | MEDICATED DRESSINGS |
| D10A | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| D10AA03 | dexamethasone |
| D10AB | Preparations containing sulfur |
| D10AD51 | tretinoin, combinations |
| D10AF05 | nadifloxacin |
| D10AF51 | clindamycin, combinations |
| D10AX03 | azelaic acid |
| D10AX05 | dapsone |
| D11AH | Agents for dermatitis, excluding corticosteroids |
| D11AX01 | minoxidil |
| D11AX24 | deoxycholic acid |
| D11AX25 | hydrogen peroxide |
| D11AX52 | gamolenic acid, combinations |
| D11AX57 | collagen, combinations |
| G01AA09 | mepartricin |
| G01AA11 | pentamycin |
| G01AA51 | nystatin, combinations |
| G01AB | Arsenic compounds |
| G01AC05 | dequalinium |
| G01AD03 | ascorbic acid |
| G01AE | Sulfonamides |
| G01AE01 | sulfatolamide |
| G01AF01 | metronidazole |
| G01AF02 | clotrimazole |
| G01AF07 | isoconazole |
| G01AX02 | inosine |
| G01BE | Sulfonamides and corticosteroids |
| G02AB03 | ergometrine |
| G02AD03 | gemeprost |
| G03AA16 | dienogest and ethinylestradiol |
| G03AB05 | desogestrel and ethinylestradiol |
| G03AB09 | norgestimate and ethinylestradiol |
| G03AC | Progestogens |
| G03AC10 | drospirenone |
| G03B | ANDROGENS |
| G03BA03 | testosterone |
| G03CA53 | estradiol, combinations |
| G03CC | Estrogens, combinations with other drugs |
| G03DA | Pregnen (4) derivatives |
| G03DB07 | promegestone |
| G03FA01 | norethisterone and estrogen |
| G03FA06 | etynodiol and estrogen |
| G03GA06 | follitropin beta |
| G03XC04 | ormeloxifene |
| G04BE | Drugs used in erectile dysfunction |
| G04BE11 | udenafil |
| G04BX06 | phenazopyridine |
| G04BX10 | succinimide |
| G04CA | Alpha-adrenoreceptor antagonists |
| G04CX04 | fexapotide |
| H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| H01 | PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |
| H01AC02 | somatrem |
| H01B | POSTERIOR PITUITARY LOBE HORMONES |
| H01BB | Oxytocin and analogues |
| H01CA01 | gonadorelin |
| H01CB04 | vapreotide |
| H01CB05 | pasireotide |
| H01CC | Anti-gonadotropin-releasing hormones |
| H01CC54 | relugolix, estradiol and norethisterone |
| H02AA03 | desoxycortone |
| H02AB08 | triamcinolone |
| H02AB10 | cortisone |
| H02AB11 | prednylidene |
| H03AA01 | levothyroxine sodium |
| H03BB52 | thiamazole, combinations |
| H04 | PANCREATIC HORMONES |
| H05BA03 | calcitonin (human synthetic) |
| H05BA04 | elcatonin |
| H05BX04 | etelcalcetide |
| H05BX06 | evocalcet |
| J01AA20 | combinations of tetracyclines |
| J01BA52 | thiamphenicol, combinations |
| J01CA02 | pivampicillin |
| J01CA06 | bacampicillin |
| J01CA08 | pivmecillinam |
| J01CE08 | benzathine benzylpenicillin |
| J01CF01 | dicloxacillin |
| J01CF05 | flucloxacillin |
| J01CR01 | ampicillin and beta-lactamase inhibitor |
| J01CR50 | combinations of penicillins |
| J01DB03 | cefalotin |
| J01DC09 | cefmetazole |
| J01DC11 | ceforanide |
| J01DD02 | ceftazidime |
| J01DD05 | cefmenoxime |
| J01DD15 | cefdinir |
| J01DD62 | cefoperazone and beta-lactamase inhibitor |
| J01DE01 | cefepime |
| J01DE51 | cefepime and beta-lactamase inhibitor |
| J01DF02 | carumonam |
| J01DH04 | doripenem |
| J01DI | Other cephalosporins and penems |
| J01EB04 | sulfapyridine |
| J01EB05 | sulfafurazole |
| J01EC02 | sulfadiazine |
| J01EE02 | sulfadiazine and trimethoprim |
| J01EE07 | sulfamerazine and trimethoprim |
| J01F | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| J01FF | Lincosamides |
| J01MA08 | fleroxacin |
| J01MA17 | prulifloxacin |
| J01MA23 | delafloxacin |
| J01RA04 | spiramycin and metronidazole |
| J01RA16 | cefixime and azithromycin |
| J01X | OTHER ANTIBACTERIALS |
| J01XA02 | teicoplanin |
| J01XB | Polymyxins |
| J01XE | Nitrofuran derivatives |
| J01XX | Other antibacterials |
| J02AB01 | miconazole |
| J04AA | Aminosalicylic acid and derivatives |
| J04AC | Hydrazides |
| J04AD | Thiocarbamide derivatives |
| J04AD01 | protionamide |
| J04AK04 | morinamide |
| J04AK05 | bedaquiline |
| J04AM05 | rifampicin, pyrazinamide and isoniazid |
| J05AA01 | metisazone |
| J05AB01 | aciclovir |
| J05AB12 | cidofovir |
| J05AB16 | remdesivir |
| J05AB18 | molnupiravir |
| J05AC | Cyclic amines |
| J05AE05 | amprenavir |
| J05AE07 | fosamprenavir |
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors |
| J05AG01 | nevirapine |
| J05AG05 | rilpivirine |
| J05AJ03 | dolutegravir |
| J05AP02 | telaprevir |
| J05AP03 | boceprevir |
| J05AP06 | asunaprevir |
| J05AP08 | sofosbuvir |
| J05AP12 | coblopasvir |
| J05AP13 | ravidasvir |
| J05AR | Antivirals for treatment of HIV infections, combinations |
| J05AR08 | emtricitabine, tenofovir disoproxil and rilpivirine |
| J05AR15 | atazanavir and cobicistat |
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine |
| J05AX23 | ibalizumab |
| J05AX24 | tecovirimat |
| J05AX31 | lenacapavir |
| J06AA | Immune sera |
| J06BB07 | vaccinia immunoglobulin |
| J06BB10 | diphtheria immunoglobulin |
| J06BB15 | mumps immunoglobulin |
| J06BC | Antibacterial monoclonal antibodies |
| J06BC04 | obiltoxaximab |
| J06BD02 | motavizumab |
| J06BD05 | sotrovimab |
| J06BD07 | casirivimab and imdevimab |
| J07 | VACCINES |
| J07AD | Brucellosis vaccines |
| J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen |
| J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen |
| J07AJ52 | pertussis, purified antigen, combinations with toxoids |
| J07AM | Tetanus vaccines |
| J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin |
| J07B | VIRAL VACCINES |
| J07BB04 | influenza, virus like particles |
| J07BC02 | hepatitis A, inactivated, whole virus |
| J07BF03 | poliomyelitis, trivalent, inactivated, whole virus |
| J07BK | Varicella zoster vaccines |
| J07BK01 | varicella, live attenuated |
| J07BX02 | ebola vaccines |
| J07C | BACTERIAL AND VIRAL VACCINES, COMBINED |
| L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L01AB01 | busulfan |
| L01AB03 | mannosulfan |
| L01BA03 | raltitrexed |
| L01BB02 | mercaptopurine |
| L01BC03 | tegafur |
| L01CB02 | teniposide |
| L01CE03 | etirinotecan pegol |
| L01CE04 | belotecan |
| L01DB | Anthracyclines and related substances |
| L01DC | Other cytotoxic antibiotics |
| L01EA06 | asciminib |
| L01EC02 | dabrafenib |
| L01ED04 | brigatinib |
| L01EE01 | trametinib |
| L01EG01 | temsirolimus |
| L01EK03 | tivozanib |
| L01EK04 | fruquintinib |
| L01EL03 | zanubrutinib |
| L01EN | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| L01EN01 | erdafitinib |
| L01EX07 | cabozantinib |
| L01EX08 | lenvatinib |
| L01EX21 | tepotinib |
| L01FD02 | pertuzumab |
| L01FD06 | margetuximab |
| L01FE | EGFR (Epidermal Growth Factor Receptor) inhibitors |
| L01FF03 | durvalumab |
| L01FF05 | atezolizumab |
| L01FX02 | gemtuzumab ozogamicin |
| L01FX09 | mogamulizumab |
| L01FX22 | loncastuximab tesirine |
| L01FX23 | tisotumab vedotin |
| L01FX25 | mosunetuzumab |
| L01FX29 | talquetamab |
| L01XA02 | carboplatin |
| L01XB | Methylhydrazines |
| L01XB01 | procarbazine |
| L01XF | Retinoids for cancer treatment |
| L01XF03 | bexarotene |
| L01XG01 | bortezomib |
| L01XH | Histone deacetylase (HDAC) inhibitors |
| L01XH02 | romidepsin |
| L01XK02 | niraparib |
| L01XK06 | pamiparib |
| L01XL10 | nadofaragene firadenovec |
| L01XX29 | denileukin diftitox |
| L01XX33 | celecoxib |
| L01XX36 | oblimersen |
| L02AB03 | gestonorone |
| L02BB03 | bicalutamide |
| L02BG02 | formestane |
| L03AA10 | lenograstim |
| L03AA12 | ancestim |
| L03AB | Interferons |
| L03AB04 | interferon alfa-2a |
| L03AB06 | interferon alfa-n1 |
| L03AB12 | albinterferon alfa-2b |
| L03AB14 | cepeginterferon alfa-2b |
| L03AC | Interleukins |
| L03AX08 | poly ICLC |
| L03AX09 | thymopentin |
| L03AX16 | plerixafor |
| L04AA | Selective immunosuppressants |
| L04AA41 | imlifidase |
| L04AC01 | daclizumab |
| L04AC13 | ixekizumab |
| L04AC16 | guselkumab |
| L04AC20 | netakimab |
| L04AD03 | voclosporin |
| L04AE01 | fingolimod |
| L04AE03 | siponimod |
| L04AF07 | deucravacitinib |
| L04AG | Monoclonal antibodies |
| L04AG07 | begelomab |
| L04AJ03 | pegcetacoplan |
| M01 | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |
| M01AA03 | oxyphenbutazone |
| M01AB03 | tolmetin |
| M01AB07 | bumadizone |
| M01AB17 | bufexamac |
| M01AE03 | ketoprofen |
| M01AE12 | oxaprozin |
| M01AE56 | naproxen and misoprostol |
| M01AX01 | nabumetone |
| M01AX14 | orgotein |
| M01AX17 | nimesulide |
| M01B | ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION |
| M01CB02 | sodium aurotiosulfate |
| M01CC02 | bucillamine |
| M02AA10 | ketoprofen |
| M02AA11 | bendazac |
| M02AA19 | flurbiprofen |
| M02AA28 | piketoprofen |
| M02AX10 | various |
| M03AA04 | dimethyltubocurarine |
| M03AB01 | suxamethonium |
| M03BB02 | chlormezanone |
| M03BB52 | chlormezanone, combinations excl. psycholeptics |
| M03BB73 | chlorzoxazone, combinations with psycholeptics |
| M03BX01 | baclofen |
| M03BX08 | cyclobenzaprine |
| M04AB | Preparations increasing uric acid excretion |
| M04AB01 | probenecid |
| M04AC02 | cinchophen |
| M05BA | Bisphosphonates |
| M05BB07 | risedronic acid and colecalciferol |
| M05BC | Bone morphogenetic proteins |
| M05BX08 | menatetrenone |
| M09A | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| M09AX09 | onasemnogene abeparvovec |
| M09AX10 | risdiplam |
| M09AX15 | delandistrogene moxeparvovec |
| N01A | ANESTHETICS, GENERAL |
| N01AF | Barbiturates, plain |
| N01BA01 | metabutethamine |
| N01BA52 | procaine, combinations |
| N01BB10 | levobupivacaine |
| N01BX02 | dyclonine |
| N02AA02 | opium |
| N02AA58 | dihydrocodeine, combinations |
| N02AA59 | codeine, combinations excl. psycholeptics |
| N02AF02 | nalbuphine |
| N02AJ09 | codeine and other non-opioid analgesics |
| N02AJ14 | tramadol and dexketoprofen |
| N02AJ19 | oxycodone and ibuprofen |
| N02AX03 | dezocine |
| N02BA04 | sodium salicylate |
| N02BA57 | ethenzamide, combinations excl. psycholeptics |
| N02BB02 | metamizole sodium |
| N02BB04 | propyphenazone |
| N02BB05 | nifenazone |
| N02BB72 | metamizole sodium, combinations with psycholeptics |
| N02BB74 | propyphenazone, combinations with psycholeptics |
| N02BE51 | paracetamol, combinations excl. psycholeptics |
| N02BG02 | rimazolium |
| N02CA04 | methysergide |
| N02CC06 | eletriptan |
| N02CD03 | fremanezumab |
| N03AD | Succinimide derivatives |
| N03AD51 | ethosuximide, combinations |
| N03AF02 | oxcarbazepine |
| N03AG05 | progabide |
| N04AA09 | phenglutarimide |
| N04B | DOPAMINERGIC AGENTS |
| N04BA04 | melevodopa |
| N04BC06 | cabergoline |
| N04BD02 | rasagiline |
| N04BX01 | tolcapone |
| N04BX03 | budipine |
| N05AD05 | pipamperone |
| N05AE | Indole derivatives |
| N05AF03 | chlorprothixene |
| N05AF04 | tiotixene |
| N05AH03 | olanzapine |
| N05AN01 | lithium |
| N05AX07 | prothipendyl |
| N05AX10 | mosapramine |
| N05BA03 | medazepam |
| N05BA04 | oxazepam |
| N05BA07 | adinazolam |
| N05BC01 | meprobamate |
| N05BE | Azaspirodecanedione derivatives |
| N05BX01 | mephenoxalone |
| N05BX04 | fabomotizole |
| N05CA | Barbiturates, plain |
| N05CA03 | butobarbital |
| N05CA04 | barbital |
| N05CA12 | reposal |
| N05CA21 | allobarbital |
| N05CD14 | remimazolam |
| N05CE03 | pyrithyldione |
| N05CH03 | tasimelteon |
| N05CM | Other hypnotics and sedatives |
| N05CM12 | apronal |
| N05CX06 | dipiperonylaminoethanol, combinations |
| N06AA07 | lofepramine |
| N06AA10 | nortriptyline |
| N06AA16 | dosulepin |
| N06AA21 | maprotiline |
| N06AA23 | quinupramine |
| N06AB02 | zimeldine |
| N06AB04 | citalopram |
| N06AF06 | iproclozide |
| N06AX01 | oxitriptan |
| N06AX08 | bifemelane |
| N06AX12 | bupropion |
| N06AX25 | Hyperici herba |
| N06DA05 | ipidacrine |
| N07A | PARASYMPATHOMIMETICS |
| N07AA01 | neostigmine |
| N07B | DRUGS USED IN ADDICTIVE DISORDERS |
| N07BA04 | cytisinicline |
| N07X | OTHER NERVOUS SYSTEM DRUGS |
| N07XX | Other nervous system drugs |
| N07XX07 | fampridine |
| N07XX11 | pitolisant |
| N07XX15 | inotersen |
| N07XX21 | eplontersen |
| P01AA02 | clioquinol |
| P01AA52 | clioquinol, combinations |
| P01AB04 | azanidazole |
| P01AB51 | metronidazole and furazolidone |
| P01AC01 | diloxanide |
| P01AX52 | emetine, combinations |
| P01BA03 | primaquine |
| P01BE02 | artemether |
| P01CA03 | fexinidazole |
| P01CB01 | meglumine antimonate |
| P02CA02 | tiabendazole |
| P02CB02 | diethylcarbamazine |
| P02D | ANTICESTODALS |
| P02DA | Salicylic acid derivatives |
| P03AA05 | thiram |
| P03AC | Pyrethrines, incl. synthetic compounds |
| P03AC03 | phenothrin |
| P03AX07 | abametapir |
| P03BA | Pyrethrines |
| P03BA01 | cyfluthrin |
| P03BA02 | cypermethrin |
| P03BX04 | dibutylsuccinate |
| R01A | DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| R01AA08 | naphazoline |
| R01AA11 | tuaminoheptane |
| R01AB03 | tetryzoline |
| R01AC | Antiallergic agents, excl. corticosteroids |
| R01AC02 | levocabastine |
| R01AD06 | betamethasone |
| R01AD13 | ciclesonide |
| R01AX08 | framycetin |
| R01AX30 | combinations |
| R02AA | Antiseptics |
| R02AA13 | acriflavinium chloride |
| R02AA19 | phenol |
| R02AA20 | various |
| R02AX03 | benzydamine |
| R03AC09 | tretoquinol |
| R03AC15 | reproterol |
| R03AK02 | isoprenaline and other drugs for obstructive airway diseases |
| R03AL04 | indacaterol and glycopyrronium bromide |
| R03AL05 | formoterol and aclidinium bromide |
| R03AL11 | formoterol, glycopyrronium bromide and budesonide |
| R03BA02 | budesonide |
| R03BC | Antiallergic agents, excl. corticosteroids |
| R03CC02 | salbutamol |
| R03CC03 | terbutaline |
| R03CC10 | carbuterol |
| R03CC13 | clenbuterol |
| R03CC15 | formoterol |
| R03DA | Xanthines |
| R03DA55 | aminophylline, combinations |
| R03DB | Xanthines and adrenergics |
| R03DB04 | theophylline and adrenergics |
| R05CA06 | senega |
| R05CB03 | carbocisteine |
| R05CB05 | mesna |
| R05DA03 | hydrocodone |
| R05DB01 | benzonatate |
| R05DB04 | isoaminile |
| R06AA52 | diphenhydramine, combinations |
| R06AC52 | histapyrrodine, combinations |
| R06AD04 | methdilazine |
| R06AE06 | oxatomide |
| R06AX08 | pyrrobutamine |
| R06AX24 | epinastine |
| R06AX25 | mizolastine |
| R06AX27 | desloratadine |
| R06AX53 | thenalidine, combinations |
| R07AB08 | dimefline |
| R07AX02 | ivacaftor |
| R07AX31 | ivacaftor and tezacaftor |
| S01AA03 | neomycin |
| S01AA07 | framycetin |
| S01AA12 | tobramycin |
| S01AA14 | benzylpenicillin |
| S01AA18 | polymyxin B |
| S01AD06 | vidarabine |
| S01AD07 | famciclovir |
| S01AE04 | lomefloxacin |
| S01AX | Other antiinfectives |
| S01AX01 | mercury compounds |
| S01AX07 | sodium borate |
| S01AX08 | hexamidine |
| S01AX14 | dibrompropamidine |
| S01BA04 | prednisolone |
| S01BC04 | flurbiprofen |
| S01BC07 | bendazac |
| S01BC10 | nepafenac |
| S01CA | Corticosteroids and antiinfectives in combination |
| S01CA08 | methylprednisolone and antiinfectives |
| S01CB05 | fluorometholone |
| S01EA02 | dipivefrine |
| S01EC04 | brinzolamide |
| S01EC05 | methazolamide |
| S01ED05 | carteolol |
| S01EE01 | latanoprost |
| S01EE51 | latanoprost and netarsudil |
| S01FA01 | atropine |
| S01FA54 | cyclopentolate, combinations |
| S01FB01 | phenylephrine |
| S01FB02 | ephedrine |
| S01FB51 | phenylephrine and ketorolac |
| S01G | DECONGESTANTS AND ANTIALLERGICS |
| S01HA01 | cocaine |
| S01HA07 | lidocaine |
| S01HA30 | combinations |
| S01JA | Colouring agents |
| S01LA03 | pegaptanib |
| S01XA01 | guaiazulen |
| S01XA22 | ocriplasmin |
| S01XA24 | cenegermin |
| S02A | ANTIINFECTIVES |
| S02AA06 | hydrogen peroxide |
| S02AA11 | polymyxin B |
| S02AA14 | gentamicin |
| S02AA18 | cefmenoxime |
| S02BA08 | fluocinolone acetonide |
| S02CA03 | hydrocortisone and antiinfectives |
| S02CA06 | dexamethasone and antiinfectives |
| S03 | OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| S03AA01 | neomycin |
| S03CA | Corticosteroids and antiinfectives in combination |
| S03CA06 | betamethasone and antiinfectives |
| V01AA01 | feather |
| V01AA05 | tree pollen |
| V03AB20 | copper sulfate |
| V03AB26 | methionine |
| V03AB29 | cholinesterase |
| V03AC | Iron chelating agents |
| V03AE04 | calcium acetate and magnesium carbonate |
| V03AE08 | ferric citrate |
| V03AF03 | calcium folinate |
| V03AF04 | calcium levofolinate |
| V03AF10 | sodium levofolinate |
| V03AG05 | sodium phosphate |
| V03AH | Drugs for treatment of hypoglycemia |
| V03AX04 | difelikefalin |
| V04 | DIAGNOSTIC AGENTS |
| V04CA02 | glucose |
| V04CC01 | sorbitol |
| V04CD01 | metyrapone |
| V04CK | Tests for pancreatic function |
| V04CM | Tests for fertility disturbances |
| V04CX04 | mannitol |
| V06DF | Milk substitutes |
| V07AC | Blood transfusion, auxiliary products |
| V07AS | Stomi equipment |
| V07AV | Technical disinfectants |
| V08 | CONTRAST MEDIA |
| V08AA02 | metrizoic acid |
| V08AC09 | tyropanoic acid |
| V08CA03 | gadodiamide |
| V08CA08 | gadobenic acid |
| V08CA09 | gadobutrol |
| V08CA11 | gadofosveset |
| V08DA06 | perflubutane, phospholipid microspheres |
| V09AA | Technetium (99mTc) compounds |
| V09AB | Iodine (123I) compounds |
| V09AB03 | iodine ioflupane (123I) |
| V09BA | Technetium (99mTc) compounds |
| V09BA02 | technetium (99mTc) medronic acid |
| V09DA05 | technetium (99mTc) galtifenin |
| V09FX02 | sodium iodide (123I) |
| V09GA06 | technetium (99mTc) stannous agent labelled cells |
| V09GB | Iodine (125I) compounds |
| V09HA04 | technetium (99mTc) sulesomab |
| V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| V09IA01 | technetium (99mTc) antiCarcinoEmbryonicAntigen antibody |
| V09IA04 | technetium (99mTc) votumumab |
| V09IX03 | iodine (125I) CC49-monoclonal antibody |
| V09IX04 | fludeoxyglucose (18F) |
| V09IX10 | fluoroethyl-L-tyrosine (18F) |
| V09XA | Iodine (131I) compounds |
| V09XX | Various diagnostic radiopharmaceuticals |
| V09XX04 | ferric (59Fe) citrate |
| V10 | THERAPEUTIC RADIOPHARMACEUTICALS |
| V10AX04 | erbium (169Er) citrate colloid |
| V10XA03 | iodine (131I) omburtamab |
| V10XX | Various therapeutic radiopharmaceuticals |
| A01A | STOMATOLOGICAL PREPARATIONS |
| A01AB06 | domiphen |
| A01AB10 | natamycin |
| A01AB24 | octenidine |
| A01AC54 | prednisolone, combinations |
| A02 | DRUGS FOR ACID RELATED DISORDERS |
| A02AA03 | magnesium peroxide |
| A02AA04 | magnesium hydroxide |
| A02AB01 | aluminium hydroxide |
| A02AB06 | aloglutamol |
| A02AC01 | calcium carbonate |
| A02AC02 | calcium silicate |
| A02AX | Antacids, other combinations |
| A02BA | H2-receptor antagonists |
| A02BA04 | nizatidine |
| A02BA51 | cimetidine, combinations |
| A02BC06 | dexlansoprazole |
| A02BD01 | omeprazole, amoxicillin and metronidazole |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin |
| A02BX05 | bismuth subcitrate |
| A02BX08 | sulglicotide |
| A02BX13 | alginic acid |
| A03AA09 | difemerine |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB17 | tiemonium iodide |
| A03AB19 | timepidium bromide |
| A03AD | Papaverine and derivatives |
| A03AD02 | drotaverine |
| A03AX13 | silicones |
| A03BA01 | atropine |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 | butylscopolamine |
| A03BB04 | fentonium |
| A03FA04 | bromopride |
| A03FA08 | cinitapride |
| A03FA09 | mosapride |
| A04AA01 | ondansetron |
| A04AD | Other antiemetics |
| A04AD02 | cerium oxalate |
| A04AD12 | aprepitant |
| A05 | BILE AND LIVER THERAPY |
| A05AX02 | hymecromone |
| A05AX06 | elafibranor |
| A05BA | Liver therapy |
| A06AB56 | senna glycosides, combinations |
| A06AB57 | cascara, combinations |
| A06AC08 | polycarbophil calcium |
| A06AD13 | sodium sulfate |
| A06AG | Enemas |
| A06AG03 | dantron, incl. combinations |
| A06AH01 | methylnaltrexone bromide |
| A07AA12 | fidaxomicin |
| A07AA13 | rifamycin |
| A07AX03 | nifuroxazide |
| A07BA01 | medicinal charcoal |
| A07BC02 | kaolin |
| A07BC04 | attapulgite |
| A07D | ANTIPROPULSIVES |
| A07DA02 | opium |
| A07EA06 | budesonide |
| A07EA07 | beclometasone |
| A07EB01 | cromoglicic acid |
| A07EC01 | sulfasalazine |
| A07EC04 | balsalazide |
| A07XA02 | ceratonia |
| A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08AA | Centrally acting antiobesity products |
| A09AA01 | diastase |
| A10A | INSULINS AND ANALOGUES |
| A10AB02 | insulin (beef) |
| A10AB06 | insulin glulisine |
| A10AE | Insulins and analogues for injection, long-acting |
| A10AE02 | insulin (beef) |
| A10AF | Insulins and analogues for inhalation |
| A10BD04 | glimepiride and rosiglitazone |
| A10BD13 | metformin and alogliptin |
| A10BD25 | metformin, saxagliptin and dapagliflozin |
| A10BG01 | troglitazone |
| A10BH02 | vildagliptin |
| A10BJ02 | liraglutide |
| A10BJ05 | dulaglutide |
| A10BX18 | dorzagliatin |
| A10XX | Other drugs used in diabetes |
| A10XX01 | teplizumab |
| A11AA | Multivitamins with minerals |
| A11CC03 | alfacalcidol |
| A11DA01 | thiamine (vit B1) |
| A11EB | Vitamin B-complex with vitamin C |
| A11HA08 | tocofersolan |
| A11JA | Combinations of vitamins |
| A12AA07 | calcium chloride |
| A12AA11 | calcium pangamate |
| A12B | POTASSIUM |
| A12CB | Zinc |
| A12CB03 | zinc protein complex |
| A14AA01 | androstanolone |
| A16AA | Amino acids and derivatives |
| A16AA05 | carglumic acid |
| A16AB08 | galsulfase |
| A16AB19 | pegvaliase |
| A16AB21 | atidarsagene autotemcel |
| A16AX06 | miglustat |
| A16AX23 | leriglitazone |
| B01AA01 | dicoumarol |
| B01AA07 | acenocoumarol |
| B01AA08 | ethyl biscoumacetate |
| B01AB06 | nadroparin |
| B01AB08 | reviparin |
| B01AC07 | dipyridamole |
| B01AD11 | tenecteplase |
| B01AE02 | lepirudin |
| B01AE04 | melagatran |
| B01AF51 | rivaroxaban and acetylsalicylic acid |
| B01AX04 | dermatan sulfate |
| B02B | VITAMIN K AND OTHER HEMOSTATICS |
| B02BB01 | fibrinogen, human |
| B02BD03 | factor VIII inhibitor bypassing activity |
| B02BX09 | fostamatinib |
| B03AA01 | ferrous glycine sulfate |
| B03AA02 | ferrous fumarate |
| B03AA10 | ferrous ascorbate |
| B03AB08 | ferric acetyl transferrin |
| B03AD01 | ferrous amino acid complex and folic acid |
| B03BA01 | cyanocobalamin |
| B03BA51 | cyanocobalamin, combinations |
| B05 | BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |
| B05AA08 | hemoglobin crosfumaril |
| B05AX | Other blood products |
| B05B | I.V. SOLUTIONS |
| B05BB | Solutions affecting the electrolyte balance |
| B05BC02 | carbamide |
| B05CA04 | sulfamethizole |
| B05CB03 | magnesium citrate |
| B05CX02 | sorbitol |
| B05CX10 | combinations |
| B05DA | Isotonic solutions |
| B05DB | Hypertonic solutions |
| B05XA02 | sodium bicarbonate |
| B05XA06 | potassium phosphate, incl. combinations with other potassium salts |
| B05XA09 | sodium phosphate |
| B05XA18 | zinc sulfate |
| B05XA20 | sodium selenite |
| B05XA31 | electrolytes in combination with other drugs |
| B05XB | Amino acids |
| B05XC | Vitamins |
| B06AX05 | exagamglogene autotemcel |
| C01AB | Scilla glycosides |
| C01AC01 | g-strophanthin |
| C01BA04 | sparteine |
| C01BA51 | quinidine, combinations excl. psycholeptics |
| C01BD05 | ibutilide |
| C01BG01 | moracizine |
| C01CA03 | norepinephrine |
| C01CA12 | dimetofrine |
| C01CA28 | centhaquine |
| C01DA02 | glyceryl trinitrate |
| C01DX03 | oxyfedrine |
| C01DX07 | etafenone |
| C01DX12 | molsidomine |
| C01DX22 | vericiguat |
| C01DX54 | benziodarone, combinations |
| C01EB03 | indometacin |
| C01EB05 | creatinolfosfate |
| C01EB22 | meldonium |
| C02AC06 | rilmenidine |
| C02BB | Secondary and tertiary amines |
| C02D | ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON |
| C02DD01 | nitroprusside |
| C02LA50 | combination of rauwolfia alkaloids and diuretics incl. other combinations |
| C02LA52 | rescinnamine and diuretics, combinations with other drugs |
| C02LC05 | moxonidine and diuretics |
| C02LF01 | guanethidine and diuretics |
| C02LG02 | hydralazine and diuretics |
| C02N | COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| C03AA03 | hydrochlorothiazide |
| C03AA04 | chlorothiazide |
| C03AB02 | hydroflumethiazide and potassium |
| C03AB03 | hydrochlorothiazide and potassium |
| C03AB06 | trichlormethiazide and potassium |
| C03BA | Sulfonamides, plain |
| C03BA09 | meticrane |
| C03BB03 | clopamide and potassium |
| C03CA01 | furosemide |
| C03CC01 | etacrynic acid |
| C03CD01 | muzolimine |
| C03DA03 | canrenone |
| C03EA | Low-ceiling diuretics and potassium-sparing agents |
| C03EA01 | hydrochlorothiazide and potassium-sparing agents |
| C03EA13 | bendroflumethiazide and potassium-sparing agents |
| C04A | PERIPHERAL VASODILATORS |
| C04AC02 | nicotinyl alcohol (pyridylcarbinol) |
| C04AD02 | xantinol nicotinate |
| C04AX10 | moxisylyte |
| C05AA | Corticosteroids |
| C05AA10 | fluocinolone acetonide |
| C05AX03 | other preparations, combinations |
| C05AX06 | phenylephrine |
| C05BA03 | heparin |
| C05BA04 | pentosan polysulfate sodium |
| C05BB05 | phenol |
| C05CX03 | Hippocastani semen |
| C07AA17 | bopindolol |
| C07AA19 | bupranolol |
| C07AB01 | practolol |
| C07AB10 | epanolol |
| C07BB03 | atenolol and thiazides |
| C07BB52 | metoprolol and thiazides, combinations |
| C07BG | Alpha and beta blocking agents and thiazides |
| C07CA03 | pindolol and other diuretics |
| C07EA | Beta blocking agents, non-selective, and vasodilators |
| C07EB | Beta blocking agents, selective, and vasodilators |
| C07FX04 | bisoprolol and acetylsalicylic acid |
| C08CA04 | nicardipine |
| C08CA07 | nisoldipine |
| C08EA01 | fendiline |
| C08GA02 | amlodipine and diuretics |
| C09 | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C09AA04 | perindopril |
| C09B | ACE INHIBITORS, COMBINATIONS |
| C09BA12 | delapril and diuretics |
| C09BA13 | moexipril and diuretics |
| C09BX05 | ramipril and bisoprolol |
| C09DA03 | valsartan and diuretics |
| C09X | OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| C10AA05 | atorvastatin |
| C10AB08 | ciprofibrate |
| C10AB12 | pemafibrate |
| C10AX02 | probucol |
| C10AX06 | omega-3-triglycerides incl. other esters and acids |
| C10AX16 | inclisiran |
| C10BA05 | atorvastatin and ezetimibe |
| C10BA11 | pravastatin and ezetimibe |
| C10BX19 | atorvastatin, amlodipine and candesartan |
| C10BX20 | rosuvastatin and telmisartan |
| D01AA07 | pyrrolnitrin |
| D01AA08 | griseofulvin |
| D01AC16 | flutrimazole |
| D01AC60 | bifonazole, combinations |
| D01AE01 | bromochlorosalicylanilide |
| D01AE24 | tavaborole |
| D02AE51 | carbamide, combinations |
| D02BA01 | aminobenzoic acid |
| D03 | PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| D03AX05 | hyaluronic acid |
| D03AX10 | enoxolone |
| D03BA01 | trypsin |
| D04AA12 | tolpropamine |
| D04AA15 | bamipine |
| D04AB04 | benzocaine |
| D04AB05 | quinisocaine |
| D05AX02 | calcipotriol |
| D05AX05 | tazarotene |
| D06AA02 | chlortetracycline |
| D06AA03 | oxytetracycline |
| D06AX13 | retapamulin |
| D06BA51 | silver sulfadiazine, combinations |
| D06BB09 | edoxudine |
| D06BX03 | tirbanibulin |
| D07AA | Corticosteroids, weak (group I) |
| D07AA02 | hydrocortisone |
| D07AC02 | fluclorolone |
| D07AC12 | halometasone |
| D07AC16 | hydrocortisone aceponate |
| D07AC17 | fluticasone |
| D07BC | Corticosteroids, potent, combinations with antiseptics |
| D07CA | Corticosteroids, weak, combinations with antibiotics |
| D07CA02 | methylprednisolone and antibiotics |
| D07CB | Corticosteroids, moderately potent, combinations with antibiotics |
| D07CB01 | triamcinolone and antibiotics |
| D07CC04 | beclometasone and antibiotics |
| D07CD | Corticosteroids, very potent, combinations with antibiotics |
| D07XB | Corticosteroids, moderately potent, other combinations |
| D07XC03 | mometasone |
| D08AC52 | chlorhexidine, combinations |
| D08AF | Nitrofuran derivatives |
| D08AJ03 | cetylpyridinium |
| D08AJ04 | cetrimide |
| D08AK05 | mercury, metallic |
| D09AA12 | chlorhexidine |
| D10AA02 | methylprednisolone |
| D10AB03 | tioxolone |
| D10AD | Retinoids for topical use in acne |
| D10AD02 | retinol |
| D10AD04 | isotretinoin |
| D10AD06 | trifarotene |
| D10AD54 | isotretinoin, combinations |
| D10AE01 | benzoyl peroxide |
| D10AE51 | benzoyl peroxide, combinations |
| D10BA | Retinoids for treatment of acne |
| D10BX01 | ichtasol |
| D11 | OTHER DERMATOLOGICAL PREPARATIONS |
| D11AH11 | delgocitinib |
| D11AX04 | lithium succinate |
| D11AX05 | magnesium sulfate |
| G01AA06 | hachimycin |
| G01AA10 | clindamycin |
| G01AB01 | acetarsol |
| G01AD01 | lactic acid |
| G01AD02 | acetic acid |
| G01AF06 | ornidazole |
| G01AF17 | oxiconazole |
| G01AF21 | tinidazole |
| G01AX | Other antiinfectives and antiseptics |
| G01BA | Antibiotics and corticosteroids |
| G02 | OTHER GYNECOLOGICALS |
| G02AD01 | dinoprost |
| G02CA03 | fenoterol |
| G02CB | Prolactine inhibitors |
| G02CB02 | lisuride |
| G02CB03 | cabergoline |
| G02CC01 | ibuprofen |
| G02CC04 | flunoxaprofen |
| G02CX06 | fezolinetant |
| G03AA15 | chlormadinone and ethinylestradiol |
| G03AB02 | lynestrenol and ethinylestradiol |
| G03AB07 | chlormadinone and ethinylestradiol |
| G03AC02 | lynestrenol |
| G03AC04 | quingestanol |
| G03AD01 | levonorgestrel |
| G03CA09 | promestriene |
| G03DA01 | gestonorone |
| G03DC31 | methylestrenolone |
| G03EK | Androgens and female sex hormones in combination with other drugs |
| G03F | PROGESTOGENS AND ESTROGENS IN COMBINATION |
| G03GA01 | chorionic gonadotrophin |
| G03HA | Antiandrogens, plain |
| G03X | OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03XA01 | danazol |
| G03XC | Selective estrogen receptor modulators |
| G04BA | Acidifiers |
| G04BD03 | meladrazine |
| G04BD05 | terodiline |
| G04BD09 | trospium |
| G04BE04 | yohimbine |
| G04BX12 | phenyl salicylate |
| G04BX14 | dapoxetine |
| G04BX15 | pentosan polysulfate sodium |
| G04CA04 | silodosin |
| G04CA52 | tamsulosin and dutasteride |
| G04CA54 | tamsulosin and tadalafil |
| G04CX01 | Prunus africanae cortex |
| H01AC06 | tesamorelin |
| H01AC09 | lonapegsomatropin |
| H01AX | Other anterior pituitary lobe hormones and analogues |
| H01BA | Vasopressin and analogues |
| H01BA03 | lypressin |
| H01BB02 | oxytocin |
| H01CC02 | cetrorelix |
| H02CA02 | osilodrostat |
| H02CA03 | ketoconazole |
| H02CA04 | levoketoconazole |
| H03BA01 | methylthiouracil |
| H04A | GLYCOGENOLYTIC HORMONES |
| H04AA01 | glucagon |
| H05AA02 | teriparatide |
| J01CE02 | phenoxymethylpenicillin |
| J01CE03 | propicillin |
| J01CF | Beta-lactamase resistant penicillins |
| J01CG01 | sulbactam |
| J01CR04 | sultamicillin |
| J01DB11 | cefroxadine |
| J01DC06 | cefonicid |
| J01DC08 | loracarbef |
| J01DD04 | ceftriaxone |
| J01DD07 | ceftizoxime |
| J01DD11 | cefpiramide |
| J01DE | Fourth-generation cephalosporins |
| J01DH06 | tebipenem pivoxil |
| J01DH55 | panipenem and betamipron |
| J01EB | Short-acting sulfonamides |
| J01EB01 | sulfaisodimidine |
| J01EB03 | sulfadimidine |
| J01ED01 | sulfadimethoxine |
| J01EE06 | sulfadiazine and tetroxoprim |
| J01FA | Macrolides |
| J01FA09 | clarithromycin |
| J01GB03 | gentamicin |
| J01GB04 | kanamycin |
| J01MA05 | temafloxacin |
| J01MA06 | norfloxacin |
| J01MA09 | sparfloxacin |
| J01MA11 | grepafloxacin |
| J01MA15 | gemifloxacin |
| J01MA19 | garenoxacin |
| J01MB01 | rosoxacin |
| J01MB07 | flumequine |
| J01MB08 | nemonoxacin |
| J01RA11 | ciprofloxacin and tinidazole |
| J01XA01 | vancomycin |
| J01XD02 | tinidazole |
| J02AA01 | amphotericin B |
| J02AA02 | hachimycin |
| J02AC06 | oteseconazole |
| J02AX01 | flucytosine |
| J02AX04 | caspofungin |
| J04AB | Antibiotics |
| J04AB05 | rifapentine |
| J04AM08 | isoniazid, sulfamethoxazole, trimethoprim and pyridoxine |
| J04BA50 | dapsone and rifampicin |
| J05AA | Thiosemicarbazones |
| J05AB | Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| J05AB02 | idoxuridine |
| J05AD | Phosphonic acid derivatives |
| J05AD01 | foscarnet |
| J05AE02 | indinavir |
| J05AE04 | nelfinavir |
| J05AE16 | ensitrelvir |
| J05AF02 | didanosine |
| J05AF08 | adefovir dipivoxil |
| J05AH | Neuraminidase inhibitors |
| J05AH01 | zanamivir |
| J05AP58 | daclatasvir, asunaprevir and beclabuvir |
| J05AR02 | lamivudine and abacavir |
| J05AR04 | zidovudine, lamivudine and abacavir |
| J05AR26 | darunavir and ritonavir |
| J05AX13 | umifenovir |
| J06AA05 | gas-gangrene sera |
| J06BA02 | immunoglobulins, normal human, for intravascular adm. |
| J06BB04 | hepatitis B immunoglobulin |
| J06BC02 | raxibacumab |
| J07AD01 | brucella antigen |
| J07AF01 | diphtheria toxoid |
| J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids |
| J07AJ02 | pertussis, purified antigen |
| J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids |
| J07AK01 | plague, inactivated, whole cell |
| J07AR | Typhus (exanthematicus) vaccines |
| J07BB01 | influenza, inactivated, whole virus |
| J07BF02 | poliomyelitis oral, trivalent, live attenuated |
| J07BJ51 | rubella, combinations with mumps, live attenuated |
| J07BN01 | covid-19, RNA-based vaccine |
| J07BX01 | smallpox and monkeypox vaccines |
| J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C |
| J07X | OTHER VACCINES |
| L01AA02 | chlorambucil |
| L01AA05 | chlormethine |
| L01AC01 | thiotepa |
| L01AC03 | carboquone |
| L01AD01 | carmustine |
| L01AX | Other alkylating agents |
| L01AX02 | pipobroman |
| L01AX04 | dacarbazine |
| L01BA01 | methotrexate |
| L01BB05 | fludarabine |
| L01BC01 | cytarabine |
| L01BC09 | floxuridine |
| L01BC52 | fluorouracil, combinations |
| L01CB | Podophyllotoxin derivatives |
| L01DA01 | dactinomycin |
| L01DC02 | plicamycin |
| L01EB04 | osimertinib |
| L01EM04 | duvelisib |
| L01EX02 | sorafenib |
| L01EX09 | nintedanib |
| L01EX10 | midostaurin |
| L01EX15 | pexidartinib |
| L01FC | CD38 (Clusters of Differentiation 38) inhibitors |
| L01FC02 | isatuximab |
| L01FD05 | trastuzumab duocarmazine |
| L01FF07 | dostarlimab |
| L01FX16 | oportuzumab monatox |
| L01FX17 | sacituzumab govitecan |
| L01XD07 | padeliporfin |
| L01XG | Proteasome inhibitors |
| L01XH05 | entinostat |
| L01XK05 | veliparib |
| L01XL04 | tisagenlecleucel |
| L01XL08 | lisocabtagene maraleucel |
| L01XL09 | tabelecleucel |
| L01XX16 | mitoguazone |
| L01XX66 | selinexor |
| L01XX69 | lurbinectedin |
| L01XX72 | tazemetostat |
| L01XX73 | sotorasib |
| L02A | HORMONES AND RELATED AGENTS |
| L02AA03 | ethinylestradiol |
| L02AB | Progestogens |
| L02AE02 | leuprorelin |
| L02BB04 | enzalutamide |
| L03A | IMMUNOSTIMULANTS |
| L03AA09 | sargramostim |
| L03AB08 | interferon beta-1b |
| L03AB10 | peginterferon alfa-2b |
| L03AX01 | lentinan |
| L03AX03 | BCG vaccine |
| L04AA19 | gusperimus |
| L04AF02 | baricitinib |
| L04AF05 | itacitinib |
| L04AG09 | emapalumab |
| L04AG11 | anifrolumab |
| L04AG13 | teprotumumab |
| L04AG16 | rozanolixizumab |
| L04AJ04 | sutimlimab |
| L04AJ05 | avacopan |
| L04AX05 | pirfenidone |
| M01AA02 | mofebutazone |
| M01AB | Acetic acid derivatives and related substances |
| M01AB02 | sulindac |
| M01AE05 | fenbufen |
| M01AE14 | dexibuprofen |
| M01AH05 | etoricoxib |
| M01AX | Other antiinflammatory and antirheumatic agents, non-steroids |
| M01AX12 | glucosaminoglycan polysulfate |
| M01AX22 | morniflumate |
| M01CB01 | sodium aurothiomalate |
| M01CC | Penicillamine and similar agents |
| M02AA06 | etofenamate |
| M02AA15 | diclofenac |
| M02AX06 | tolperisone |
| M03AC07 | doxacurium chloride |
| M03AC08 | fazadinium bromide |
| M03AX | Other muscle relaxants, peripherally acting agents |
| M03BA01 | phenprobamate |
| M03BA03 | methocarbamol |
| M03BA05 | febarbamate |
| M03BA51 | phenprobamate, combinations excl. psycholeptics |
| M04AB04 | isobromindione |
| M04AB05 | lesinurad |
| M05BA01 | etidronic acid |
| M05BA07 | risedronic acid |
| M05BB08 | zoledronic acid, calcium and colecalciferol, sequential |
| M05BC01 | dibotermin alfa |
| M05BX | Other drugs affecting bone structure and mineralization |
| M09AA01 | hydroquinine |
| M09AB52 | trypsin, combinations |
| M09AX | Other drugs for disorders of the musculo-skeletal system |
| M09AX03 | ataluren |
| M09AX06 | eteplirsen |
| N01 | ANESTHETICS |
| N01AH06 | remifentanil |
| N01AX15 | xenon |
| N01AX63 | nitrous oxide, combinations |
| N01BB07 | etidocaine |
| N01BC01 | cocaine |
| N01BX01 | ethyl chloride |
| N02A | OPIOIDS |
| N02AA | Natural opium alkaloids |
| N02AC01 | dextromoramide |
| N02AC74 | dextropropoxyphene, combinations with psycholeptics |
| N02AG04 | hydromorphone and antispasmodics |
| N02AJ13 | tramadol and paracetamol |
| N02BA | Salicylic acid and derivatives |
| N02BA05 | salicylamide |
| N02BA09 | dipyrocetyl |
| N02BA10 | benorilate |
| N02BF03 | mirogabalin |
| N02BG07 | flupirtine |
| N02BG08 | ziconotide |
| N02BG10 | cannabinoids |
| N02CA51 | dihydroergotamine, combinations |
| N02CC02 | naratriptan |
| N02CX06 | oxetorone |
| N03AB | Hydantoin derivatives |
| N03AB02 | phenytoin |
| N03AB03 | amino(diphenylhydantoin) valeric acid |
| N03AB05 | fosphenytoin |
| N03AB52 | phenytoin, combinations |
| N03AD02 | phensuximide |
| N03AD03 | mesuximide |
| N03AG02 | valpromide |
| N03AX21 | retigabine |
| N04AA03 | metixene |
| N04AA11 | bornaprine |
| N04AC30 | etybenzatropine |
| N04BC01 | bromocriptine |
| N05AB05 | thiopropazate |
| N05AB08 | thioproperazine |
| N05AD02 | trifluperidol |
| N05AD03 | melperone |
| N05AD07 | benperidol |
| N05AD10 | lumateperone |
| N05AE04 | ziprasidone |
| N05AF05 | zuclopenthixol |
| N05AG01 | fluspirilene |
| N05AH06 | clotiapine |
| N05AL | Benzamides |
| N05AL03 | tiapride |
| N05AX13 | paliperidone |
| N05BA02 | chlordiazepoxide |
| N05BA14 | pinazepam |
| N05BB | Diphenylmethane derivatives |
| N05BB01 | hydroxyzine |
| N05BC04 | mebutamate |
| N05BX | Other anxiolytics |
| N05CA19 | thiopental |
| N05CB01 | combinations of barbiturates |
| N05CC | Aldehydes and derivatives |
| N05CC04 | dichloralphenazone |
| N05CD | Benzodiazepine derivatives |
| N05CD05 | triazolam |
| N05CF01 | zopiclone |
| N05CM03 | bromisoval |
| N05CM06 | propiomazine |
| N05CM10 | hexapropymate |
| N05CM15 | methylpentynol |
| N05CX | Hypnotics and sedatives in combination, excl. barbiturates |
| N06AG02 | moclobemide |
| N06AX | Other antidepressants |
| N06AX05 | trazodone |
| N06AX23 | desvenlafaxine |
| N06BA05 | pemoline |
| N06BA15 | dexmethylphenidate and serdexmethylphenidate |
| N06BC01 | caffeine |
| N06BX09 | linopirdine |
| N06BX10 | nizofenone |
| N06BX18 | vinpocetine |
| N06BX21 | temgicoluril |
| N06C | PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
| N06DX30 | combinations |
| N07AB | Choline esters |
| N07BB01 | disulfiram |
| N07BB02 | calcium carbimide |
| N07BB05 | nalmefene |
| N07C | ANTIVERTIGO PREPARATIONS |
| N07XX01 | tirilazad |
| N07XX02 | riluzole |
| P01AA01 | broxyquinoline |
| P01AA04 | chlorquinaldol |
| P01AA05 | tilbroquinol |
| P01AA30 | tilbroquinol and tiliquinol |
| P01AB03 | ornidazole |
| P01AC02 | clefamide |
| P01AX02 | emetine |
| P01BC01 | quinine |
| P01BC02 | mefloquine |
| P01BE01 | artemisinin |
| P01BF05 | artenimol and piperaquine |
| P01CB | Antimony compounds |
| P01CC02 | nitrofural |
| P01CX02 | suramin sodium |
| P02BA03 | arpraziquantel |
| P02BX01 | bithionol |
| P02BX02 | niridazole |
| P02BX04 | triclabendazole |
| P02CB01 | piperazine |
| P02CC01 | pyrantel |
| P02CE01 | levamisole |
| P02CX | Other antinematodals |
| P02DX01 | desaspidin |
| P03A | ECTOPARASITICIDES, INCL. SCABICIDES |
| P03AA02 | potassium polysulfide |
| P03AA04 | disulfiram |
| P03AC51 | pyrethrum, combinations |
| P03AC54 | permethrin, combinations |
| P03AX02 | copper oleinate |
| P03BA04 | tetramethrin |
| R01AD04 | flunisolide |
| R01B | NASAL DECONGESTANTS FOR SYSTEMIC USE |
| R02 | THROAT PREPARATIONS |
| R02A | THROAT PREPARATIONS |
| R02AA06 | cetylpyridinium |
| R02AA09 | benzethonium |
| R02AA17 | cetrimonium |
| R02AB03 | fusafungine |
| R02AD | Anesthetics, local |
| R03AC17 | bitolterol |
| R03AK04 | salbutamol and sodium cromoglicate |
| R03AK08 | formoterol and beclometasone |
| R03AK11 | formoterol and fluticasone |
| R03AK13 | salbutamol and beclometasone |
| R03AK14 | indacaterol and mometasone |
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate |
| R03BA | Glucocorticoids |
| R03BA06 | triamcinolone |
| R03BB07 | umeclidinium bromide |
| R03C | ADRENERGICS FOR SYSTEMIC USE |
| R03CB02 | methoxyphenamine |
| R03DA02 | choline theophyllinate |
| R03DA06 | etamiphylline |
| R03DA10 | bufylline |
| R03DA57 | theobromine, combinations |
| R03DB01 | diprophylline and adrenergics |
| R03DC03 | montelukast |
| R03DX01 | amlexanox |
| R03DX05 | omalizumab |
| R05C | EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS |
| R05CA08 | creosote |
| R05CA12 | Hederae helicis folium |
| R05CB06 | ambroxol |
| R05CB15 | erdosteine |
| R05D | COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS |
| R05DA01 | ethylmorphine |
| R05DB07 | oxolamine |
| R05DB12 | bibenzonium bromide |
| R05DB15 | zipeprol |
| R05DB19 | dropropizine |
| R05DB20 | combinations |
| R05FA02 | opium derivatives and expectorants |
| R05X | OTHER COLD PREPARATIONS |
| R06AA06 | chlorphenoxamine |
| R06AA07 | diphenylpyraline |
| R06AB | Substituted alkylamines |
| R06AB07 | talastine |
| R06AD05 | hydroxyethylpromethazine |
| R06AE04 | chlorcyclizine |
| R06AE05 | meclozine |
| R06AX07 | triprolidine |
| R06AX28 | rupatadine |
| R06AX29 | bilastine |
| R06AX31 | quifenadine |
| R07 | OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07A | OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07AB03 | pentetrazol |
| S01AA05 | tyrothricin |
| S01AA20 | antibiotics in combination with other drugs |
| S01AA21 | amikacin |
| S01AA22 | micronomicin |
| S01AA30 | combinations of different antibiotics |
| S01AB02 | sulfafurazole |
| S01AE07 | moxifloxacin |
| S01AX16 | picloxydine |
| S01AX24 | polihexanide |
| S01BA11 | desonide |
| S01BA16 | difluprednate |
| S01BB | Corticosteroids and mydriatics in combination |
| S01BC01 | indometacin |
| S01CA09 | chloroprednisone and antiinfectives |
| S01CA11 | clobetasone and antiinfectives |
| S01CB03 | hydrocortisone |
| S01EA03 | apraclonidine |
| S01EA05 | brimonidine |
| S01EB01 | pilocarpine |
| S01EB08 | aceclidine |
| S01EE | Prostaglandin analogues |
| S01EE04 | travoprost |
| S01EX | Other antiglaucoma preparations |
| S01EX06 | omidenepag |
| S01FA | Anticholinergics |
| S01GA03 | xylometazoline |
| S01GX13 | bilastine |
| S01H | LOCAL ANESTHETICS |
| S01HA05 | procaine |
| S01K | SURGICAL AIDS |
| S01KA02 | hypromellose |
| S01KX | Other surgical aids |
| S01KX01 | chymotrypsin |
| S01LA07 | abicipar pegol |
| S01XA02 | retinol |
| S01XA06 | ethylmorphine |
| S01XA11 | nandrolone |
| S01XA14 | heparin |
| S03AA04 | chlorhexidine |
| V01AA03 | house dust mites |
| V03 | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB | Antidotes |
| V03AB09 | dimercaprol |
| V03AB27 | 4-dimethylaminophenol |
| V03AB31 | prussian blue |
| V03AB34 | fomepizole |
| V03AB35 | sugammadex |
| V03AE02 | sevelamer |
| V03AM | Drugs for embolisation |
| V03AX | Other therapeutic products |
| V03AX02 | nalfurafine |
| V04CE02 | sulfobromophthalein |
| V04CJ01 | thyrotropin |
| V04CL | Tests for allergic diseases |
| V04CM01 | gonadorelin |
| V04CX | Other diagnostic agents |
| V04CX03 | methacholine |
| V04CX10 | pafolacianine |
| V06B | PROTEIN SUPPLEMENTS |
| V06DB | Fat/carbohydrates/proteins/minerals/vitamins, combinations |
| V07AA | Plasters |
| V07AB | Solvents and diluting agents, incl. irrigating solutions |
| V07AZ | Chemicals and reagents for analysis |
| V08AA07 | acetrizoic acid |
| V08AB02 | iohexol |
| V08AB03 | ioxaglic acid |
| V08AB05 | iopromide |
| V08AB11 | iobitridol |
| V08AC | Watersoluble, hepatotropic X-ray contrast media |
| V08CA | Paramagnetic contrast media |
| V08DA05 | sulfur hexafluoride, phospholipid microspheres |
| V09A | CENTRAL NERVOUS SYSTEM |
| V09AA01 | technetium (99mTc) exametazime |
| V09AX01 | indium (111In) pentetic acid |
| V09AX06 | florbetaben (18F) |
| V09CA01 | technetium (99mTc) pentetic acid |
| V09CX01 | sodium iodohippurate (123I) |
| V09DA02 | technetium (99mTc) etifenin |
| V09DB01 | technetium (99mTc) nanocolloid |
| V09DB07 | technetium (99mTc) phytate |
| V09E | RESPIRATORY SYSTEM |
| V09EB01 | technetium (99mTc) macrosalb |
| V09EX | Other respiratory system diagnostic radiopharmaceuticals |
| V09EX03 | xenon (133Xe) gas |
| V09GX | Other cardiovascular system diagnostic radiopharmaceuticals |
| V09HB01 | indium (111In) oxinate labelled cells |
| V09HB02 | indium (111In) tropolonate labelled cells |
| V09IA02 | technetium (99mTc) antimelanoma antibody |
| V09IA06 | technetium (99mTc) arcitumomab |
| V09IX11 | fluoroestradiol (18F) |
| V09XA02 | iodocholesterol (131I) |
| V10AX03 | dysprosium (165Dy) colloid |
| V10X | OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
| V20 | SURGICAL DRESSINGS |
| A01 | STOMATOLOGICAL PREPARATIONS |
| A01AA51 | sodium fluoride, combinations |
| A01AB05 | polynoxylin |
| A01AB07 | oxyquinoline |
| A01AB15 | tibezonium iodide |
| A01AB16 | mepartricin |
| A01AB18 | clotrimazole |
| A01AB19 | sodium perborate |
| A01AC04 | prednisolone |
| A01AD01 | epinephrine |
| A01AD05 | acetylsalicylic acid |
| A01AD06 | adrenalone |
| A01AD07 | amlexanox |
| A02AD05 | almasilate |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BB01 | misoprostol |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin |
| A02BD17 | vonoprazan and amoxicillin |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX12 | bismuth subnitrate |
| A02BX77 | gefarnate, combinations with psycholeptics |
| A03AA07 | dicycloverine |
| A03AB03 | oxyphenonium |
| A03AB14 | pipenzolate |
| A03AX04 | pinaverium |
| A03AX14 | valethamate |
| A03AX15 | menthae piperitae aetheroleum |
| A03AX58 | alverine, combinations |
| A03BB05 | cimetropium bromide |
| A03CA34 | propantheline and psycholeptics |
| A03CB | Belladonna and derivatives in combination with psycholeptics |
| A03CB02 | belladonna total alkaloids and psycholeptics |
| A03CB31 | hyoscyamine and psycholeptics |
| A03DA | Synthetic anticholinergic agents in combination with analgesics |
| A03DB | Belladonna and derivatives in combination with analgesics |
| A03DB04 | butylscopolamine and analgesics |
| A03DC | Other antispasmodics in combination with analgesics |
| A03FA10 | acotiamide |
| A04 | ANTIEMETICS AND ANTINAUSEANTS |
| A04AD13 | casopitant |
| A05AA | Bile acids and derivatives |
| A05BA01 | arginine glutamate |
| A05BA03 | silymarin |
| A05BA05 | epomediol |
| A05BA08 | glycyrrhizic acid |
| A05BA09 | metadoxine |
| A06AA | Softeners, emollients |
| A06AB09 | bisoxatin |
| A06AD01 | magnesium carbonate |
| A06AD10 | mineral salts in combination |
| A06AD15 | macrogol |
| A06AD17 | sodium phosphate |
| A06AD18 | sorbitol |
| A06AG10 | docusate sodium, incl. combinations |
| A06AH02 | alvimopan |
| A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07AA03 | natamycin |
| A07AA07 | amphotericin B |
| A07AA51 | neomycin, combinations |
| A07AB02 | phthalylsulfathiazole |
| A07B | INTESTINAL ADSORBENTS |
| A07CA | Oral rehydration salt formulations |
| A07DA | Antipropulsives |
| A07DA04 | difenoxin |
| A07EA05 | tixocortol |
| A07EC03 | olsalazine |
| A07FA03 | escherichia coli |
| A07X | OTHER ANTIDIARRHEALS |
| A07XA | Other antidiarrheals |
| A07XA04 | racecadotril |
| A08AA06 | etilamfetamine |
| A08AA10 | sibutramine |
| A08AX | Other antiobesity drugs |
| A09AA03 | pepsin |
| A09AA04 | tilactase |
| A09AC01 | pepsin and acid preparations |
| A10 | DRUGS USED IN DIABETES |
| A10AE04 | insulin glargine |
| A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| A10BA01 | phenformin |
| A10BB07 | glipizide |
| A10BB10 | metahexamide |
| A10BB12 | glimepiride |
| A10BD06 | glimepiride and pioglitazone |
| A10BD14 | metformin and repaglinide |
| A10BD16 | metformin and canagliflozin |
| A10BD22 | metformin and evogliptin |
| A10BD26 | metformin and lobeglitazone |
| A10BD28 | metformin and teneligliptin |
| A10BF02 | miglitol |
| A10BG | Thiazolidinediones |
| A10BJ04 | albiglutide |
| A10BK03 | empagliflozin |
| A10BX05 | pramlintide |
| A11 | VITAMINS |
| A11CB | Vitamin A and D in combination |
| A11CC04 | calcitriol |
| A11CC06 | calcifediol |
| A11EX | Vitamin B-complex, other combinations |
| A11GB01 | ascorbic acid (vit C) and calcium |
| A11H | OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA02 | pyridoxine (vit B6) |
| A11HA05 | biotin |
| A11HA30 | dexpanthenol |
| A11JC | Vitamins, other combinations |
| A12A | CALCIUM |
| A12AA09 | calcium citrate lysine complex |
| A12AA20 | calcium (different salts in combination) |
| A12BA | Potassium |
| A12CA01 | sodium chloride |
| A12CB01 | zinc sulfate |
| A12CB02 | zinc gluconate |
| A12CC04 | magnesium citrate |
| A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AB15 | velmanase alfa |
| A16AB25 | olipudase alfa |
| A16AX10 | eliglustat |
| A16AX14 | migalastat |
| A16AX20 | lonafarnib |
| A16AX22 | tiomolibdic acid |
| B01 | ANTITHROMBOTIC AGENTS |
| B01AA09 | clorindione |
| B01AC | Platelet aggregation inhibitors excl. heparin |
| B01AC09 | epoprostenol |
| B01AC11 | iloprost |
| B01AC18 | triflusal |
| B01AC23 | cilostazol |
| B01AD08 | saruplase |
| B01AD10 | drotrecogin alfa (activated) |
| B01AD13 | apadamtase alfa and cinaxadamtase alfa |
| B01AE03 | argatroban |
| B01AF01 | rivaroxaban |
| B01AF04 | betrixaban |
| B02BC02 | oxidized cellulose |
| B02BC07 | collagen |
| B02BC09 | epinephrine |
| B02BD11 | catridecacog |
| B03 | ANTIANEMIC PREPARATIONS |
| B03AA | Iron bivalent, oral preparations |
| B03AA03 | ferrous gluconate |
| B03AB02 | saccharated iron oxide |
| B03AD02 | ferrous fumarate and folic acid |
| B03AE02 | iron, multivitamins and folic acid |
| B03XA02 | darbepoetin alfa |
| B05AA02 | other plasma protein fractions |
| B05AA06 | gelatin agents |
| B05BA01 | amino acids |
| B05CA | Antiinfectives |
| B05CA05 | taurolidine |
| B05CA06 | mandelic acid |
| B05CX01 | glucose |
| B05XA03 | sodium chloride |
| B05ZB | Hemofiltrates |
| B06 | OTHER HEMATOLOGICAL AGENTS |
| B06AA02 | fibrinolysin and desoxyribonuclease |
| B06AX03 | voxelotor |
| C01AA03 | digitalis leaves |
| C01AX02 | peruvoside |
| C01BA05 | ajmaline |
| C01BC | Antiarrhythmics, class Ic |
| C01BG11 | vernakalant |
| C01CA04 | dopamine |
| C01CA06 | phenylephrine |
| C01CA24 | epinephrine |
| C01CA30 | combinations |
| C01CE01 | amrinone |
| C01CX09 | angiotensin II |
| C01DA04 | methylpropylpropanediol dinitrate |
| C01DA52 | glyceryl trinitrate, combinations |
| C01DX | Other vasodilators used in cardiac diseases |
| C01DX21 | serelaxin |
| C01DX51 | itramin tosilate, combinations |
| C01EA | Prostaglandins |
| C01EB | Other cardiac preparations |
| C02AA01 | rescinnamine |
| C02AA03 | combinations of rauwolfia alkaloids |
| C02AA06 | methoserpidine |
| C02BA | Sulfonium derivatives |
| C02BC | Bisquaternary ammonium compounds |
| C02CA03 | trimazosin |
| C02CA06 | urapidil |
| C02DB01 | dihydralazine |
| C02DD | Nitroferricyanide derivatives |
| C02KB | Tyrosine hydroxylase inhibitors |
| C02KD | Serotonin antagonists |
| C02KX01 | bosentan |
| C02LA04 | methoserpidine and diuretics |
| C02LA07 | bietaserpine and diuretics |
| C02LB01 | methyldopa (levorotatory) and diuretics |
| C02LG73 | picodralazine and diuretics, combinations with psycholeptics |
| C03AA01 | bendroflumethiazide |
| C03AA09 | cyclothiazide |
| C03AH | Thiazides, combinations with psycholeptics and/or analgesics |
| C03BA04 | chlortalidone |
| C03BA07 | clofenamide |
| C03BA11 | indapamide |
| C03BB02 | quinethazone and potassium |
| C03BB04 | chlortalidone and potassium |
| C03BC | Mercurial diuretics |
| C03BD | Xanthine derivatives |
| C03CX | Other high-ceiling diuretics |
| C03EA07 | cyclopenthiazide and potassium-sparing agents |
| C03EA12 | metolazone and potassium-sparing agents |
| C04AA31 | bamethan |
| C04AE02 | nicergoline |
| C04AE54 | dihydroergocristine, combinations |
| C04AF | Enzymes |
| C04AX23 | butalamine |
| C04AX27 | cinepazide |
| C05AB | Antibiotics |
| C05AD01 | lidocaine |
| C05AD03 | benzocaine |
| C05AE | Muscle relaxants |
| C05B | ANTIVARICOSE THERAPY |
| C05BB04 | sodium tetradecyl sulfate |
| C05BX51 | calcium dobesilate, combinations |
| C05CA54 | troxerutin, combinations |
| C05CX01 | tribenoside |
| C05CX02 | naftazone |
| C05XX01 | beperminogene perplasmid |
| C07AA01 | alprenolol |
| C07AA06 | timolol |
| C07AB11 | s-atenolol |
| C07AB14 | landiolol |
| C07AG | Alpha and beta blocking agents |
| C07CA | Beta blocking agents, non-selective, and other diuretics |
| C07CB03 | atenolol and other diuretics |
| C07DA | Beta blocking agents, non-selective, thiazides and other diuretics |
| C07DB | Beta blocking agents, selective, thiazides and other diuretics |
| C07DB01 | atenolol, thiazides and other diuretics |
| C07FX03 | metoprolol and acetylsalicylic acid |
| C08CA05 | nifedipine |
| C08CA09 | lacidipine |
| C08CA11 | manidipine |
| C08CA15 | benidipine |
| C08DB01 | diltiazem |
| C08EX02 | perhexiline |
| C09AA02 | enalapril |
| C09BB10 | trandolapril and verapamil |
| C09CA02 | eprosartan |
| C09CA03 | valsartan |
| C09CA04 | irbesartan |
| C09D | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS |
| C09DA09 | azilsartan medoxomil and diuretics |
| C09DA10 | fimasartan and diuretics |
| C09DB01 | valsartan and amlodipine |
| C09DB05 | irbesartan and amlodipine |
| C09DX04 | valsartan and sacubitril |
| C09DX06 | candesartan, amlodipine and hydrochlorothiazide |
| C09DX07 | irbesartan, amlodipine and hydrochlorothiazide |
| C10AA01 | simvastatin |
| C10AA08 | pitavastatin |
| C10AB09 | etofibrate |
| C10AB10 | clofibride |
| C10AD | Nicotinic acid and derivatives |
| C10AD04 | aluminium nicotinate |
| C10AD06 | acipimox |
| C10AX05 | meglutol |
| C10BA07 | rosuvastatin and omega-3 fatty acids |
| C10BX | Lipid modifying agents in combination with other drugs |
| C10BX09 | rosuvastatin and amlodipine |
| C10BX14 | rosuvastatin, amlodipine and perindopril |
| D | DERMATOLOGICALS |
| D01AA | Antibiotics |
| D01AC01 | clotrimazole |
| D01AC11 | oxiconazole |
| D01AC12 | fenticonazole |
| D01AC21 | neticonazole |
| D01AC22 | lanoconazole |
| D01AE03 | tribromometacresol |
| D01AE07 | chlorphenesin |
| D01AE09 | sulbentine |
| D01AE17 | dimazole |
| D01AE18 | tolnaftate |
| D01AE23 | butenafine |
| D01AE25 | liranaftate |
| D01BA | Antifungals for systemic use |
| D01BA02 | terbinafine |
| D02AB | Zinc products |
| D04A | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA01 | thonzylamine |
| D04AA02 | mepyramine |
| D04AA04 | tripelennamine |
| D04AA09 | chloropyramine |
| D04AA16 | pheniramine |
| D04AA22 | isothipendyl |
| D04AA33 | diphenhydramine methylbromide |
| D04AB02 | cinchocaine |
| D05AA | Tars |
| D05BA | Psoralens for systemic use |
| D06AX | Other antibiotics for topical use |
| D06AX07 | gentamicin |
| D06BB | Antivirals |
| D06BB01 | idoxuridine |
| D06BB53 | aciclovir, combinations |
| D06BX01 | metronidazole |
| D06BX02 | ingenol mebutate |
| D07AB11 | hydrocortisone buteprate |
| D07AB19 | dexamethasone |
| D07AC05 | fluocortolone |
| D07AC07 | fludroxycortide |
| D07AC09 | budesonide |
| D07AC14 | methylprednisolone aceponate |
| D07BB02 | desonide and antiseptics |
| D07BC01 | betamethasone and antiseptics |
| D07CB03 | fluorometholone and antibiotics |
| D07X | CORTICOSTEROIDS, OTHER COMBINATIONS |
| D07XA02 | prednisolone |
| D07XC04 | diflucortolone |
| D08AC | Biguanides and amidines |
| D08AC01 | dibrompropamidine |
| D08AE01 | hexachlorophene |
| D08AF01 | nitrofural |
| D08AH01 | dequalinium |
| D08AJ06 | didecyldimethylammonium chloride |
| D08AX08 | ethanol |
| D09AB01 | zinc bandage without supplements |
| D09AX | Soft paraffin dressings |
| D10AA | Corticosteroids, combinations for treatment of acne |
| D11AE01 | metandienone |
| D11AH09 | ruxolitinib |
| D11AX12 | pyrithione zinc |
| D11AX18 | diclofenac |
| D11AX22 | ivermectin |
| D11AX23 | aminobenzoate potassium |
| G01AC01 | diiodohydroxyquinoline |
| G01AF | Imidazole derivatives |
| G01AF04 | miconazole |
| G01AF05 | econazole |
| G01AF11 | ketoconazole |
| G01AX01 | clodantoin |
| G01AX09 | methylrosaniline |
| G01AX13 | protiofate |
| G01AX15 | copper usnate |
| G01AX16 | hexetidine |
| G02A | UTEROTONICS |
| G02AD04 | carboprost |
| G02AX | Other uterotonics |
| G02BA | Intrauterine contraceptives |
| G02C | OTHER GYNECOLOGICALS |
| G02CA | Sympathomimetics, labour repressants |
| G02CB04 | quinagolide |
| G02CB05 | metergoline |
| G02CX01 | atosiban |
| G02CX04 | Cimicifugae rhizoma |
| G03AA11 | norgestimate and ethinylestradiol |
| G03AB03 | levonorgestrel and ethinylestradiol |
| G03AC06 | medroxyprogesterone |
| G03CA57 | conjugated estrogens |
| G03DB | Pregnadien derivatives |
| G03DB02 | megestrol |
| G03DC02 | norethisterone |
| G03EA03 | prasterone and estrogen |
| G03FB08 | dydrogesterone and estrogen |
| G03FB11 | trimegestone and estrogen |
| G03GA03 | serum gonadotrophin |
| G03GA04 | urofollitropin |
| G03HA01 | cyproterone |
| G03XB01 | mifepristone |
| G03XC05 | ospemifene |
| G04 | UROLOGICALS |
| G04BD04 | oxybutynin |
| G04BD10 | darifenacin |
| G04BX17 | sodium salicylate and methenamine |
| G04C | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| G04CA01 | alfuzosin |
| G04CA55 | doxazosin and finasteride |
| G04CB02 | dutasteride |
| H01AC07 | somapacitan |
| H01CB | Somatostatin and analogues |
| H01CC01 | ganirelix |
| H02AA | Mineralocorticoids |
| H02AA01 | aldosterone |
| H02AB02 | dexamethasone |
| H02AB05 | paramethasone |
| H02AB14 | cloprednol |
| H03 | THYROID THERAPY |
| H03A | THYROID PREPARATIONS |
| H03BA | Thiouracils |
| H03BX01 | diiodotyrosine |
| H04AA | Glycogenolytic hormones |
| H05AA | Parathyroid hormones and analogues |
| H05BA01 | calcitonin (salmon synthetic) |
| H05BX03 | doxercalciferol |
| J01 | ANTIBACTERIALS FOR SYSTEMIC USE |
| J01AA10 | penimepicycline |
| J01B | AMPHENICOLS |
| J01CA01 | ampicillin |
| J01CA04 | amoxicillin |
| J01CF03 | meticillin |
| J01CF04 | oxacillin |
| J01CG | Beta-lactamase inhibitors |
| J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors |
| J01CR02 | amoxicillin and beta-lactamase inhibitor |
| J01DB | First-generation cephalosporins |
| J01DC | Second-generation cephalosporins |
| J01DC03 | cefamandole |
| J01DC10 | cefprozil |
| J01DD | Third-generation cephalosporins |
| J01DD08 | cefixime |
| J01DD10 | cefetamet |
| J01DD14 | ceftibuten |
| J01DD16 | cefditoren |
| J01DD52 | ceftazidime and beta-lactamase inhibitor |
| J01DD63 | ceftriaxone and beta-lactamase inhibitor |
| J01DF | Monobactams |
| J01DF01 | aztreonam |
| J01DH | Carbapenems |
| J01DI01 | ceftobiprole medocaril |
| J01EC | Intermediate-acting sulfonamides |
| J01ED | Long-acting sulfonamides |
| J01EE | Combinations of sulfonamides and trimethoprim, incl. derivatives |
| J01FA13 | dirithromycin |
| J01FA14 | flurithromycin |
| J01FG | Streptogramins |
| J01GB12 | arbekacin |
| J01MA01 | ofloxacin |
| J01MA03 | pefloxacin |
| J01MA14 | moxifloxacin |
| J01MA25 | lascufloxacin |
| J01RA01 | penicillins, combinations with other antibacterials |
| J01RA07 | azithromycin, fluconazole and secnidazole |
| J01RA12 | ciprofloxacin and ornidazole |
| J01XB01 | colistin |
| J01XB02 | polymyxin B |
| J01XD01 | metronidazole |
| J01XE01 | nitrofurantoin |
| J01XX02 | xibornol |
| J01XX07 | nitroxoline |
| J02AA | Antibiotics |
| J02AC05 | isavuconazole |
| J04AA03 | calcium aminosalicylate |
| J04AB02 | rifampicin |
| J04AD03 | ethionamide |
| J04AM03 | ethambutol and isoniazid |
| J04BA03 | aldesulfone sodium |
| J05A | DIRECT ACTING ANTIVIRALS |
| J05AB13 | penciclovir |
| J05AB14 | valganciclovir |
| J05AB15 | brivudine |
| J05AE | Protease inhibitors |
| J05AF01 | zidovudine |
| J05AF13 | tenofovir alafenamide |
| J05AP | Antivirals for treatment of HCV infections |
| J05AP07 | daclatasvir |
| J05AP54 | elbasvir and grazoprevir |
| J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat |
| J05AR23 | atazanavir and ritonavir |
| J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir |
| J05AX01 | moroxydine |
| J05AX09 | maraviroc |
| J06BA01 | immunoglobulins, normal human, for extravascular adm. |
| J06BB01 | anti-D (rh) immunoglobulin |
| J06BB05 | rabies immunoglobulin |
| J06BB06 | rubella immunoglobulin |
| J06BB14 | measles immunoglobulin |
| J07AC | Anthrax vaccines |
| J07AG | Haemophilus influenzae B vaccines |
| J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated |
| J07AJ | Pertussis vaccines |
| J07AK | Plague vaccines |
| J07AL02 | pneumococcus, purified polysaccharides antigen conjugated |
| J07AN01 | tuberculosis, live attenuated |
| J07BB | Influenza vaccines |
| J07BB02 | influenza, inactivated, split virus or surface antigen |
| J07BC | Hepatitis vaccines |
| J07BD01 | measles, live attenuated |
| J07BG01 | rabies, inactivated, whole virus |
| J07BH02 | rota virus, pentavalent, live, reassorted |
| J07BL01 | yellow fever, live attenuated |
| J07BX06 | enterovirus 71 vaccines |
| J07CA08 | haemophilus influenzae B and hepatitis B |
| L01A | ALKYLATING AGENTS |
| L01AC02 | triaziquone |
| L01AD | Nitrosoureas |
| L01AD04 | streptozocin |
| L01AG01 | etoglucid |
| L01AX01 | mitobronitol |
| L01B | ANTIMETABOLITES |
| L01BB | Purine analogues |
| L01BC58 | decitabine, combinations |
| L01CA03 | vindesine |
| L01CB01 | etoposide |
| L01DB06 | idarubicin |
| L01DB08 | pirarubicin |
| L01EA | BCR-ABL tyrosine kinase inhibitors |
| L01EA01 | imatinib |
| L01EB09 | lazertinib |
| L01ED01 | crizotinib |
| L01EE | Mitogen-activated protein kinase (MEK) inhibitors |
| L01EE04 | selumetinib |
| L01EF01 | palbociclib |
| L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L01EJ | Janus-associated kinase (JAK) inhibitors |
| L01EJ03 | pacritinib |
| L01EL01 | ibrutinib |
| L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| L01EN04 | futibatinib |
| L01EX19 | ripretinib |
| L01EX25 | umbralisib |
| L01FA | CD20 (Clusters of Differentiation 20) inhibitors |
| L01FB | CD22 (Clusters of Differentiation 22) inhibitors |
| L01FB02 | moxetumomab pasudotox |
| L01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| L01FF06 | cemiplimab |
| L01FF10 | retifanlimab |
| L01FF11 | sugemalimab |
| L01FF12 | serplulimab |
| L01FX01 | edrecolomab |
| L01FX11 | bermekimab |
| L01XD | Sensitizers used in photodynamic/radiation therapy |
| L01XG02 | carfilzomib |
| L01XG03 | ixazomib |
| L01XH01 | vorinostat |
| L01XL | Antineoplastic cell and gene therapy |
| L01XX08 | pentostatin |
| L01XX10 | masoprocol |
| L01XX24 | pegaspargase |
| L01XX35 | anagrelide |
| L01XX40 | omacetaxine mepesuccinate |
| L01XX57 | plitidepsin |
| L01XX59 | enasidenib |
| L01XX75 | tebentafusp |
| L01XY | Combinations of antineoplastic agents |
| L02AA02 | polyestradiol phosphate |
| L02AE51 | leuprorelin and bicalutamide |
| L02BA01 | tamoxifen |
| L02BA04 | elacestrant |
| L02BG01 | aminoglutethimide |
| L02BX01 | abarelix |
| L03AB05 | interferon alfa-2b |
| L03AX11 | tasonermin |
| L03AX19 | dasiprotimut-T |
| L03AX22 | leniolisib |
| L04AA15 | alefacept |
| L04AA24 | abatacept |
| L04AA58 | efgartigimod alfa |
| L04AB07 | opinercept |
| L04AC07 | tocilizumab |
| L04AC11 | siltuximab |
| L04AC12 | brodalumab |
| L04AC15 | sirukumab |
| L04AC23 | olokizumab |
| L04AC25 | levilimab |
| L04AD02 | tacrolimus |
| L04AG05 | vedolizumab |
| L04AG10 | inebilizumab |
| L04AG14 | ublituximab |
| L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L04AH02 | everolimus |
| M01AB01 | indometacin |
| M01AB14 | proglumetacin |
| M01AC | Oxicams |
| M01AC56 | meloxicam, combinations |
| M01AE01 | ibuprofen |
| M01AE04 | fenoprofen |
| M01AE10 | indoprofen |
| M01AE18 | naproxcinod |
| M01AE51 | ibuprofen, combinations |
| M01AG | Fenamates |
| M01AX23 | tenidap |
| M01AX25 | chondroitin sulfate |
| M01AX26 | avocado and soyabean oil, unsaponifiables |
| M01BA01 | phenylbutazone and corticosteroids |
| M02 | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA02 | mofebutazone |
| M02AA25 | aceclofenac |
| M02AA26 | nimesulide |
| M02AA27 | dexketoprofen |
| M02AB02 | zucapsaicin |
| M02AX | Other topical products for joint and muscular pain |
| M03AA01 | alcuronium |
| M03AA02 | tubocurarine |
| M03AC | Other quaternary ammonium compounds |
| M03AC04 | atracurium |
| M03BA52 | carisoprodol, combinations excl. psycholeptics |
| M03BA53 | methocarbamol, combinations excl. psycholeptics |
| M03BA71 | phenprobamate, combinations with psycholeptics |
| M03BB03 | chlorzoxazone |
| M03BX53 | pridinol, combinations |
| M03BX55 | thiocolchicoside, combinations |
| M04AA | Preparations inhibiting uric acid production |
| M04AB03 | benzbromarone |
| M04AC01 | colchicine |
| M04AX | Other antigout preparations |
| M04AX02 | pegloticase |
| M05BA03 | pamidronic acid |
| M05BX06 | romosozumab |
| M09AB02 | collagenase clostridium histolyticum |
| M09AX08 | golodirsen |
| N | NERVOUS SYSTEM |
| N01AA | Ethers |
| N01AB | Halogenated hydrocarbons |
| N01AG01 | narcobarbital |
| N01AH01 | fentanyl |
| N01AH03 | sufentanil |
| N01AH05 | anileridine |
| N01AH51 | fentanyl, combinations |
| N01AX03 | ketamine |
| N01AX04 | propanidid |
| N01BA05 | benzocaine |
| N01BA53 | tetracaine, combinations |
| N01BB06 | cinchocaine |
| N01BB57 | etidocaine, combinations |
| N02AJ17 | oxycodone and paracetamol |
| N02B | OTHER ANALGESICS AND ANTIPYRETICS |
| N02BA01 | acetylsalicylic acid |
| N02BA15 | carbasalate calcium |
| N02BA79 | dipyrocetyl, combinations with psycholeptics |
| N02BB | Pyrazolones |
| N02BF01 | gabapentin |
| N02CB | Corticosteroid derivatives |
| N02CD02 | galcanezumab |
| N02CD07 | atogepant |
| N03A | ANTIEPILEPTICS |
| N03AA02 | phenobarbital |
| N03AC01 | paramethadione |
| N03AC03 | ethadione |
| N03AE01 | clonazepam |
| N03AG | Fatty acid derivatives |
| N03AX03 | sultiame |
| N03AX19 | carisbamate |
| N03AX23 | brivaracetam |
| N04 | ANTI-PARKINSON DRUGS |
| N04AA05 | profenamine |
| N04AA12 | tropatepine |
| N04AB02 | orphenadrine (chloride) |
| N04BA07 | foslevodopa and decarboxylase inhibitor |
| N04BB | Adamantane derivatives |
| N04BD | Monoamine oxidase B inhibitors |
| N04CX01 | istradefylline |
| N05A | ANTIPSYCHOTICS |
| N05AA | Phenothiazines with aliphatic side-chain |
| N05AA04 | acepromazine |
| N05AB04 | prochlorperazine |
| N05AE05 | lurasidone |
| N05AF02 | clopenthixol |
| N05AG02 | pimozide |
| N05AH05 | asenapine |
| N05AL07 | levosulpiride |
| N05AN | Lithium |
| N05AX | Other antipsychotics |
| N05BA06 | lorazepam |
| N05BA12 | alprazolam |
| N05BA13 | halazepam |
| N05BC | Carbamates |
| N05BD | Dibenzo-bicyclo-octadiene derivatives |
| N05CA09 | vinbarbital |
| N05CA15 | methohexital |
| N05CD03 | flunitrazepam |
| N05CD06 | lormetazepam |
| N05CD07 | temazepam |
| N05CD08 | midazolam |
| N05CD13 | cinolazepam |
| N05CD15 | nimetazepam |
| N05CE02 | methyprylon |
| N05CF03 | zaleplon |
| N05CJ03 | daridorexant |
| N06AA | Non-selective monoamine reuptake inhibitors |
| N06AA03 | imipramine oxide |
| N06AA04 | clomipramine |
| N06AA09 | amitriptyline |
| N06AA17 | amoxapine |
| N06AB05 | paroxetine |
| N06AB08 | fluvoxamine |
| N06AX03 | mianserin |
| N06AX06 | nefazodone |
| N06AX22 | agomelatine |
| N06BA01 | amfetamine |
| N06BA08 | fenozolone |
| N06BA12 | lisdexamfetamine |
| N06BX03 | piracetam |
| N06BX22 | phenibut |
| N06DA | Anticholinesterases |
| N06DA52 | donepezil and memantine |
| N06DX02 | Ginkgo folium |
| N07AX02 | choline alfoscerate |
| N07BA | Drugs used in nicotine dependence |
| N07BA03 | varenicline |
| N07CA | Antivertigo preparations |
| N07CA04 | acetylleucine |
| N07XX03 | xaliproden |
| N07XX12 | patisiran |
| P01 | ANTIPROTOZOALS |
| P01A | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES |
| P01AC | Dichloroacetamide derivatives |
| P01AC03 | etofamide |
| P01BB02 | cycloguanil embonate |
| P01BB51 | proguanil and atovaquone |
| P01BB52 | chloroquine and proguanil |
| P01BC | Methanolquinolines |
| P01BE03 | artesunate |
| P01BF03 | artesunate and amodiaquine |
| P01BX | Other antimalarials |
| P01CB02 | sodium stibogluconate |
| P02BB01 | metrifonate |
| P02CE | Imidazothiazole derivatives |
| P02CX02 | bephenium |
| P02CX03 | moxidectin |
| P02DA01 | niclosamide |
| P03 | ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS |
| P03AX | Other ectoparasiticides, incl. scabicides |
| P03BX02 | dimethylphthalate |
| R01AA | Sympathomimetics, plain |
| R01AA07 | xylometazoline |
| R01AB05 | ephedrine |
| R01AC06 | thonzylamine |
| R01AD02 | prednisolone |
| R01AD05 | budesonide |
| R01AD08 | fluticasone |
| R01AD11 | triamcinolone |
| R01AD58 | fluticasone, combinations |
| R01AX01 | calcium hexamine thiocyanate |
| R01AX03 | ipratropium bromide |
| R01AX07 | hexamidine |
| R01BA51 | phenylpropanolamine, combinations |
| R02AA02 | dequalinium |
| R02AA14 | oxyquinoline |
| R02AA16 | benzalkonium |
| R02AB02 | tyrothricin |
| R02AD03 | cocaine |
| R03 | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03AC02 | salbutamol |
| R03AC07 | isoetarine |
| R03AL01 | fenoterol and ipratropium bromide |
| R03AL06 | olodaterol and tiotropium bromide |
| R03AL07 | formoterol and glycopyrronium bromide |
| R03BA03 | flunisolide |
| R03BA09 | fluticasone furoate |
| R03BB | Anticholinergics |
| R03BB02 | oxitropium bromide |
| R03BB06 | glycopyrronium bromide |
| R03DA03 | proxyphylline |
| R03DA11 | doxofylline |
| R03DA51 | diprophylline, combinations |
| R03DB03 | proxyphylline and adrenergics |
| R05CA | Expectorants |
| R05CA03 | guaifenesin |
| R05CA09 | guaiacolsulfonate |
| R05CB11 | stepronin |
| R05DA08 | pholcodine |
| R05DB13 | butamirate |
| R05F | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| R05FA | Opium derivatives and expectorants |
| R05FB | Other cough suppressants and expectorants |
| R06 | ANTIHISTAMINES FOR SYSTEMIC USE |
| R06A | ANTIHISTAMINES FOR SYSTEMIC USE |
| R06AA04 | clemastine |
| R06AA54 | clemastine, combinations |
| R06AB52 | dexchlorpheniramine, combinations |
| R06AC04 | tripelennamine |
| R06AD07 | mequitazine |
| R06AE09 | levocetirizine |
| R06AX13 | loratadine |
| R06AX17 | ketotifen |
| R06AX32 | sequifenadine |
| R07AB01 | doxapram |
| R07AB05 | bemegride |
| R07AB09 | mepixanox |
| R07AB53 | pentetrazol, combinations |
| R07AX | Other respiratory system products |
| R07AX32 | ivacaftor, tezacaftor and elexacaftor |
| S01AA02 | chlortetracycline |
| S01AA11 | gentamicin |
| S01AA27 | cefuroxime |
| S01AA29 | dibekacin |
| S01AB | Sulfonamides |
| S01AD02 | trifluridine |
| S01AE08 | besifloxacin |
| S01AX04 | nitrofural |
| S01AX15 | propamidine |
| S01BA01 | dexamethasone |
| S01BA07 | fluorometholone |
| S01BA12 | formocortal |
| S01BB02 | prednisolone and mydriatics |
| S01BC02 | oxyphenbutazone |
| S01BC06 | piroxicam |
| S01BC08 | salicylic acid |
| S01CB01 | dexamethasone |
| S01CC | Antiinflammatory agents, non-steroids and antiinfectives in combination |
| S01E | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| S01EC02 | diclofenamide |
| S01EC03 | dorzolamide |
| S01ED01 | timolol |
| S01ED04 | metipranolol |
| S01ED06 | befunolol |
| S01EX01 | guanethidine |
| S01EX05 | netarsudil |
| S01FB | Sympathomimetics excl. antiglaucoma preparations |
| S01GA01 | naphazoline |
| S01GA52 | tetryzoline, combinations |
| S01KA51 | hyaluronic acid, combinations |
| S02AA05 | clioquinol |
| S02AA07 | neomycin |
| S02AA15 | ciprofloxacin |
| S02AA17 | fosfomycin |
| S02BA07 | betamethasone |
| S02DC | Indifferent preparations |
| S03AA30 | antiinfectives, combinations |
| S03B | CORTICOSTEROIDS |
| S03CA02 | prednisolone and antiinfectives |
| S03D | OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| V01AA | Allergen extracts |
| V01AA08 | food |
| V01AA20 | various |
| V03AB06 | thiosulfate |
| V03AB17 | methylthioninium chloride |
| V03AB22 | amyl nitrite |
| V03AB54 | pralidoxime and atropine |
| V03AE01 | polystyrene sulfonate |
| V03AE10 | sodium zirconium cyclosilicate |
| V03AF07 | rasburicase |
| V03AF11 | arginine and lysine |
| V03AZ | Nerve depressants |
| V03AZ01 | ethanol |
| V04CA01 | tolbutamide |
| V04CC02 | magnesium sulfate |
| V04CC04 | ceruletide |
| V04CE03 | methacetin (13C) |
| V04CF | Tuberculosis diagnostics |
| V04CG03 | histamine phosphate |
| V04CH | Tests for renal function and ureteral injuries |
| V04CX06 | hexaminolevulinate |
| V04CX11 | lithium chloride |
| V06AA | Low-energy diets |
| V06C | INFANT FORMULAS |
| V06DC02 | fructose |
| V07AT | Cosmetics |
| V08AA08 | iocarmic acid |
| V08AB | Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| V08AB01 | metrizamide |
| V08AB10 | iomeprol |
| V08AC08 | sodium iopodate |
| V08B | X-RAY CONTRAST MEDIA, NON-IODINATED |
| V08CX | Other magnetic resonance imaging contrast media |
| V09AA02 | technetium (99mTc) bicisate |
| V09AX | Other central nervous system diagnostic radiopharmaceuticals |
| V09CX03 | sodium iothalamate (125I) |
| V09DB | Technetium (99mTc), particles and colloids |
| V09DB03 | technetium (99mTc) millimicrospheres |
| V09DX | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
| V09EX01 | krypton (81mKr) gas |
| V09GA01 | technetium (99mTc) sestamibi |
| V09GA02 | technetium (99mTc) tetrofosmin |
| V09GX01 | thallium (201Tl) chloride |
| V09HX01 | gallium (67Ga) citrate |
| V09IA | Technetium (99mTc) compounds |
| V09IA05 | technetium (99mTc) depreotide |
| V09IB01 | indium (111In) pentetreotide |
| V09IX13 | methionine (11C) |
| V09IX15 | copper (64Cu) dotatate |
| V09IX17 | PSMA-1007 (18F) |
| V09XA03 | iodine (131I) human albumin |
| V10AA02 | yttrium (90Y) ferrihydroxide colloid |
| V10BX | Various pain palliation radiopharmaceuticals |
| V10BX03 | rhenium (186Re) etidronic acid |
| V10XA53 | tositumomab/iodine (131I) tositumomab |
| V10XX02 | ibritumomab tiuxetan (90Y) |
| V10XX03 | radium (223Ra) dichloride |
| A01AB25 | oxytetracycline |
| A07F | ANTIDIARRHEAL MICROORGANISMS |
| A10BX01 | guar gum |
| G | GENITO URINARY SYSTEM AND SEX HORMONES |
| L01FA01 | rituximab |
| N05CJ01 | suvorexant |
| N06AA06 | trimipramine |
| N06AX11 | mirtazapine |
| N07XX08 | tafamidis |
| P01BA01 | chloroquine |
| R03BB54 | tiotropium bromide, combinations |
| S01J | DIAGNOSTIC AGENTS |
| V09GA03 | technetium (99mTc) teboroxime |
| V09IX01 | iobenguane (123I) |
| C01BB02 | mexiletine |
| C02LK | Alkaloids, excl. rauwolfia, in combination with diuretics |
| C10AB07 | ronifibrate |
| D06BA02 | sulfathiazole |
| G03CC04 | estrone |
| L01XL11 | lifileucel |
| M01AB05 | diclofenac |
| M03AB | Choline derivatives |
| N06AG03 | toloxatone |
| V08CA05 | mangafodipir |
| B01AB07 | parnaparin |
| C09XA53 | aliskiren and amlodipine |
| J05AX18 | letermovir |
| L01EX04 | vandetanib |
| N02CC01 | sumatriptan |
| N05CD01 | flurazepam |
| A03CA03 | oxyphencyclimine and psycholeptics |
| A07XA51 | albumin tannate, combinations |
| B01AB10 | tinzaparin |
| B05XA15 | potassium lactate |
| C09AA09 | fosinopril |
| H01AC04 | sermorelin |
| L04AJ | Complement inhibitors |
| N02BA67 | magnesium salicylate, combinations excl. psycholeptics |
| N05CF | Benzodiazepine related drugs |
| N07BC05 | levomethadone |
| P03AA | Sulfur containing products |
| R05DB26 | nepinalone |
| B01AC28 | limaprost |
| L01XX58 | epacadostat |
| N01AX05 | alfaxalone |
| N05AC02 | thioridazine |
| N06BA04 | methylphenidate |
| N06CB | Psychostimulants in combination with psycholeptics |
| R05CB10 | combinations |
| R05DB24 | tipepidine |
| V03AF08 | palifermin |
| A03DA02 | pitofenone and analgesics |
| A14A | ANABOLIC STEROIDS |
| A14AA09 | norethandrolone |
| C09BA03 | lisinopril and diuretics |
| D06BB10 | imiquimod |
| D08AK | Mercurial products |
| G03AA02 | quingestanol and ethinylestradiol |
| H03BB01 | carbimazole |
| J04AK01 | pyrazinamide |
| N03AA | Barbiturates and derivatives |
| N05BX03 | etifoxine |
| R01AA13 | tymazoline |
| A05AA05 | ursodoxicoltaurine |
| G01 | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS |
| G02CB06 | terguride |
| G03DC04 | ethisterone |
| G03FA02 | hydroxyprogesterone and estrogen |
| N02CC03 | zolmitriptan |
| R03DX03 | fenspiride |
| S03CA07 | methylprednisolone and antiinfectives |
| A08AB01 | orlistat |
| A10AC04 | insulin lispro |
| A16AB16 | idursulfase beta |
| C02AC05 | moxonidine |
| C02LA | Rauwolfia alkaloids and diuretics in combination |
| D05AX04 | tacalcitol |
| D06AX09 | mupirocin |
| D11AX21 | brimonidine |
| J01RA13 | norfloxacin and tinidazole |
| L01CA02 | vincristine |
| M01AA01 | phenylbutazone |
| M09AX01 | hyaluronic acid |
| N06AX02 | tryptophan |
Generated Narrative: ValueSet
Expansion based on codesystem WHO ATC version2020-05
This value set contains 1,000 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |